<chapter label="CHAPTER 2" id="ch0002"><title><emphasis role="strong">Cardiovascular</emphasis></title>
<sect1 id="ch0002s0022"><title><emphasis role="strong">HYPERTENSION: SEVERE</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Multifactorial</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Complex interactions between the vasculature, kidneys, sympathetic nervous system, baroreceptors, renin-angiotensin-aldosterone system, and insulin resistance</para></listitem></orderedlist>
</listitem>
<listitem><para>Mosaic theory</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Genetic disposition</para></listitem>
<listitem><para>Environmental: dietary Na+/fat intake, trace metals, stress, smoking</para></listitem>
<listitem><para>Anatomical: abnormalities of vascular system</para></listitem>
<listitem><para>Adaptive: e.g., regulation of intracellular Na+ and Ca++ by cell membrane ion pumps</para></listitem>
<listitem><para>Neural: variety of complex nerve mechanisms</para></listitem>
<listitem><para>Endocrine: pheochromocytoma, primary aldosteronism</para></listitem>
<listitem><para>Humoral: varied agents that constrict and dilate blood vessels</para></listitem>
<listitem><para>Hemodynamic: blood volume or viscosity, intrarenal hemodynamics</para></listitem></orderedlist>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Classification and Severity&mdash;(Scordo, 2015; American Heart Association ([AHA], 2014; Scordo &amp; Pickett, 2015; Weber et al, 2014) (American College of Cardiology/American Heart Association [ACC/AHA], 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Normal adult blood pressure (BP)&mdash;less than 120/&lt;80 mm Hg</para></listitem>
<listitem><para>Elevated blood pressure&mdash;120&ndash;129/&lt;80 mm Hg</para></listitem>
<listitem><para>Hypertension stage 1&mdash;systolic blood pressure (SBP) 130&ndash;139 mm Hg or diastolic blood pressure (DBP) 80&ndash;89 mm Hg</para></listitem>
<listitem><para>Hypertension stage 2&mdash;SBP &ge;140 mm Hg or DBP &ge;90 mm Hg</para></listitem>
<listitem><para>Hypertensive crisis&mdash;SBP higher than 180 mm Hg or DBP higher than 120 mm Hg</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Primary (essential), which accounts for approximately 90% to 95% of all cases, has no identifiable cause</para></listitem>
<listitem><para>Secondary hypertension, which accounts for 2% to 10% of all cases, occurs because of an identifiable, sometimes correctable, pathological condition, such as kidney disorders, adrenal gland tumors, or primary aldosteronism; medications; drugs; or other chemicals.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis>&mdash;<emphasis role="strong">(Centers for Disease Control and Prevention [CDC], National Center for Health Statistics, 2015; Davis, 2015; Mozaffarian et al, 2015)</emphasis></para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Between 2013 and 2014, 33.5% of adults ages 20 and over reportedly had hypertension (measured high blood pressure and/or taking antihypertensive medication).</para></listitem>
<listitem><para>Men have a higher prevalence until about age 45; from age 45 to 64 years, the percentages are nearly equal between men and women. Beyond age 64 years, a higher percentage of women have hypertension than men (Mozaffarian et al, 2015).</para></listitem>
<listitem><para>Uncontrolled hypertension occurs in almost half of adults (Davis, 2015).</para></listitem></orderedlist>
</listitem>
<listitem><para>Mortality (CDC, 2015a): High blood pressure was reported as a primary or contributing cause of death for more than 410,000 Americans in 2014.</para></listitem>
<listitem><para>Cost: In 2015, the CDC Vital Statistics Cooperative Program reported that high blood pressure costs the nation $48.6 billion each year (total includes the cost of healthcare services, medications to treat high blood pressure, and missed days of work) (CDC, 2015a).</para></listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0022note0012"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Atrial hypertrophy: </emphasis>Increased atrial volume and pressure.</para>
<para><emphasis role="strong">(DBP): </emphasis>Diastolic blood pressure.</para>
<para><emphasis role="strong">Hypokalemia: </emphasis>Low serum potassium.</para>
<para><emphasis role="strong">Resistant hypertension: </emphasis>Blood pressure remains high despite treatment with different types of blood pressure medications. Some studies suggest that people with resistant hypertension have associated risk factors such as <emphasis role="strong">diabetes</emphasis>, <emphasis role="strong">obstructive sleep apnea</emphasis>, enlargement of the heart chambers, and/or <emphasis role="strong">chronic kidney disease </emphasis>(Beckerman, 2015).</para>
<para><emphasis role="strong">Systemic vascular resistance (SVR): </emphasis>An index of arterial compliance or constriction throughout the body; equal to BP divided by cardiac output.</para>
<para><emphasis role="strong">(SBP): </emphasis>Systolic blood pressure.</para>
<para><emphasis role="strong">Target organ disease or damage (TOD): </emphasis>Organ or system of organs that are primarily affected by hypertension, such as the heart, kidneys, and brain.</para>
</note>
<sect2 id="ch0002s0023"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Although hypertension is usually treated in a community setting, complications or cardiovascular compromise may require inpatient care, especially when target organ disease (TOD) is present. Most interventions included here can be used in either setting.</para>
</sect2>
<sect2 id="ch0002s0024"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0004s0114">Cerebrovascular accident (CVA)/stroke</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0008s0244">Acute kidney injury</link></para>
<para><link linkend="ch0008s0249">Renal failure: Chronic kidney disease</link></para>
<table frame="top" id="ch0002s0022ta0006"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">**CLIENT MAY NOT HAVE REPORTABLE SYMPTOMS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Sedentary lifestyle (major risk factor for hypertension)</para></listitem>
<listitem><para>Weakness, fatigue</para></listitem>
<listitem><para>Shortness of breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Elevated heart rate</para></listitem>
<listitem><para>Change in heart rhythm</para></listitem>
<listitem><para>Tachypnea</para></listitem>
<listitem><para>Dyspnea with exertion</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>History of elevated BP over time</para></listitem>
<listitem><para>Presence of TOD, such as atherosclerotic, valvular, or coronary artery heart disease, including myocardial infarction (MI), angina, heart failure (HF), and cerebrovascular disease</para></listitem>
<listitem><para>Episodes of palpitations, diaphoresis</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Pulses:</emphasis> Bounding carotid, jugular, radial pulsations</para></listitem>
<listitem><para>Pulse disparities, particularly femoral delay as compared with radial or brachial pulsation and absence of or diminished popliteal, posterior tibial, pedal pulses</para></listitem>
<listitem><para><emphasis role="bi">Apical pulse:</emphasis> Point of maximal impulse (PMI) possibly displaced or forceful</para></listitem>
<listitem><para><emphasis role="bi">Heart rate and rhythm:</emphasis> Tachycardia, various dysrhythmias</para></listitem>
<listitem><para><emphasis role="bi">Heart sounds:</emphasis> Accentuated S<subscript>2</subscript> at base; S<subscript>3</subscript> in early HF; S<subscript>4</subscript>, which reflects rigid left ventricle and left ventricular hypertrophy; murmurs of valvular stenosis; vascular bruits audible over carotid, femoral, or epigastrium</para></listitem>
<listitem><para>Jugular vein distension (JVD)</para></listitem>
<listitem><para><emphasis role="bi">Extremities:</emphasis> Discoloration of skin; cool temperature, indicating peripheral vasoconstriction; and slow or delayed capillary refill, indicating vasoconstriction</para></listitem>
<listitem><para><emphasis role="bi">Skin:</emphasis> Pallor, cyanosis, and diaphoresis, suggesting pulmonary congestion and hypoxemia, or flushing, suggesting pheochromocytoma</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Multiple stress factors, such as relationship, financial, or job-related concerns</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Narrowed focus</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Past or present renal insult, such as kidney infection, renovascular obstruction, or history of kidney disease</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May have decreased urinary output, if kidney failure is present, or increased output, if taking diuretics</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Food preferences that are high calorie, high salt, high fat, and high cholesterol, such as fried foods, cheese, eggs, or licorice</para></listitem>
<listitem><para>Low dietary intake of potassium, calcium, and magnesium</para></listitem>
<listitem><para>Nausea, vomiting</para></listitem>
<listitem><para>Recent weight changes</para></listitem>
<listitem><para>Current or history of diuretic use</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Normal weight or obesity. <emphasis>Note:</emphasis> Being overweight is a significant risk factor for hypertension. Obesity and older age are two risk factors especially in clients of older age and resistant hypertension (Davis, 2015).</para></listitem>
<listitem><para>Presence of edema</para></listitem>
<listitem><para>Venous congestion, JVD</para></listitem>
<listitem><para>Glycosuria&mdash;When patients have both hypertension and diabetes, their risk for cardiovascular disease doubles (AHA, 2016a)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of numbness or weakness on one side of the body; transient ischemia attach (TIA) or stroke</para></listitem>
<listitem><para>Fainting spells or dizziness</para></listitem>
<listitem><para>Throbbing, suboccipital headaches, usually present on awakening and disappearing spontaneously after several hours</para></listitem>
<listitem><para>Visual disturbances, such as diplopia and blurred vision</para></listitem>
<listitem><para>Episodes of epistaxis</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Mental status:</emphasis> Changes in alertness, orientation, speech pattern and content, affect, thought process, or memory</para></listitem>
<listitem><para><emphasis role="bi">Motor responses:</emphasis> Decreased strength, hand grip, and deep tendon reflexes</para></listitem>
<listitem><para><emphasis role="bi">Optic retinal changes:</emphasis> From mild sclerosis and arterial narrowing to marked retinal and sclerotic changes with edema or papilledema, exudates, hemorrhage, and arterial nicking, although dependent on severity and duration of hypertension and resulting TOD</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Severe, throbbing occipital headaches located in suboccipital region, present on awakening and disappearing spontaneously after several hours</para></listitem>
<listitem><para>Stiffness of neck, dizziness, and blurred vision</para></listitem>
<listitem><para>Abdominal pain or masses, suggesting pheochromocytoma</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Reluctance to move head, rubbing head, avoidance of bright lights and noise, wrinkled brow, clenched fists; grimacing and guarding behaviors</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dyspnea associated with activity or exertion</para></listitem>
<listitem><para>Tachypnea, orthopnea, paroxysmal nocturnal dyspnea</para></listitem>
<listitem><para>Cough with or without sputum production</para></listitem>
<listitem><para>Smoking history (major risk factor)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Respiratory distress or use of accessory muscles</para></listitem>
<listitem><para>Adventitious breath sounds, such as crackles or wheezes</para></listitem>
<listitem><para>Pallor or cyanosis generally associated with advanced cardiopulmonary effects of sustained or severe hypertension</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Transient episodes of numbness, unilateral paresthesias</para></listitem>
<listitem><para>Lightheadedness with position change</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Impaired coordination or gait</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Postmenopausal (major risk factor)</para></listitem>
<listitem><para>Erectile dysfunction (ED), which may be associated with hypertension or antihypertensive medications</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Familial risk factors, including hypertension, atherosclerosis, heart disease, diabetes mellitus, and cerebrovascular or kidney disease</para></listitem>
<listitem><para>Ethnic or racial risk factors, such as increased prevalence in African American and Southeast Asian populations</para></listitem>
<listitem><para>Use of birth control pills or other hormone replacement therapy</para></listitem>
<listitem><para>Drug and alcohol use</para></listitem>
<listitem><para>Use of herbal supplements to manage BP, such as garlic, hawthorn, black cohash, celery seed, coleus, and evening primrose</para></listitem>
</itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with self-monitoring of BP as well as periodic evaluation of and alterations in medication therapy</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject>Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0022ta0007"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN) and creatinine (Cr):</emphasis> BUN measures the amount of urea nitrogen in the blood. Cr measures the amount of creatinine in blood or urine.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about renal perfusion and function and can reveal cause if hypertension is related to kidney dysfunction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Glucose:</emphasis> Measures the amount of glucose in the blood at the time of sample collection.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyperglycemia may result from elevated catecholamine levels and insulin resistance, which increases BP.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum potassium:</emphasis> Potassium is an electrolyte that helps regulate the amount of fluid in the body, stimulate muscle contraction, and maintain a stable acid-base balance.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypokalemia may indicate the presence of primary aldosteronism as a possible cause of hypertension or it may be a side effect of diuretic therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Lipid panel, including total lipids, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, total cholesterol, triglycerides:</emphasis> The group of tests that make up a lipid profile has been shown to be good indicators of risk for heart attack or stroke.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A predisposition for or presence of atheromatous plaque is indicated by the following: HDL levels that are less than 40 mg/dL in men and less than 50 mg/dL in women, triglycerides that are more than 150 mg/dL, and an increase in small-particle LDL. One recent study reported a strong association of hypertension with elevated cholesterols, well as insulin resistance in hypothyroid adults (Purohit &amp; Mathur, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Thyroid studies:</emphasis> Blood test and scan to evaluate thyroid function; most commonly used laboratory test is the measurement of thyroid-stimulating hormone (TSH).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypothyroidism and triiodothyronine (T3) deficiency have been found to be associated with peripheral vasoconstriction, which is also associated with hypertension (Stabouli et al, 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum/urine aldosterone level:</emphasis> May be done to assess for primary aldosteronism as cause of hypertension.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated in primary aldosteronism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Renin:</emphasis> An enzyme that activates the renin-angiotensin system and screens for essential, renal, or renovascular hypertension.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated in renovascular and malignant hypertension and salt-wasting disorders.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">C-reactive protein (CRP):</emphasis> A member of the class of acute phase reactants. Serum levels rise dramatically during inflammatory processes occurring in the body.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>CRP is an indicator of vascular inflammation and can indicate athlerosclerotic disease that causes renal artery disease and hypertension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart that can demonstrate conduction disturbances, enlarged heart, and chamber strain patterns.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Broad, notched P wave is one of the earliest signs of hypertensive heart disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Kidney and renography nuclear scan (also called renogram):</emphasis> Assists in diagnosing renal disorders.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines if hypertension is due to kidney disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urine creatinine clearance:</emphasis> Determines extent of nephron damage in known kidney disease.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduced in hypertensive patient with renal damage.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Uric acid:</emphasis> Measures end-product of purine metabolism, providing one index of renal function.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Hyperuricemia has been implicated as a risk factor for the development of hypertension.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0025"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain or enhance cardiovascular functioning.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment regimen.</para></listitem>
<listitem><para>Support active client control of condition.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0026"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>BP within acceptable limits for individual.</para></listitem>
<listitem><para>Cardiovascular and systemic complications prevented or minimized.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Necessary lifestyle or behavioral changes initiated.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0002s0022note0013"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Risk Factors May Include</emphasis></para>
<para>Altered afterload [e.g., increased systemic vascular resistance]</para>
<para>Altered contractility [e.g., ventricular hypertrophy or rigidity; myocardial ischemia]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>(Not applicable; presence of signs and symptoms establishes an <emphasis>actual</emphasis> diagnosis)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Circulation Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain BP within individually acceptable range.</para>
<para>Demonstrate stable cardiac rhythm and rate within normal range.</para>
<para>Participate in activities that reduce BP and cardiac workload.</para>
</note>
<note role="none" id="ch0002s0022note0014"><table frame="top" id="ch0002s0022ta0008"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hypertension Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Measure BP in both arms. Take three readings, 3 to 5 minutes apart while client is at rest, then sitting, and then standing for initial evaluation. Use correct cuff size and accurate technique. Take note of elevations in systolic as well as diastolic readings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serial measurements using correct equipment provide a more complete picture of vascular involvement and scope of problem. Progressive diastolic readings above 120 mm Hg are considered first accelerated, then malignant (very severe). Systolic hypertension also is an established risk factor for cerebrovascular disease and ischemic heart disease even when diastolic pressure is not elevated. In younger client with normal systolic readings, elevated diastolic numbers may indicate prehypertension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note presence and quality of central and peripheral pulses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bounding carotid, jugular, radial, and femoral pulses may be observed and palpated. Pulses in the legs and feet may be diminished, reflecting effects of vasoconstriction and venous congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate heart tones and breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>S<subscript>4</subscript> is commonly heard in severely hypertensive clients because of the presence of atrial hypertrophy. Development of S<subscript>3</subscript> indicates ventricular hypertrophy and impaired cardiac functioning. Presence of crackles or wheezes may indicate pulmonary congestion secondary to developing or chronic heart failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe skin color, moisture, temperature, and capillary refill time.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of pallor; cool, moist skin; and delayed capillary refill time may be due to peripheral vasoconstriction or reflect cardiac decompensation and decreased output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for dependent and generalized edema.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate onset of heart or kidney failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide calm, restful surroundings, minimize environmental activity and noise. Consider limiting the number of visitors or length of visitation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps reduce sympathetic stimulation and promotes relaxation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain activity restrictions (such as bedrest or chair rest) during crisis situation and schedule periods of uninterrupted rest; assist client with self-care activities as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces physical stress and tension that affect BP and the course of hypertension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide comfort measures, such as back and neck massage or elevation of head.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases discomfort and may reduce sympathetic stimulation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct in relaxation techniques, guided imagery, and distractions, if client is interested and able to participate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can reduce stressful stimuli and produce calming effect, thereby reducing BP.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor response to medications that control BP.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Response to drug therapy is dependent on both the individual drugs and their synergistic effects. Because of potential side effects and drug interactions, it is important to use the smallest number and lowest dosage of medications possible.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications as indicated.</para></entry>
<entry rowsep="0" morerows="1" colsep="0" valign="top">
<para>ACEIs may be first-line drugs in early hypertension treatment and are considered first-line drugs for clients with documented congestive heart failure (CHF), diabetes, and those at risk for renal failure (Davis, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="6" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angiotensin-converting enzyme inhibitors (ACEIs), such as enalapril (Vasotec), fosinopril (Monopril), trandolapril (Mavik), diovan (Teveten)</para></entry>
</row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angiotensin II receptor blockers (ARBs), such as candesartan (Atacand), valsartan (Diovan), losartan (Cozaar), and irbesartan (Avapro)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ARBs block the action of angiotensin II. As a result, blood vessels dilate and BP is reduced. <emphasis>Note:</emphasis> For people of African or Caribbean family origin, an ARB may be preferred over an ACEI in combination with a CCB (from 2011 guidelines per Davis, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calcium channel blockers (CCBs), such as nifedipine (Adalat), diltiazem (Cardizem), amlodipine (Norvasc), nicardipine (Cardene)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calcium channel blockers work by slowing the movement of calcium into the cells of the heart and blood vessel walls, which makes it easier for the heart to pump and widens blood vessels. As a result, the heart doesn&rsquo;t have to work as hard, and blood pressure lowers. Can be used to treat hypertension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretics, for example, thiazide (e.g., bendroflumethiazide [Naturetin], hydrochlorothiazide [HCTZ]) or thiazide-like diuretics (e.g., chlortalidone [Thalidone]; indapamide [Lozal]) and loop diuretics, such as furosemide (Lasix), bumetanide (Bumex)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretics may be offered for uncomplicated hypertension and may be used alone or in association with other drugs to reduce BP in clients with relatively normal renal function. <emphasis>Note:</emphasis> Loop diuretics are less commonly used for routine treatment of hypertension but are especially useful in the presence of edema associated with congestive heart failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers, such as acebutolol (Sectral), atenolol (Tenormin), metoprolol (Lopressor), bisoprolol (Zibeta), nadolol (Corgard), carvedilol (Coreg), propranolol (Inderal), labetalol (Tandate), timolol (Blocarden)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers are not a preferred initial therapy for hypertension but may be considered in appropriate populations, such as those with an intolerance or contraindication to ACEIs and ARBs; women of childbearing potential; and clients with heart failure and cardiovascular disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Combination drugs, such as amlodipine and benazepril (Lotrel), hydralazine and hydrochlorothiazide (Vaseretic), nadolol and bendroflumethiazide (Corzide), hydralazine and hydrochlorothiazide (Apresazide)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Combination treatment means another class of blood pressure medication is added as a drug in order to increase treatment effectiveness. This is sometimes referred to as &ldquo;stepped&rdquo; therapy. There are also combination antihypertensives such as beta blockers and diuretics: ACEIs and ARBs or diuretics, etc. <emphasis>Note:</emphasis> Studies show that many people obtain better blood pressure control with combination treatment than with one drug (Beckerman, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Direct-acting parenteral vasodilators, such as diazoxide (Hyperstat), nitroprusside (Nitropress), and labetalol (Normodyne)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These are given intravenously (IV) for management of hypertensive emergencies.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Implement dietary restrictions, as indicated, such as reducing sodium and calories, and avoiding refined carbohydrates, high-fat foods, and highly processed foods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Limiting sodium and sodium-rich processed foods can help manage fluid retention and, with associated hypertensive response, decrease myocardial workload. A balanced diet lower in calories, fat, and sodium and rich in calcium, potassium, and magnesium may help lower BP.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for surgery when indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>When hypertension is due to pheochromocytoma, removing the tumor corrects the condition.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0022note0015"><title><emphasis role="strong">NURSING DIAGNOSIS: Activity Intolerance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Generalized weakness</para>
<para>Imbalance between oxygen supply and demand</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports fatigue; feeling weak</para>
<para>Abnormal heart rate or BP response to activity</para>
<para>Exertional discomfort or dyspnea</para>
<para>ECG changes reflecting ischemia, arrhythmias</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Endurance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in necessary and desired activities.</para>
<para>Report a measurable increase in activity tolerance.</para>
<para>Demonstrate a decrease in physiological signs of intolerance.</para>
</note>
<note role="none" id="ch0002s0022note0016"><table frame="top" id="ch0002s0022ta0009"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Energy Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess the client&rsquo;s response to activity, noting pulse rate more than 20 beats per minute faster than resting rate; marked increase in BP (systolic increases more than 40 mm Hg or diastolic increases more than 20 mm Hg) during and after activity, dyspnea or chest pain, excessive fatigue and weakness, and diaphoresis, dizziness, and syncope.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in baseline are helpful in assessing physiological responses to the stress of activity and, if present, are indicators of overexertion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client in energy-conserving techniques, such as using chair when showering, sitting to brush teeth or comb hair, and carrying out activities at a slower pace.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Energy-saving techniques reduce the energy expenditure, thereby assisting in equalization of oxygen supply and demand.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Encourage progressive activity and self-care when tolerated. Provide assistance as needed.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Gradual activity progression prevents a sudden increase in cardiac workload. Provide assistance only as needed, which encourages independence in performing activities.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0022note0017"><title><emphasis role="strong">NURSING DIAGNOSIS: Acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Physical agent [increased cerebral vascular pressure]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbal/coded report</para>
<para>Positioning to avoid pain</para>
<para>Self-focus</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report pain or discomfort is relieved or controlled.</para>
<para>Verbalize methods that provide relief.</para>
<para>Follow prescribed pharmacological regimen.</para>
</note>
<note role="none" id="ch0002s0022note0018"><table frame="top" id="ch0002s0022ta0010"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine specifics of pain&mdash;location (e.g., suboccipital region), characteristics (e.g., throbbing, neck stiffness, blurred vision), intensity (0 to 10, or similar scale), onset (e.g., present on awakening), and duration (e.g., disappears spontaneously after being up and about). Note nonverbal cues (e.g., reluctance to move head, rubbing head, avoidance of bright lights/noise).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates diagnosis of problem and initiation of appropriate therapy. Helpful in evaluating effectiveness of therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage and maintain bedrest during acute phase, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes stimulation and promotes relaxation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide or recommend nonpharmacological measures for relief of headache, such as placing a cool cloth to forehead; back and neck rubs; quiet, dimly lit room; relaxation techniques, such as guided imagery and distraction; and diversional activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measures that reduce cerebral vascular pressure and that slow or block sympathetic response are effective in relieving headache and associated complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Eliminate or minimize vasoconstricting activities that may aggravate headache, such as straining at stool, prolonged coughing, and bending over.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Activities that increase vasoconstriction accentuate the headache in the presence of increased cerebral vascular pressure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client with ambulation, as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dizziness and blurred vision frequently are associated with vascular headache. Client may also experience episodes of postural hypotension, causing weakness when ambulating.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer analgesics, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduce or control pain and decrease stimulation of the sympathetic nervous system.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer antianxiety agents, such as lorazepam (Ativan), alprazolam (Xanax), and diazepam (Valium).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May aid in the reduction of tension and discomfort that is intensified by stress.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0022note0019"><title><emphasis role="strong">NURSING DIAGNOSIS: Overweight</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Energy expenditure below energy intake based on standard assessment</para>
<para>Portion sizes larger than recommended</para>
<para>High frequency of restaurant or fried foods</para>
<para>Average daily physical activity is less than recommended for gender and age</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Adult BMI greater than 25 kg/m<superscript>2</superscript></para>
<para>Sedentary lifestyle</para>
<para>Dysfunctional eating patterns</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Treatment Regimen</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify correlation between hypertension and obesity.</para>
<para><emphasis role="strong">Weight-Loss Behavior</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate appropriate changes in lifestyle and behaviors, including eating patterns, food quantity and quality, to attain desirable body weight with optimal maintenance of health.</para>
<para>Initiate and maintain individually appropriate exercise program.</para>
</note>
<note role="none" id="ch0002s0022note0020"><table frame="top" id="ch0002s0022ta0011"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Weight-Reduction Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess client&rsquo;s understanding of direct relationship between hypertension and obesity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obesity is an added risk with hypertension because of the disproportion between fixed aortic capacity and increased cardiac output associated with increased body mass. Reduction in weight may reduce or eliminate the need for drug therapy needed to control BP. <emphasis>Note:</emphasis> Research suggests that losing just 10 pounds can help lower blood pressure 8 to 15 points (Mayo Clinic Staff, 2015a).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss necessity for decreased caloric intake and limited intake of fats, salt, and sugar, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Faulty eating habits contribute to atherosclerosis and obesity that can predispose to hypertension and subsequent complications, such as stroke, kidney disease, and heart failure. Excessive salt intake expands the intravascular fluid volume and may damage kidneys, which can further aggravate hypertension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s desire to lose weight.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Motivation for weight reduction is internal. The individual must want to lose weight or the program most likely will not succeed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review usual daily caloric intake and dietary choices.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies current strengths and weaknesses in dietary program. Aids in determining individual need for adjustment and teaching.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish a realistic weight-reduction plan with the client, such as weight loss of 1 to 2 pounds per week.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Slow reduction in weight is associated with fat loss with muscle sparing and generally reflects a change in eating habits.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to maintain a diary of food intake, including when and where eating takes place and the circumstances and feelings around which the food was eaten.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides a database for both the adequacy of nutrients eaten and the relationship of emotion to eating. Helps focus attention on factors that client can control or change.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct and assist client in appropriate food selections, such as implementing a diet rich in fruits, vegetables, and low-fat dairy foods referred to as the Dietary Approaches to Stop Hypertension (DASH) diet. Help the client identify&mdash;and thus avoid&mdash;foods high in saturated fat, such as butter, cheese, eggs, ice cream, and meat, and those that are high in cholesterol, such as whole dairy products, shrimp, and organ meats.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Moderation and use of low-fat products in place of total abstinence from certain food items may prevent client&rsquo;s sense of deprivation and enhance commitment to achieving health goals. Avoiding foods high in saturated fat and cholesterol is important in preventing progressing atherogenesis. The DASH diet, in conjunction with exercise, weight loss, and limits on salt intake, may reduce or even eliminate the need for drug therapy in early stages of hypertension (Mayo Clinic Staff, 2015a).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to dietitian or weight management programs, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Can provide additional counseling and assistance with meeting individual dietary needs.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0022note0021"><title><emphasis role="strong">NURSING DIAGNOSIS: Ineffective Coping</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Situational crisis</para>
<para>Insufficient sense of control</para>
<para>Inadequate resources</para>
<para>Ineffective tension release strategies</para>
<para>Inadequate level of confidence in ability to cope</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports inability to deal with situation or ask for help</para>
<para>Ineffective coping strategies</para>
<para>Inadequate problem-solving</para>
<para>Destructive behavior toward self [overeating/smoking/failing to take medications], or use of forms of coping that impedes adaptive behavior</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Coping</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify ineffective coping behaviors and consequences.</para>
<para>Verbalize awareness of own coping abilities and strengths.</para>
<para>Identify potential stressful situations and steps to avoid or modify them.</para>
<para>Meet psychological needs, as evidenced by identification of options and use of resources.</para>
</note>
<note role="none" id="ch0002s0022note0022"><table frame="top" id="ch0002s0022ta0012"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Coping Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess effectiveness of coping strategies by observing behaviors, such as ability to verbalize feelings and concerns, and willingness to participate in the treatment plan.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adaptive mechanisms are necessary to appropriately alter one&rsquo;s lifestyle, deal with the chronicity of hypertension, and integrate prescribed therapies into daily living.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note reports of sleep disturbances, increasing fatigue, impaired concentration, irritability, decreased tolerance of headache, and inability to cope or problem-solve.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Manifestations of maladaptive coping mechanisms may be indicators of repressed anger and may contribute to hypertension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client to identify specific stressors and possible strategies for coping with them.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recognition of stressors is often the first step in altering one&rsquo;s response to the stressor.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Include client in planning of care and encourage maximum participation in treatment plan and with the multidisciplinary team.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involvement provides client with an ongoing sense of control, improves coping skills, and enhances commitment to achieving health goals. Ongoing intensive assessment and management by a team can promote timely adjustments to therapeutic regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to evaluate life priorities and personal goals. Ask questions such as, &ldquo;Is what you are doing getting you what you want?&rdquo;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Focuses client&rsquo;s attention on reality of present situation relative to client&rsquo;s goals. Strong work ethic, need for &ldquo;control,&rdquo; and outward focus may have led to lack of attention to personal needs.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Assist client to identify and begin planning for necessary lifestyle changes. Assist to adjust, rather than abandon, personal and family goals.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Necessary changes should be realistically prioritized so client can avoid being overwhelmed and feeling powerless.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0022note0023"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity of healthcare system or therapeutic regimen</para>
<para>Economically disadvantaged</para>
<para>Perceived seriousness of condition, susceptibility, benefit, or barrier</para>
<para>Insufficient knowledge of therapeutic regimen</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Failure to take action to reduce risk factors</para>
<para>Failure to include treatment regimen in daily living</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Health-Promoting Behavior</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process and need and desire to change actions to achieve agreed-upon health goals.</para>
<para>Demonstrate behaviors and changes in lifestyle necessary to maintain therapeutic regimen.</para>
<para>Identify drug side effects and possible complications that necessitate medical attention.</para>
<para>Maintain BP within individually acceptable parameters.</para>
<para>Describe reasons for therapeutic actions and treatment regimen.</para>
</note>
<note role="none" id="ch0002s0022note0024"><table frame="top" id="ch0002s0022ta0013"><title/>
<tgroup colsep="0" rowsep="0" cols="4">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<colspec colnum="4" colname="4" align="left" colsep="0"/>
<spanspec spanname="1-3" namest="1" nameend="3"/>
<spanspec spanname="2-3" namest="2" nameend="3"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-3">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Assist client in identifying modifiable risk factors, such as obesity; diet high in sodium, saturated fats, and cholesterol; sedentary lifestyle; smoking; alcohol intake of more than two ounces per day on a regular basis; and a stressful lifestyle.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These risk factors contribute to hypertension and cardiovascular and renal disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Problem-solve with client to identify ways in which appropriate lifestyle changes can be made to reduce modifiable risk factors.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changing &ldquo;comfortable or usual&rdquo; behavior patterns can be very difficult and stressful. Support, guidance, and empathy can enhance client&rsquo;s success in accomplishing his or her health goals.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Discuss importance of eliminating smoking and assist client in formulating a plan to quit smoking. Refer to smoking cessation program or healthcare provider for helpful medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nicotine increases catecholamine discharge, resulting in increased heart rate, BP, vasoconstriction, and myocardial workload, and reduces tissue oxygenation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Reinforce the importance of adhering to treatment regimen and keeping follow-up appointments.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lack of engagement in the treatment plan is a common reason for failure of antihypertensive therapy. Therefore, ongoing evaluation for client participation is critical to successful treatment. When client understands causative factors and consequences of inadequate intervention and is motivated to achieve health, the client typically participates in treatment interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Instruct in and demonstrate BP self-monitoring technique, if needed. Observe client/significant other (SO) return demonstration. Evaluate client&rsquo;s hearing, visual acuity, manual dexterity, and coordination.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitoring BP at home is reassuring to client because it provides visual feedback to determine treatment outcomes and helps promote early detection of deleterious changes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Help client develop a simple, convenient schedule for taking medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individualizing schedule to fit client&rsquo;s personal habits may make it easier to get in the habit of including antihypertensives in healthcare management activities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Explain prescribed medications along with their rationale, dosage, and expected and adverse side effects, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adequate information and understanding about side effects can enhance client&rsquo;s commitment to the treatment plan. For instance, mood changes, initial weight gain, and dry mouth are common and often subside with time.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Diuretics:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="7" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Take daily or larger dose in the early morning.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Scheduling doses early in the day minimizes nighttime urination.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh self on a regular schedule and record.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Primary indicator of effectiveness of diuretic therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Avoid or limit alcohol intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The combined vasodilating effect of alcohol and the volume-depleting effect of a diuretic greatly increase the risk of orthostatic hypotension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Notify physician if unable to tolerate food or fluid.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dehydration can develop rapidly if intake is poor and client continues to take a diuretic</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Antihypertensives:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Take prescribed dose on a regular schedule; avoid skipping, altering, or making up doses; and do not discontinue without notifying the healthcare provider. Review potential side effects and drug interactions, and discuss need for informing healthcare provider about onset of adverse effects such as erectile dysfunction (ED).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because clients often cannot feel the difference the medication is making in BP, it is critical that there be understanding about the medication&rsquo;s actions and side effects. For example, abruptly discontinuing a drug may cause rebound hypertension, leading to severe complications, or medication may need to be altered to reduce adverse effects. <emphasis>Note: </emphasis>Many drugs used to treat hypertension have been linked to ED. Drugs may need to be changed or dose adjusted.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Rise slowly from a lying to standing position, sitting for a few minutes before standing. Sleep with the head slightly elevated. Suggest frequent position changes and leg exercises when lying down.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measures reduce potential for orthostatic hypotension associated with the use of vasodilators and diuretics.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend avoiding hot baths, steam rooms, and saunas, especially with concomitant use of alcoholic beverages.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents vasodilation with potential for dangerous side effects of syncope and hypotension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Instruct client to consult healthcare provider before taking other prescription or over-the-counter (OTC) medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Any drug that contains a sympathetic nervous stimulant may increase BP or counteract effects of antihypertensive medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Instruct client, as indicated, about increasing intake of foods and fluids high in potassium, such as oranges, bananas, figs, dates, tomatoes, potatoes, raisins, apricots, Gatorade, and fruit juices, and foods and fluids high in calcium, such as low-fat milk, yogurt, or calcium supplements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some diuretics can deplete potassium levels. Dietary potassium is a desirable means of correcting deficits and may be more palatable to the client than drug supplements. Correcting mineral deficiencies can also affect BP.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Review the signs and symptoms that require the client to notify the healthcare provider, such as headache present on awakening that does not abate; sudden and continued increase of BP; chest pain; shortness of breath; irregular or increased pulse rate; significant weight gain (2 lb/d or 5 lb/wk); peripheral or abdominal swelling; visual disturbances; frequent, uncontrollable nosebleeds; depression or emotional lability; severe dizziness or episodes of fainting; muscle weakness or cramping; nausea or vomiting; or excessive thirst.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection and reporting of developing complications, decreased effectiveness of drug regimen, or adverse reactions allow for timely intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Explain rationale for prescribed dietary regimen&mdash;usually a diet low in sodium, saturated fat, and cholesterol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excess saturated fats, cholesterol, sodium, alcohol, and calories have been defined as nutritional risks in hypertension. A diet low in fat and high in polyunsaturated fat reduces BP, possibly through prostaglandin balance in both normotensive and hypertensive people.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Help client identify sources of sodium intake, such as table salt, salty snacks, processed meats and cheeses, sauerkraut, sauces, canned soups and vegetables, baking soda, baking powder, and monosodium glutamate. Emphasize the importance of reading ingredient labels of foods and OTC drugs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A moderately low-salt diet may be sufficient to control mild hypertension or reduce or eliminate the need for drug therapy to control BP.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Encourage foods rich in essential fatty acids, such as salmon, cod, mackerel, and tuna.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Omega-3 fatty acids in fish tend to relax artery walls, reducing blood pressure. They also make blood thinner and less likely to clot.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Encourage client to establish a regular exercise program, incorporating aerobic exercise within client&rsquo;s capabilities. Stress the importance of avoiding isometric activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Besides helping to lower BP, aerobic activity aids in toning the cardiovascular system. Isometric exercise can increase serum catecholamine levels, further elevating BP.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Demonstrate application of ice pack to the back of the neck and pressure over the distal third of nose, and recommend that client lean head forward if nosebleed occurs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nasal capillaries may rupture as a result of excessive vascular pressure. Cold temperature and pressure constrict capillaries to slow or halt bleeding. Leaning forward reduces the amount of blood that is swallowed.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Provide information regarding community resources, and support client in making lifestyle changes. Initiate referrals, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Community resources, such as the American Heart Association, &ldquo;coronary clubs,&rdquo; stop smoking clinics, alcohol or drug rehabilitation, weight-loss programs, stress management classes, and counseling services, may be helpful in client&rsquo;s efforts to initiate and maintain lifestyle changes.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0022note0025"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for Activity Intolerance</emphasis>&mdash;risk for circulatory problem or respiratory condition, physical deconditioning, age</para></listitem>
<listitem><para><emphasis role="bi">Overweight</emphasis>&mdash;energy expenditure below energy intake based on standard assessment, portion sizes larger than recommended, average daily physical activity is less than recommended for gender and age</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, perceived seriousness</para></listitem>
<listitem><para><emphasis role="bi">Sexual Dysfunction</emphasis>&mdash;altered body function (activity intolerance, side effects of medications)</para></listitem>
<listitem><para><emphasis role="bi">readiness for enhanced family Coping</emphasis>&mdash;SO(s) moves in direction of health promotion</para></listitem></itemizedlist></note>
</sect2></sect1>
<sect1 id="ch0002s0027"><title><emphasis role="strong">HEART FAILURE: CHRONIC</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Remodeling of the myocardium (as a structural response to injury) changes the heart from an efficient football shape to an inefficient basketball shape, making coordinated contractility difficult.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Ventricular dilation (systolic dysfunction) results in poor contractility and inadequate emptying of chamber.</para></listitem>
<listitem><para>Ventricular stiffening (diastolic dysfunction) impairs ability of chamber to relax and receive and eject blood.</para></listitem></orderedlist>
</listitem>
<listitem><para>Failure of the left and/or right chambers of the heart results in insufficient output to meet metabolic needs of organ and tissues.</para></listitem>
<listitem><para>Cardiac-related elevation of pulmonary or systemic venous pressures leads to organ congestion.</para></listitem>
<listitem><para>Backward heart failure (HF): Passive engorgement of the veins caused by elevated systemic venous pressure or a &ldquo;backward&rdquo; rise in pressure proximal to the failing cardiac chambers (right ventricular failure).</para></listitem>
<listitem><para>Forward HF: Decreased cardiac output with reduced forward flow into the aorta, systemic circulation (inadequate renal blood flow leads to sodium and water retention), and increasing pulmonary venous pressure results in fluid accumulation in alveoli (left ventricular failure).</para></listitem>
<listitem><para>Myocardial muscle dysfunction associated with left ventricular hypertrophy (LVH) causes decreased cardiac output, activating neurohormones.</para></listitem>
<listitem><para>Elevated circulating or tissue levels of neurohormones, norepinephrine, angiotensin II, aldosterone, endothelin, vasopressin, and cytokines cause sodium retention and peripheral vasoconstriction, increasing hemodynamic stresses on the ventricle.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Classification</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Stages (American College of Cardiology/American Heart Association [ACC/AHA], 2013; Oberg &amp; Guarneri, 2016). Guidelines include specific recommendations for each stage.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Stage A&mdash;high risk for HF associated with such conditions as hypertension, diabetes, and obesity. Treatment is focused on comorbidities and reduction of cardiotoxic agents (e.g., tobacco/other drug use).</para></listitem>
<listitem><para>Stage B&mdash;presence of structural heart disease, causing damage, such as LVH or previous myocardial infarction (MI), but is asymptomatic. Treatment is focused on retarding the progression of ventricular remodeling and delaying the onset of HF symptoms.</para></listitem>
<listitem><para>Stage C&mdash;clients with past or current HF symptoms associated with structural heart disease and damage, such as advanced ventricular remodeling. Treatment is focused on modifying fluid and dietary intake and drug therapies as well as nonpharmacological measures, such as biventricular pacing and valvular or revascularization surgery, to improve left ventricular function and client&rsquo;s functional abilities.</para></listitem>
<listitem><para>Stage D&mdash;refractory advanced HF symptoms at rest or with minimal exertion and frequently requiring intervention in the acute setting. Treatment is focused on promoting clinical stability, including supportive therapy to sustain life, such as left ventricular assist device, continuous intravenous (IV) inotropic therapy, experimental surgery or drugs, a heart transplant, or end-of-life or hospice care.</para></listitem></orderedlist>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Multifactorial</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Complex clinical syndrome resulting from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood (ACC/AHA, 2013).</para></listitem>
<listitem><para>Risk factors and comorbidities&mdash;hypertension; obesity; diabetes; coronary artery disease (CAD); peripheral and cerebrovascular disease; valvular heart disease with onset of atrial fibrillation (AF); sleep disorders such as sleep apnea; history of exposure to cardiotoxins, for example, chemotherapy, alcohol, and cocaine; family history of cardiomyopathy.</para></listitem></orderedlist>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: 5.7 million Americans have HF (American Heart Association [AHA] Statistical Update, 2016).</para></listitem>
<listitem><para>Mortality: The number of any-mention deaths attributable to HF in the United States in 2013 was approximately 300,000 (American Heart Association News, 2015).</para></listitem>
<listitem><para>Cost: Direct and indirect costs estimated to be $30.7 billion annually in 2012 (AHA, 2015a).</para></listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0027note0026"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Angiotensin-converting enzyme inhibitor (ACEI) (also called ACE inhibitor): </emphasis>Medication that blocks the action of the angiotensin-converting enzyme in the lungs so that angiotensin I is not converted into angiotensin II. The production of this powerful blood vessel constrictor is thereby prevented and blood vessels remain dilated, which results in lower blood pressure.</para>
<para><emphasis role="strong">Angiotensin receptor blocker (ARB): </emphasis>Medication that blocks the chemical receptors for angiotensin II on the small arteries. Therefore, the angiotensin cannot cause these arteries to constrict, which lowers blood pressure.</para>
<para><emphasis role="strong">Ascites: </emphasis>Accumulation of fluid in the abdominal cavity can be associated with increased blood pressure in the veins draining the liver, with impaired drainage in the lymph system, and with low levels of albumin and other proteins in the blood.</para>
<para><emphasis role="strong">Bendopnea: </emphasis>Shortness of breath that occurs while bending over at the waist. Phrase coined by researchers in a Texas study that found this symptom in individuals with advanced forms of heart failure. The presence of bendopnea was more commonly experienced by those who had significant fluid retention, as well as elevated cardiac pressures (Thibodeau et al, 2014).</para>
<para><emphasis role="strong">Cardiac remodeling: </emphasis>The left ventricular chamber dilates and becomes more spherical. This condition increases the stress on the myocardial walls and depresses cardiac performance. Remodeling often precedes symptoms and may contribute to worsening of symptoms despite treatment (Paul &amp; Hice, 2014).</para>
<para><emphasis role="strong">Heart failure (HF): </emphasis>A clinical syndrome characterized by inadequate systemic perfusion to meet the body&rsquo;s metabolic demands because of impaired cardiac pump function owing to a weakened or thickened heart muscle. Heart failure may be left-sided (systolic) or right-sided (diastolic) (Oberg &amp; Guarneri, 2016).</para>
<para><emphasis role="strong">Heart sounds: </emphasis>S<subscript>1</subscript> corresponds to the closure of mitral and tricuspid valves. S<subscript>2</subscript> corresponds to closure of the aortic and pulmonary valves. S<subscript>3</subscript>, heard mid-diastolic at the apex, is a low-pitched gallop or blowing sound sometimes called a ventricular gallop and is a common sign of left ventricular failure or distension in adults.</para>
<para><emphasis role="strong">Positive hepatojugular reflex: </emphasis>An elevation of venous pressure, visible in the jugular veins and measurable in the veins of the arm, which is produced by firm pressure with the flat hand over the abdomen in active or impending congestive heart failure.</para>
<para><emphasis role="strong">Pulsus alternans: </emphasis>Alternating weak and strong beats of the pulse associated with weak left ventricular function.</para>
<para><emphasis role="strong">Pulse pressure: </emphasis>Difference between systolic and diastolic blood pressures.</para></note>
<sect2 id="ch0002s0028"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Although generally managed at the community level, an inclient stay may be required for periodic exacerbation of failure or development of complications.</para>
</sect2>
<sect2 id="ch0002s0029"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0032">Acute coronary syndrome</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0002s0022">Hypertension: severe</link></para>
<para><link linkend="ch0002s0053">Cardiac surgery</link></para>
<para><link linkend="ch0002s0047">Dysrhythmias</link></para>
<para><link linkend="ch0002s0059">Aortic aneurysms</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<table frame="top" id="ch0002s0027ta0014"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fatigue, exhaustion progressing throughout the day</para></listitem>
<listitem><para>Inability to perform normal daily activities, such as making bed, climbing stairs, and so on</para></listitem>
<listitem><para>Exercise intolerance</para></listitem>
<listitem><para>Dyspnea at rest or with exertion</para></listitem>
<listitem><para>Insomnia, inability to sleep flat</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Limited exercise tolerance</para></listitem>
<listitem><para>Fatigue</para></listitem>
<listitem><para>Restlessness, mental status changes, such as anxiety and lethargy</para></listitem>
<listitem><para>Vital sign changes with activity</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of hypertension, recent or past MIs, multiple MIs, previous episodes of HF, valvular heart disease, cardiac surgery, endocarditis, systemic lupus erythematosus, anemia, septic shock</para></listitem>
<listitem><para>Feeling that heart is skipping, fluttering, pounding, or &ldquo;stopping&rdquo;</para></listitem>
<listitem><para>Swelling of feet, legs, abdomen, or &ldquo;belt too tight&rdquo;</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood pressure (BP)</emphasis> May be low with cardiac pump failure; in normal range with mild or chronic HF; or high with fluid overload, left-sided HF, and increased systemic vascular resistance (SVR)</para></listitem>
<listitem><para><emphasis role="bi">Pulses:</emphasis> Peripheral pulses diminished; central pulses may be bounding, for example, visible jugular, carotid, abdominal pulsations, pulse pressure narrow, reflecting reduced ventricular stroke volume</para></listitem>
<listitem><para>Pulsus alternans may be noted</para></listitem>
<listitem><para><emphasis role="bi">Heart rate and rhythm:</emphasis> Tachycardia; dysrhythmias such as atrial fibrillation, premature ventricular contractions, heart blocks</para></listitem>
<listitem><para><emphasis role="bi">Apical pulse:</emphasis> Point of maximal intensity (PMI) diffuse and displaced to the left</para></listitem>
<listitem><para><emphasis role="bi">Heart sounds:</emphasis> S<subscript>1</subscript> and S<subscript>2</subscript> possibly softened; S<subscript>3</subscript> gallop rhythm diagnostic of congestive HF; S<subscript>4</subscript> can occur with hypertension; systolic and diastolic murmurs can indicate the presence of valvular stenosis or insufficiency, causing or exacerbating heart failure.</para></listitem>
<listitem><para>Skin tissue color pale, ashen, dusky, or cyanotic</para></listitem>
<listitem><para>Nail beds pale or cyanotic, with slow capillary refill</para></listitem>
<listitem><para>Edema dependent, generalized, or pitting, especially in extremities</para></listitem>
<listitem><para>Bulging neck veins (jugular vein distention [JVD])</para></listitem>
<listitem><para>Liver enlarged and palpable; positive hepatojugular reflex may be present in right-sided HF</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Anxiety, apprehension, fear</para></listitem>
<listitem><para>Depression</para></listitem>
<listitem><para>Stress related to illness or financial concerns (job, cost of medical care)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Various behavioral manifestations, for example, anxiety, anger, fear, irritability</para></listitem>
<listitem><para>Studies have shown that older adults (especially) may experience depression along with coronary heart disease and heart failure and associated decreased functional abilities (Sin et al, 2015)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased voiding, dark urine</para></listitem>
<listitem><para>Night voiding</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased daytime urination and increased nighttime urination (nocturia)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of diet high in salt and processed foods, fat, sugar, and caffeine</para></listitem>
<listitem><para>Loss of appetite, anorexia</para></listitem>
<listitem><para>Nausea, vomiting</para></listitem>
<listitem><para>Significant weight gain (may not respond to diuretic use)</para></listitem>
<listitem><para>Tight clothing or shoes</para></listitem>
<listitem><para>Use of diuretics</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Rapid or continuous weight gain</para></listitem>
<listitem><para>Abdominal distention, suggesting ascites or liver engorgement</para></listitem>
<listitem><para>Generalized edema, including whole-body or lower extremity swelling&mdash;edema generalized, dependent, pitting, brawny</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">HYGIENE</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fatigue, weakness, exhaustion during self-care activities</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Appearance indicative of neglect of personal care</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weakness</para></listitem>
<listitem><para>Dizziness</para></listitem>
<listitem><para>Fainting episodes</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Lethargy, confusion, disorientation</para></listitem>
<listitem><para>Behavior changes, irritability</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Chest pain</para></listitem>
<listitem><para>Chronic or acute angina</para></listitem>
<listitem><para>Right upper abdominal pain (right-sided HF)</para></listitem>
<listitem><para>Generalized muscle aches and pains</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Restlessness</para></listitem>
<listitem><para>Narrowed focus and withdrawal</para></listitem>
<listitem><para>Guarding behavior</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dyspnea with exertion or rest</para></listitem>
<listitem><para>Nocturnal dyspnea that interrupts sleep (also sometimes called paroxysmal nocturnal dyspnea [PND]) relieved by sitting up or standing. This symptom is often present in exacerbations of heart failure (Fogoros, 2017a).</para></listitem>
<listitem><para>Sleeping sitting up or with several pillows</para></listitem>
<listitem><para>Cough with or without sputum production, especially when recumbent</para></listitem>
<listitem><para>Use of respiratory aids, for example, oxygen or medications</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachypnea</para></listitem>
<listitem><para>Shallow, labored breathing</para></listitem>
<listitem><para>Gasping for air, often coughing, and feeling a compelling need to get out of bed (PND)</para></listitem>
<listitem><para>Use of accessory muscles, nasal flaring</para></listitem>
<listitem><para>Moist cough with left-sided HF (congestive)</para></listitem>
<listitem><para>Dry persistent cough</para></listitem>
<listitem><para>Sputum may be blood-tinged, pink, and frothy (pulmonary edema)</para></listitem>
<listitem><para>Breath sounds may be diminished, with bibasilar crackles and wheezes</para></listitem>
<listitem><para>Mentation may be diminished; lethargy, restlessness present</para></listitem>
<listitem><para>Pallor or cyanosis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Changes in mentation and confusion</para></listitem>
<listitem><para>Loss of strength or muscle tone</para></listitem>
<listitem><para>Increasing risk for falls</para></listitem>
<listitem><para>Skin excoriations, rashes</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SOCIAL INTERACTION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased participation in usual social activities</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Many factors impact patient understanding and implementation of self-management, including health literacy (the average HF patient has low health literacy), cognitive impairment, learning ability, language barriers, readiness to learn/sense of priority, influence of illness, the need to learn a large volume of information within a short period of time, and healthcare provider education training.</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of developing HF at young age (genetic form)</para></listitem>
<listitem><para>Family risk factors, such as heart disease, hypertension, diabetes</para></listitem>
<listitem><para>Use or misuse of cardiac medications</para></listitem>
<listitem><para>Use of vitamins, herbal supplements, for example, niacin, coenzyme Q10, garlic, ginkgo, black hellebore, dandelion, or aspirin</para></listitem>
<listitem><para>Recent or recurrent hospitalizations</para></listitem>
<listitem><para>Evidence of failure to improve</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Assistance with shopping, transportation, self-care needs, homemaker and maintenance tasks</para></listitem>
<listitem><para>Alteration in medication use or therapy</para></listitem>
<listitem><para>Changes in physical layout of home</para></listitem>
<listitem><para>May need oxygen at home</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0027ta0015"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Atrial natriuretic peptide (ANP):</emphasis> Hormone secreted from right atrial cells when pressure increases.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased in congestive HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Beta-type natriuretic peptide (BNP):</emphasis> Neurohormone secreted from the cardiac ventricles as a response to ventricular volume and fluid overload.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The level of BNP in the blood increases when symptoms of HF worsen and decreases when symptoms of HF improve to stable condition. Elevation of BNP correlates with both the severity of symptoms and the prognosis in congestive HF. A level of BNP that is greater than 100 pg/mL is predictive of HF and increased risk of sudden death and 1-year mortality (Kociol et al, 2011). <emphasis>Note:</emphasis> A variation of BNP, called N-terminal BNP, also is useful in diagnosing heart failure and in some laboratories is used instead of BNP (Mayo Clinic Staff, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Liver enzyme tests, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (formally referred to as SPGT and SGOT):</emphasis> To determine degree of end-organ involvement.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated in liver congestion, which may be present in right-sided HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Erythrocyte sedimentation rate (ESR):</emphasis> Shows the alteration of blood proteins caused by inflammatory and necrotic processes.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be elevated, indicating acute systemic inflammatory reaction, especially if viral infection is cause of HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Bleeding and clotting times:</emphasis> Clotting factors, prothrombin time (PT), partial thromboplastin time (PTT), platelets.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies those at risk for excessive clot formation and identifies therapeutic range for anticoagulant therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Electrolytes (sodium, potassium, chloride, magnesium, calcium):</emphasis> Elements or chemicals needed for the body and heart to work properly.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Electrolytes may be altered because of fluid shifts and decreased renal function associated with HF and medications (e.g., diuretics, ACE inhibitors) used in HF treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Arterial blood gas (ABG):</emphasis> Measures arterial pH, PCO<subscript>2</subscript>, and PO<subscript>2</subscript>. Evaluates respiratory function and provides a measure for determining acid-base balance.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Left ventricular failure is characterized by mild respiratory alkalosis (early); respiratory acidosis, with hypoxemia; and increased PCO<subscript>2</subscript>, with decompensated HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Albumin and transferrin, total protein:</emphasis> Plasma proteins exert oncotic pressure needed to keep fluid in the capillaries.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be decreased as a result of reduced protein intake (nutritional) or reduced protein synthesis (congested liver associated with HF).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Thyroid studies:</emphasis> Blood test and scan to evaluate thyroid function. The most commonly used laboratory screening test is the measurement of thyroid-stimulating hormone (TSH).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased thyroid activity suggests thyroid hyperactivity as precipitator of HF. Hypothyroidism can also cause or exacerbate HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN) and creatinine:</emphasis> BUN levels reflect the balance between production and excretion of urea. Creatine is an end-product of creatinine metabolism and must be cleared from blood via the kidneys.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated BUN suggests decreased renal perfusion as may occur with HF or as a side effect of prescribed medications (e.g., diuretics and ACE inhibitors). Elevation of both BUN and creatinine is typical in HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs and structures within the chest.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May demonstrate calcification in valve areas or aorta, causing blood flow obstruction, or cardiac enlargement, indicating HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An abnormal ECG can point out the underlying cause of HF, such as ventricular hypertrophy, valvular dysfunction, ischemia, and myocardial damage patterns.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Echocardiography (also called two-dimensional echocardiogram or Doppler ultrasound):</emphasis> Evaluates the left ventricle, including size, valvular function, wall thickness, and pumping action as measured by the ejection fraction (EF).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reveal enlarged chamber dimensions or alterations in valvular and ventricular function and structure. EF is reduced (less than 50%), indicating systolic dysfunction, or &ldquo;preserved&rdquo; (normal is 50% to 65%), indicating diastolic dysfunction. (AHA, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Stress test (also called exercise treadmill or exercise ECG):</emphasis> Raises heart rate and BP by means of exercise; heart rate can also be raised pharmacologically using such drugs as dobutamine or dipyridamole.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps detect valvular heart disease ventricular remodeling and structural anomalies and problems with coronary circulation affecting heart function.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac angiography (also called cardiac catheterization):</emphasis> Assesses patency of coronary arteries, reveals abnormal heart and valve size or shape, and evaluates ventricular contractility. Pressures can be measured within each chamber of the heart and across the valves.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Abnormal pressures indicate problems with ventricular function, helping to identify valvular stenosis or insufficiency and differentiating right-sided versus left-sided HF.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0030"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Improve myocardial contractility and systemic perfusion.</para></listitem>
<listitem><para>Reduce fluid volume overload.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease and prognosis, therapy needs, and prevention of recurrences.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0031"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Cardiac output adequate for individual needs.</para></listitem>
<listitem><para>Complications prevented or resolved.</para></listitem>
<listitem><para>Optimum level of activity and functioning attained.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0002s0027note0027"><title><emphasis role="strong">NURSING DIAGNOSIS: decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Altered contractility (such as valvular defects and ventricular aneurysm)</para>
<para>Alteration in heart rate, rhythm</para>
<para>Altered afterload (e.g., systemic vascular resistance)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Altered heart rate/rhythm: Bradycardia, tachycardia, arrhythmias, ECG changes</para>
<para>Variations in blood pressure readings (hypotension, hypertension)</para>
<para>Decreased peripheral pulses</para>
<para>S<subscript>3</subscript>, S<subscript>4</subscript> heart sounds</para>
<para>Orthopnea, crackles, jugular vein distension, edema, weight gain</para>
<para>Skin color changes, clammy skin</para>
<para>Oliguria</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display vital signs within acceptable limits, dysrhythmias absent or controlled, and no symptoms of failure, for example, hemodynamic parameters within acceptable limits and urinary output adequate.</para>
<para>Report decreased episodes of dyspnea and angina.</para>
<para><emphasis role="strong">Self-Management: Heart Failure</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in activities that reduce cardiac workload.</para>
</note>
<note role="none" id="ch0002s0027note0028"><table frame="top" id="ch0002s0027ta0016"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hemodynamic Regulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate apical pulse; assess heart rate, rhythm, and document dysrhythmia if telemetry available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia is usually present, even at rest, to compensate for decreased ventricular contractility. Premature atrial contractions (PACs), paroxysmal atrial tachycardia (PAT), PVCs, multifocal atrial tachycardia (MAT), and AF are common dysrhythmias associated with HF, although others may also occur. <emphasis>Note:</emphasis> Intractable ventricular dysrhythmias unresponsive to medication suggest ventricular aneurysm.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note heart sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>S<subscript>1</subscript> and S<subscript>2</subscript> may be weak because of diminished pumping action. Gallop rhythms are common (S<subscript>3</subscript> and S<subscript>4</subscript>), produced as blood flows into noncompliant, distended chambers. Murmurs may reflect valvular incompetence and stenosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Palpate peripheral pulses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased cardiac output may be reflected in diminished radial, popliteal, dorsalis pedis, and posttibial pulses. Pulses may be fleeting or irregular to palpation, and pulsus alternans may be present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor BP</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In early, moderate, or chronic HF, BP may be elevated because of increased SVR. In advanced HF, the body may no longer be able to compensate, and profound or irreversible hypotension may occur. <emphasis>Note:</emphasis> Many clients with HF have consistently low systolic BP (80 to 100 mm Hg) due to their disease process and the medications they take.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Inspect skin for pallor and cyanosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pallor is indicative of diminished peripheral perfusion secondary to inadequate cardiac output, vasoconstriction, and anemia. Cyanosis may develop in refractory HF. Dependent areas are often blue or mottled as venous congestion increases.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor urine output, noting decreasing output and dark or concentrated urine.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Kidneys respond to reduced cardiac output by retaining water and sodium. Urine output is usually decreased during the day because of fluid shifts into tissues but may be increased at night because fluid returns to circulation when client is recumbent.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note changes in sensorium, for example, lethargy, confusion, disorientation, anxiety, and depression.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate inadequate cerebral perfusion secondary to decreased cardiac output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage rest, semi-recumbent in bed or chair. Assist with physical care, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Physical rest should be maintained during acute or refractory HF to improve efficiency of cardiac contraction and to decrease myocardial oxygen consumption and workload.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide quiet environment, explain medical and nursing management, help client avoid stressful situations, listen and respond to expressions of feelings or fears.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Physical and psychological rest helps reduce stress, which can produce vasoconstriction, elevating BP and increasing heart rate and work.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide bedside commode. Have client avoid activities eliciting a vasovagal response, for instance, straining during defecation and holding breath during position changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Commode use decreases work of getting to bathroom or struggling to use bedpan. Vasovagal maneuver causes vagal stimulation followed by rebound tachycardia, which further compromises cardiac function and output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Elevate legs, avoiding pressure under knee. Encourage active and passive exercises. Increase ambulation and activity as tolerated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases venous stasis and may reduce incidence of thrombus and embolus formation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Check for calf tenderness; diminished pedal pulse; and swelling, local redness, or pallor of extremity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduced cardiac output, venous pooling and stasis, and enforced bedrest increase risk of thrombophlebitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Withhold digoxin, as indicated, and notify physician if marked changes occur in cardiac rate or rhythm or signs of digoxin toxicity occur.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Incidence of toxicity is high (20%) because of narrow margin between therapeutic and toxic ranges. Digoxin may have to be discontinued in the presence of toxic drug levels, a slow heart rate, or low potassium level. (Refer to CP: <link linkend="ch0002s0047">Dysrhythmias</link>; ND: <link linkend="ch0002s0048note0075">risk for Poisoning [Digoxin Toxicity]</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer supplemental oxygen, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases available oxygen for myocardial uptake to combat effects of hypoxia and ischemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A variety of medications (usually a combination of a diuretic, an ACEI, or ARB and beta blocker) may be used to increase stroke volume, improve contractility, and reduce congestion. <emphasis>Note:</emphasis> New first-line drugs that have recently been approved for treatment of heart failure include sacubitril/valsartan (Entresto) and ivabradine (Corlanor). These drugs are given to improve outcomes in certain types of heart failure associated with low ventricular output or to clients who are unable to respond well to beta blockers (Husar, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="2" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Loop diuretics, such as furosemide (Lasix), ethacrynic acid (Edecrin), and bumetanide (Bumex); thiazide and thiazide-like diuretics, such as hydrochlorothiazide (HCTZ) and metolazone (Zaroxolyn)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretics, in conjunction with restriction of dietary sodium and fluids, often lead to clinical improvement in clients with stages I and II HF. In general, type and dosage of diuretic depend on cause and degree of HF and state of renal function. Preload reduction is most useful in treating clients with a relatively normal cardiac output accompanied by congestive symptoms. Loop diuretics block chloride reabsorption, thus interfering with the reabsorption of sodium and water.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ACE inhibitors, such as enalapril (Vasotec), captopril (Capoten), lisinopril (Prinivil), quinapril (Accupril), ramipril (Altace), and moexipril (Univasc)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ACE inhibitors represent first-line therapy to control HF by decreasing ventricular filling pressures and SVR while increasing cardiac output with little or no change in BP and heart rate.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ARBs (also known as angiotensin II receptor antagonists), such as candesartan (Atacand), losartan (Cozaar), eprosartan (Teveten), irbesartan (Avapro), and valsartan (Diovan)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antihypertensive and cardioprotective effects are attributable to selective blockade of AT<subscript>1</subscript> (angiotensin II) receptors and angiotensin II synthesis. <emphasis>Note:</emphasis> ARBs used in combination with ACE inhibitors and beta blockers are thought to have decreased hospitalizations for HF clients.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="5" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vasodilators, such as nitrates (Nitro-Dur, Isordil); arteriodilators such as hydralazine (Apresoline); combination drugs, such as prazosin (Minipress) and nesiritide (Natrecor)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vasodilators are used to increase cardiac and renal output, reducing circulating volume (preload and afterload), and decreasing SVR, thereby reducing ventricular workload. <emphasis>Note:</emphasis> Nesiritide is used in acutely decompensated congestive HF and has been used with digoxin, diuretics, and ACE inhibitors. Parenteral vasodilators are reserved for clients with severe HF or those unable to take oral medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&beta;-adrenergic receptor antagonists (also called beta blockers), carvedilol (Coreg), bisoprolol (Zebeta), metoprolol (Lopressor, Toprol), nebivolol (Bystolic), acebutolol (Sectral), atenolol (Tenormin), betaxolol (Kerlone), carteolol (Cartrol), esmolol (Brevibloc), penbutolol (Levatol), nadolol (Corgard), and pindolol (Visken)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in the treatment of HF by blocking the cardiac effects of chronic adrenergic stimulation. Many clients experience improved activity tolerance and EF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inotropic agents, such as amrinone (Inocor), milrinone (Primacor), and vesnarinone (Arkin-Z)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These medications are useful for short-term treatment of HF unresponsive to cardiac glycosides, vasodilators, and diuretics in order to increase myocardial contractility and produce vasodilation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Digoxin (Lanoxin)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Digoxin is no longer used routinely in HF but may be prescribed for symptomatic individuals with late-stage HF on maximal medication therapy (Suter et al, 2012). <emphasis>Note:</emphasis> In 2015, the American Geriatrics Society (AGS) stated that digoxin is to be &ldquo;avoided as first-line therapy for heart failure &hellip; and may be associated with increased mortality&rdquo; (AGS, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antianxiety agents and sedatives</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allays anxiety and breaks the feedback cycle of anxiety to catecholamine release to anxiety. Promotes rest and relaxation, reducing oxygen demand and myocardial workload.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anticoagulants, such as low-dose heparin, and warfarin (Coumadin), or antiplatelet agents, for example, low-dose aspirin, clopidogrel (Plavix), and tirofiban (Aggrastat)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used prophylactically to prevent thrombus and embolus formation in the presence of risk factors, such as venous stasis, enforced bedrest, cardiac dysrhythmias, and history of previous thrombotic episodes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer IV solutions, restricting total amount, as indicated. Avoid saline solutions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because of existing elevated left ventricular pressure, client may not tolerate increased fluid volume (preload). Clients with HF also excrete less sodium, which causes fluid retention and increases myocardial workload.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor and replace electrolytes, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid shifts and use of diuretics can alter electrolytes (especially potassium and chloride), which affect cardiac rhythm and contractility.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor serial ECG and chest x-ray changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ST-segment depression and T-wave flattening can develop because of increased myocardial oxygen demand, even if no CAD is present. Chest x-ray may show enlarged heart and changes of pulmonary congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Measure cardiac output and other functional parameters, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac index, preload and afterload, contractility, and cardiac work can be measured noninvasively by using thoracic electrical bioimpedance (TEB) technique. TEB is useful in determining effectiveness of therapeutic interventions and response to activity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for insertion and maintain pacemaker or pacemaker/defibrillator, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be necessary to correct bradydysrhythmias unresponsive to drug intervention, which can aggravate congestive failure and produce pulmonary edema. <emphasis>Note:</emphasis> Biventricular pacemaker and cardiac defibrillators are designed to provide resynchronization for the heart by simultaneous electrical activation of both the right and left sides of the heart, thereby creating a more effective and efficient pump.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for surgery, such as valve replacement, angioplasty, and coronary artery bypass grafting (CABG), as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>HF due to ventricular aneurysm or valvular dysfunction may require aneurysmectomy or valve replacement to improve myocardial contractility and function. Revascularization of cardiac muscle by CABG may be done to improve cardiac function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top"/>
<entry rowsep="0" morerows="0" colsep="0" valign="top"><para>Cardiomyoplasty</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiomyoplasty, an experimental procedure in which the latissimus dorsi muscle is wrapped around the heart and electrically stimulated to contract with each heartbeat, may be done to augment ventricular function while the client is awaiting cardiac transplantation or when transplantation is not an option. <emphasis>Note:</emphasis> Cellular cardiomyoplasty is a developing therapy that uses stem cells or progenitor cells for injured heart to improve cardiac function and mitigate heart failure. A significant improvement in cardiac function, metabolism, and perfusion has been observed in clinical trials; however, the procedure requires further study (Lamb et al, 2015).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with and maintain mechanical circulatory support system, such as intra-aortic balloon pump (IABP) or left-ventricular assist device (LVAD), when indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>An IABP may be inserted into the aorta as a temporary support to the failing heart in the critically ill client with potentially reversible HF. A short (external) or long-term (implanted) LVAD may also be used, sometimes as a bridge to transplantation. A growing use of the LVAD is in so-called destination therapy (DT). The DT population typically includes individuals with end-stage heart failure and poor predictive survival in their current medical state. These people are also noneligible for transplantation, usually due to advanced age, significant comorbidities, or psychosocial issues contraindicating transplant. Clients who undergo LVAD implantation live the rest of their lives with the device in place.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0027note0029"><title><emphasis role="strong">NURSING DIAGNOSIS: Activity Intolerance</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Imbalance between oxygen supply and demand</para>
<para>Generalized weakness</para>
<para>Sedentary lifestyle</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports fatigue, feeling weak</para>
<para>Abnormal blood pressure/heart rate in response to activity</para>
<para>Exertional dyspnea</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Endurance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in desired activities; meet own self-care needs.</para>
<para>Achieve measurable increase in activity tolerance, evidenced by reduced fatigue and weakness and by vital signs within acceptable limits during activity.</para>
</note>
<note role="none" id="ch0002s0027note0030"><table frame="top" id="ch0002s0027ta0017"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Energy Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Check vital signs before and immediately after activity during acute episode or exacerbation of HF, especially if client is receiving vasodilators, diuretics, or beta blockers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Orthostatic hypotension can occur with activity because of medication effect (vasodilation), fluid shifts (diuresis), or compromised cardiac pumping function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Document cardiopulmonary response to activity. Note tachycardia, dysrhythmias, dyspnea, diaphoresis, and pallor.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Compromised myocardium and inability to increase stroke volume during activity may cause an immediate increase in heart rate and oxygen demands, thereby aggravating weakness and fatigue.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess level of fatigue, and evaluate for other precipitators and causes of fatigue, for example, HF treatments, pain, cachexia, anemia, and depression.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fatigue because of advanced HF can be profound and is related to hemodynamic, respiratory, and peripheral muscle abnormalities. Fatigue is also a side effect of some medications (e.g., beta blockers). Other key causes of fatigue should be evaluated and treated as appropriate and desired.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate accelerating activity intolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May denote increasing cardiac decompensation rather than overactivity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide assistance with self-care activities, as indicated. Intersperse activity with rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meets client&rsquo;s personal care needs without undue myocardial stress or excessive oxygen demand.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Implement graded cardiac rehabilitation and activity program.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Strengthens and improves cardiac function under stress if cardiac dysfunction is not irreversible. Gradual increase in activity avoids excessive myocardial workload and oxygen consumption.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0027note0031"><title><emphasis role="strong">NURSING DIAGNOSIS: excess Fluid Volume</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Compromised regulatory mechanism (reduced glomerular filtration rate, increased antidiuretic hormone [ADH] production, and sodium and water retention)</para>
<para>Excess sodium intake</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Orthopnea, S<subscript>3</subscript> heart sound</para>
<para>Oliguria, increase in central venous pressure, positive hepatojugular reflex</para>
<para>Weight gain over short period of time; edema</para>
<para>Blood pressure changes</para>
<para>Pulmonary congestion, adventitious breath sounds</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Overload Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate stabilized fluid volume with balanced intake and output, breath sounds clear or clearing, vital signs within acceptable range, stable weight, and absence of edema.</para>
<para>Verbalize understanding of individual dietary and fluid restrictions.</para>
</note>
<note role="none" id="ch0002s0027note0032"><table frame="top" id="ch0002s0027ta0018"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2"><para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom"><para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor urine output, noting amount and color, as well as time of day when diuresis occurs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Urine output may be scanty and concentrated (especially during the day) because of reduced renal perfusion. Recumbency favors diuresis; therefore, urine output may be increased at night or during bedrest.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor 24-hour intake and output (I&amp;O) balance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretic therapy may result in sudden or excessive fluid loss, creating a circulating hypovolemia, even though edema and ascites remain in the client with advanced HF or CHF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain chair rest or bedrest in semi-Fowler&rsquo;s position during acute phase.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recumbency increases glomerular filtration and decreases production of ADH, thereby enhancing diuresis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Establish fluid intake schedule if fluids are medically restricted, incorporating beverage preferences when possible. Give frequent mouth care and ice chips as part of fluid allotment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involving client in therapy regimen may enhance sense of control and cooperation with restrictions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Documents changes in or resolution of edema in response to therapy. A gain of 5 lb represents approximately 2 L of fluid. Conversely, diuretics can result in rapid and excessive fluid shifts and weight loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess for distended neck and peripheral vessels. Inspect dependent body areas for edema with and without pitting; note presence of generalized body edema (anasarca).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excessive fluid retention may be manifested by venous engorgement and edema formation. Peripheral edema begins in feet and ankles, or dependent areas, and ascends as failure worsens. Pitting edema is generally obvious only after retention of at least 10 lb of fluid. Increased vascular congestion&mdash;associated with right-sided HF&mdash;eventually results in systemic tissue edema.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Change position frequently. Elevate feet when sitting. Inspect skin surface, keep dry, and provide padding, as indicated. (Refer to ND: <link linkend="ch0002s0027note0037">risk for impaired Skin Integrity</link>.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Edema formation, slowed circulation, altered nutritional intake, and prolonged immobility or bedrest are cumulative stressors that affect skin integrity and require close supervision and preventive interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate breath sounds, noting decreased and adventitious sounds, for example, crackles and wheezes. Note presence of increased dyspnea, tachypnea, orthopnea, paroxysmal nocturnal dyspnea, and persistent cough.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excess fluid volume often leads to pulmonary congestion. Symptoms of pulmonary edema may reflect acute left-sided HF. With right-sided HF, respiratory symptoms of dyspnea, cough, and orthopnea may have slower onset but are more difficult to reverse.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate reports of sudden extreme dyspnea and air hunger, need to sit straight up, sensation of suffocation, and feelings of panic or impending doom.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate development of complications, such as pulmonary edema or embolus, which differs from orthopnea or paroxysmal nocturnal dyspnea in that it develops much more rapidly and requires immediate intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor BP and central venous pressure (CVP) (if available).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypertension and elevated CVP suggest fluid volume excess and may reflect developing or increasing pulmonary congestion, HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess bowel sounds. Note complaints of anorexia, nausea, abdominal distention, and constipation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Visceral congestion, occurring in progressive HF, can alter gastrointestinal function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide small, frequent, easily digestible meals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduced gastric motility can adversely affect digestion and absorption. Small, frequent meals may enhance digestion and prevent abdominal discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Measure abdominal girth, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In progressive right-sided HF, fluid may shift into the peritoneal space, causing increasing abdominal girth (ascites).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Palpate abdomen. Note reports of right upper-quadrant pain or tenderness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Advancing HF leads to venous congestion, resulting in abdominal distention, liver engorgement (hepatomegaly), and pain. This can alter liver function and impair or prolong drug metabolism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note increased lethargy, hypotension, and muscle cramping.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These are signs of potassium and sodium deficits that may occur because of fluid shifts and diuretic therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Diuretics, such as furosemide (Lasix), bumetanide (Bumex), and torsemide (Demadex)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases rate of urine flow and may inhibit reabsorption of sodium and chloride in the renal tubules.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium-sparing thiazides such as spironolactone (Aldactone), amiloride (Midamor), and triamterene (Direnium)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes diuresis without excessive potassium losses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium supplements, such as K-Dur, K-Lor, and Micro-K</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Replaces potassium that is lost as a common side effect of diuretic therapy, which can adversely affect cardiac function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain fluid and sodium restrictions, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid restriction is not a general recommendation, but fluids should be restricted to less than 2 L/day in patients who have significant hyponatremia (&lt;130 mEq/L). Fluid restriction may also be considered when patients have difficulty controlling fluid retention despite high diuretic doses and sodium restriction (Heart Failure Society of America [HFSA], 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Consult with dietitian.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be necessary to provide diet acceptable to client that meets caloric needs within sodium restriction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor chest x-ray.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reveals changes indicative of increase or resolution of pulmonary congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor complete blood count (CBC) and electrolytes, especially potassium and sodium.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyponatremia and anemia may be signs of disease progression. Hypokalemia is a common adverse effect of diuretic treatment, and hyperkalemia may complicate therapy with ACE inhibitors, ARBs, and aldosterone antagonists (Suter et al, 2012).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with other therapies such as dialysis, or ultrafiltration, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Although not frequently used, mechanical fluid removal rapidly reduces circulating volume, especially in pulmonary edema refractory to other therapies.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0027note0033"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for impaired Gas Exchange</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Ventilation-perfusion imbalance [such as in altered blood flow, increased vascular resistance; heart failure]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Gas Exchange</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate adequate ventilation and oxygenation of tissues by ABG values and oximetry within client&rsquo;s usual parameters, and be free of symptoms of respiratory distress.</para>
<para>Participate in treatment regimen (e.g., breathing exercise, effective coughing, use of oxygen) within level of ability and situation.</para>
</note>
<note role="none" id="ch0002s0027note0034"><table frame="top" id="ch0002s0027ta0019"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds, noting crackles and wheezes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reveals presence of pulmonary congestion or collection of secretions, indicating need for further intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client in effective coughing and deep breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clears airways and facilitates oxygen delivery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage frequent position changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps prevent atelectasis and pneumonia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain chair rest and bedrest in a semi-Fowler&rsquo;s position, with head of bed elevated 20 to 30 degrees.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces oxygen consumption and demands and promotes maximal lung inflation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and graph serial ABG values and pulse oximetry.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypoxemia can be severe during pulmonary congestion. Compensatory acid-base changes are usually present in chronic HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases alveolar oxygen concentration, which may correct or reduce tissue hypoxemia.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated, such as diuretics, such as furosemide (Lasix)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Diuresis helps reduce pulmonary congestion, enhancing gas exchange.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0027note0035"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for chronic Pain</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Chronic physical disease or condition</para>
<para>Altered ability to continue previous activities</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para><para><emphasis role="strong">Pain Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize and demonstrate relief or control of pain or discomfort.</para>
<para>Demonstrate and initiate behavioral modifications of lifestyle and appropriate use of therapeutic interventions.</para>
</note>
<note role="none" id="ch0002s0027note0036"><table frame="top" id="ch0002s0027ta0020"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Chronic</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for presence of pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain may or may not be reported as a symptom associated with heart failure. Some studies indicate that pain (as a separate entity) has been understudied in this population. Unexpected sources of pain related to HF and the medications used to manage it include visceral ischemia, musculoskeletal fatigue, ascites-related pain, and skin breakdown secondary to prolonged edema (Evangelista et al, 2009). One recent study found that chronic noncardiac pain is reported by 76% of people with chronic heart failure (McDonald et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note coexisting condition(s).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many HF clients are elderly and have multiple chronic conditions, such as angina, arthritis, gout, back pain, claudication, and neuropathies.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for lifestyle effects of heart failure as well as pain, such as deconditioning, severe fatigue, weight loss or gain, sleep difficulties, and depression.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain issues should be addressed and managed, when present, even though it may not be possible to determine if pain is a result of the HF itself (associated with underperfused organs) or be related to other conditions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide anticipatory guidance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In client with HF in which pain is common, educating client and significant other (SO) about when, where, and how to seek interventions or treatment may reduce limitations imposed by pain. If pain is present, pain management should be initiated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with treatment of underlying or coexisting conditions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes general well-being.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer analgesics, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Promotes rest and relaxation and may enhance ability to engage in desired activities.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0027note0037"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for impaired Skin Integrity</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Impaired circulation; alteration in sensation</para>
<para>Alteration in fluid volume including presence of edema; alteration in skin turgor</para>
<para>Inadequate nutrition (associated with alteration in metabolism; obesity or emaciation)</para>
<para>Mechanical factor (e.g., shearing forces, pressure, physical immobility)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control: Pressure</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain skin integrity.</para>
<para>Demonstrate behaviors or techniques to prevent skin breakdown.</para>
</note>
<note role="none" id="ch0002s0027note0038"><table frame="top" id="ch0002s0027ta0021"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pressure Ulcer Prevention</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect skin, noting skeletal prominences, presence of edema, and areas of altered circulation and pigmentation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Skin is at risk because of impaired peripheral circulation, obesity or emaciation, edema, physical immobility, and alterations in nutritional status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage and instruct in frequent position changes in bed and chair. Assist with active or passive range of motion (ROM) exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces pressure on tissues, improving circulation and reducing time any one area is deprived of full blood flow.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide and instruct in good skin care (e.g., shower instead of bath, washing areas thoroughly using mild soap, drying gently and lubricating with lotion or emollient).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excessive dryness or moisture damages skin and hastens breakdown.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide skin care to incontinent client. Change continence pads/brief/diapers as needed. Cleanse perineal areas daily and after each incontinence event. Apply skin-protectant ointment to area as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meticulous cleansing and care of skin of the incontinent client can prevent or minimize skin breakdown.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage early and ongoing mobilization.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes circulation and reduces risks associated with immobility.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Check fit of shoes or slippers and change as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dependent edema may cause shoes to fit poorly, thereby increasing risk of pressure and skin breakdown on feet.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid intramuscular route for medication administration.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Interstitial edema and impaired circulation impede drug absorption and predispose to tissue breakdown and development of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide alternating pressure, air- or water-filled mattress, and elbow and heel protectors.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces pressure to sensitive/fragile skin and may improve circulation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Consult with nutritionist if indicated regarding nutrients and vitamins that aid in tissue repair and skin health.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Client with heart failure is often elderly and debilitated. Supplements may be needed to promote general well-being and healthy skin/tissue.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0027note0039"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity of therapeutic regimen or healthcare system</para>
<para>Insufficient knowledge or excessive demands of therapeutic regimen</para>
<para>Economic demands; insufficient support</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports difficulty with prescribed regimen</para>
<para>Failure to include treatment regimen in daily living</para>
<para>Failure to take action to reduce risk factors</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Heart Failure</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify relationship of ongoing therapies (treatment program) to reduction of recurrent episodes and prevention of complications.</para>
<para>List signs and symptoms that require immediate intervention.</para>
<para>Identify own stress and risk factors and some techniques for handling them.</para>
<para>Initiate necessary lifestyle and behavioral changes.</para>
</note>
<note role="none" id="ch0002s0027note0040"><table frame="top" id="ch0002s0027ta0022"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss normal heart function. Include information regarding client&rsquo;s variance from normal function. Explain difference between heart attack and HF and that client has a chronic condition that requires long-term management (if heart failure is not acute and resolvable).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge of disease process and expectations can facilitate client&rsquo;s participation in management of HF, including prescribed treatment regimen if teaching is individualized to the client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reinforce treatment rationale. Include SO and family members in teaching as appropriate, especially for complicated regimens such as management of technology, for example, implantable cardioverter-defibrillator (ICD) or LVAD, dobutamine infusion home therapy when client does not respond to customary combination therapy or cannot be weaned from dobutamine, or in those awaiting heart transplant.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may believe it is acceptable to alter postdischarge regimen when feeling well and symptom free or when feeling below par, which can increase the risk of exacerbation of symptoms. Understanding of regimen, medications, technology, and restrictions may augment cooperation with control of symptoms. Home IV therapy requires a significant commitment by caregivers to operate and troubleshoot infusion pump, change dressing for peripherally inserted central catheter (PICC) line, and monitor I&amp;O and signs and symptoms of HF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage developing a regular home exercise program and provide guidelines for activity, including sexual activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes maintenance of muscle tone and organ function for overall sense of well-being. Changing sexual habits (e.g., sex in morning when well rested, client on top, inclusion of other physical expressions of affection) may be difficult but provides opportunity for continuing satisfying sexual relationship.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss importance of being as active as possible without becoming exhausted and need for rest between activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keeping as active as possible is important in maintaining strength and function, as well as mood. However, excessive physical activity or overexertion can further weaken the heart, exacerbating failure, and necessitates adjustment of exercise program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss importance of sodium limitation. Provide list of sodium content of common foods that are to be avoided or limited. Encourage reading of labels on food and drug packages.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dietary intake of sodium of more than 2 g/day can offset effect of diuretic. Most common source of sodium is table salt and obviously salty foods, although canned soups and vegetables, luncheon meats, and dairy products also may contain high levels of sodium.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refer to dietitian for counseling specific to individual needs and dietary customs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be helpful in meeting client&rsquo;s nutrition needs, especially in the presence of obesity (major risk factor for developing HF), diabetes, or presence of nausea and vomiting and resulting wasting syndrome (cardiac cachexia). Eating six small meals and using liquid dietary supplements and vitamin supplements can limit inappropriate weight loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review medications, purpose, and side effects. Provide both oral and written instructions, including (and not limited to) taking medicine as directed, contacting healthcare provider if you think your medicine is not helping, or if you have adverse side effects. Keep an updated list of the medicines, vitamins, and herbs you take. Carry your medicine list with you to medical appointments and keep on person (if possible) in case of an emergency.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding therapeutic needs, ways to properly manage medication regimen, and importance of prompt reporting of side effects can prevent occurrence of drug-related complications. Anxiety may block comprehension of input or details, and client and SO may refer to written material at later date to refresh memory.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend taking diuretic early in morning.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides adequate time for drug effect before bedtime to prevent or limit interruption of sleep.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct and receive return demonstration of ability to take and record pulse and BP, and when to notify healthcare provider, for example, about parameters above or below preset rate and changes in rhythm or regularity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes self-monitoring of condition and response to therapies. Early detection of changes allows for timely intervention and may prevent complications, such as digoxin toxicity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain and discuss client&rsquo;s role in control of risk factors, such as smoking and alcohol abuse, and precipitating or aggravating factors, such as high-salt diet, inactivity or overexertion, and exposure to extremes in temperature.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adds to body of knowledge and permits client to make informed decisions regarding control of condition and prevention of recurrence or complications. Smoking potentiates vasoconstriction; sodium intake promotes water retention and edema formation. Improper balance between activity and rest and exposure to temperature extremes may result in exhaustion, increased myocardial workload, and increased risk of respiratory infections. Alcohol can depress cardiac contractility. Limitation of alcohol use to social occasions or maximum of one drink per day may be tolerated unless cardiomyopathy is alcohol induced, which requires complete abstinence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review signs and symptoms that require immediate medical attention, such as rapid and significant weight gain, increased swelling in legs and feet, shortness of breath, increased fatigue, cough, hemoptysis, and fever.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Self-monitoring increases client responsibility in health maintenance and aids in prevention of complications such as pulmonary edema, pneumonia. Weight gain of more than 3 lb in 1 week requires medical evaluation or adjustment of diuretic therapy. <emphasis>Note:</emphasis> Client should weigh daily in morning without clothing, after voiding and before eating.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide opportunities for client and SO to ask questions, discuss concerns, and make necessary lifestyle changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chronicity and recurrent, debilitating nature of HF often exhausts coping abilities and supportive capacity of both client and SO, leading to depression.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Address caregiver&rsquo;s concerns and needs. Refer for support, assistance, and resources, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Caregiver burden can exhaust SO&rsquo;s coping capabilities and health, especially when client has advanced HF, has a ventricular assist device, or is awaiting heart transplantation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss general health risks, such as infection, and recommend avoidance of crowds and individuals with respiratory infections and obtaining yearly influenza immunization and pneumonia immunization.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This population is at increased risk for infection because of circulatory compromise, potential immunosuppression, and chronicity of disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of reporting signs and symptoms of digoxin toxicity (as indicated): development of gastrointestinal and visual disturbances, changes in pulse rate and rhythm, and worsening of HF.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early recognition of developing complications and involvement of healthcare provider may prevent toxicity and hospitalization.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify community resources or support groups and visiting home health nurse, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May need additional assistance with self-monitoring and home management, especially when HF is progressive.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Discuss importance of advance directives and of communicating plan and wishes to family and primary care providers.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Up to 50% of all deaths from HF are sudden, with many occurring at home, possibly without significant worsening of symptoms. The presumption is that sudden cardiac death is produced by a lethal cardiac arrhythmia, as well as structural and functional changes in the heart (Tomaselli &amp; Zipes, 2004). If client chooses to refuse life-support measures, an alternative contact person (rather than 911) needs to be designated should cardiac arrest occur.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0027note0041"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following discharge from care setting (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Activity Intolerance</emphasis>&mdash;imbalance between oxygen supply and demand, generalized weakness</para></listitem>
<listitem><para><emphasis role="bi">excess Fluid Volume</emphasis>&mdash;compromised regulatory mechanism, diuretic use, individual fluid and salt intake</para></listitem>
<listitem><para><emphasis role="bi">risk for impaired Skin Integrity</emphasis>&mdash;physical immobilization, changes in skin turgor, impaired circulation, edema</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, perceived seriousness</para></listitem>
<listitem><para><emphasis role="bi">impaired Home Maintenance</emphasis>&mdash;disease (chronic, debilitating condition), insufficient finances, inadequate support systems</para></listitem>
<listitem><para><emphasis role="bi">Self-Care Deficit [specify]</emphasis>&mdash;weakness, fatigue, decreased motivation</para></listitem></itemizedlist></note>
</sect2>
</sect1>
<sect1 id="ch0002s0032"><title><emphasis role="strong">ACUTE CORONARY SYNDROME (ACS)</emphasis></title>
<para>Acute coronary syndrome (ACS) is an umbrella term for a situation where the blood supply to the heart muscle is suddenly blocked, producing a variety of clinical symptoms compatible with myocardial ischemia, and precipitating a medical emergency.</para>
<para>ACS includes (1) unstable angina (UA), (2) non-ST-segment elevation myocardial infarction (NSTEMI), and (3) ST-segment elevation myocardial infarction (STEMI).</para>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology (American Heart Association [AHA], 2015a; Fogoros, 2016a; Mayo Clinic, 2016b)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>The disorder is characterized by a narrowing of coronary arteries due to atherosclerotic plaque, damaging the internal linings of coronary arteries. This condition is known as coronary artery disease (CAD).</para></listitem>
<listitem><para>As the process progresses, oxygen transport to the heart muscle is restricted, resulting in myocardial ischemia and pain.</para></listitem>
<listitem><para>Hard plaque causes hardened arteries, whereas soft plaque can cause formation of blood clots, either of which can restrict blood flow. There can be plaque rupture or clot formation, causing a sudden reduction of blood flow and a partial or complete occlusion of the coronary artery.</para></listitem>
<listitem><para>Angina (chest pain) is characteristic of ACS. Pain may or may not radiate to jaw, neck, back, or arm. Anginal equivalents may include dyspnea, diaphoresis, nausea, and lightheadedness. Pain may be accompanied by changes in vital signs, decreased oxygen saturation (SaO<subscript>2</subscript>), or cardiac dysrhythmias.</para></listitem>
<listitem><para>Women often present with atypical symptoms, such as &ldquo;indigestion,&rdquo; palpitations, nausea, numbness in the hands, and discomfort (not necessarily pain) and not necessarily in the chest. Other women have reported shortness of breath, pressure or pain in the lower chest or upper abdomen, dizziness, lightheadedness or fainting, upper back pressure, or extreme fatigue (AHA, 2015b).</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Types of ACS (Fogoros, 2016a)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Unstable angina (UA)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>May be new onset of pain with exertion or at rest, or acceleration in frequency, duration, or intensity of chest pain.</para></listitem>
<listitem><para>Occurs in no regular pattern, usually lasts longer (15 minutes), not generally relieved with rest or medications.</para></listitem>
<listitem><para>Electrocardiographic (ECG) manifestations include ST-segment depression and inverted T waves. These changes are transient and not always detected.</para></listitem>
<listitem><para>Cardiac biomarkers are not elevated.</para></listitem></orderedlist>
</listitem>
<listitem><para>Non-ST-segment elevation myocardial infarction (NSTEMI)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Pain and angina equivalents may be much the same as in UA or may be of longer duration and more intense.</para></listitem>
<listitem><para>ECG manifestations include ST-segment depression and inverted T waves, which may persist after resolution of ischemia and pain.</para></listitem>
<listitem><para>Cardiac biomarkers are elevated.</para></listitem></orderedlist>
</listitem>
<listitem><para>ST-segment elevation myocardial infarction (STEMI)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>ECG manifestations include ST-segment elevation in two adjoining leads (diagnostic of STEMI) and abnormal Q waves that appear because of alterations in electrical conductivity of the infarcted myocardial cells.</para></listitem>
<listitem><para>The imbalance between oxygen supply and demand is severe enough to cause tissue necrosis, and the client requires emergency revascularization.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis>Note:</emphasis> Both NSTEMI and unstable angina can be considered &ldquo;incomplete&rdquo; heart attacks. These two forms of ACS need similar, aggressive medical management to reduce the likelihood that they will progress to a STEMI (often called a &ldquo;completed&rdquo; MI) (Fogoros, 2016a).</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Etiology (Fogoros, 2016a; Go et al, 2013; Mayo Clinic Staff, 2016a; Scordo &amp; Pickett, 2017)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Coronary artery disease (CAD) common cause with plaque formation narrowing vessels and pieces of plaque breaking off, creating emboli, and coronary artery obstruction.</para></listitem>
<listitem><para>Risk factors&mdash;age (older than 45 for men, and 55 for women).</para></listitem>
<listitem><para>Presence of &ldquo;metabolic syndrome&rdquo; (see <link linkend="ch0002s0032note0042">Glossary</link>).</para></listitem>
<listitem><para>Being overweight or obese, lack of physical activity, smoking.</para></listitem>
<listitem><para>Type 2 diabetes and family history of chest pain, heart disease, or stroke.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Statistics (Mozaffarian et al, 2015)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Based on 2013 mortality data, there are an estimated 85.6 million Americans living with some form of cardiovascular disease. Of these, more than 43 million are estimated to be over the age of 60.</para></listitem>
<listitem><para>Mortality: From 2003 to 2013, death rates attributable to cardiovascular disease (CVD) declined 28.8% yet still accounted for almost one of every three deaths in the United States. There were 614,348 deaths from heart disease in 2014. Heart disease accounted for 24.5% of all deaths in males and 22.3% of all deaths in females (Heron, 2016 [data are for 2014]).</para></listitem>
<listitem><para>Cost: The estimated direct and indirect costs of cardiovascular diseases and stroke for 2011 to 2012 were $316.6 billion (Mozaffarian et al, 2015). <emphasis>Note:</emphasis> Compiling accurate costs of the various treatments for coronary artery diseases is problematic because of absence of standardization of costs across the United States, as well as the wide variety of individual treatments. For example, one consumer information website (updated 2017) listed a range of $11,298 to $36,221 for an average heart stent placement surgery in Oregon. At a hospital in Wisconsin, placement of one cardiac stent that is coated with long-release medication carries a median hospital charge of $41,228 (&ldquo;Heart Stent Cost,&rdquo; 2017).</para></listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0032note0042"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Angioplasty: </emphasis>See Percutaneous coronary interventions (PCIs), below.</para>
<para><emphasis role="strong">Cardiac biomarkers: </emphasis>Substances that are released into the blood when the heart is damaged or stressed. Measurement of these biomarkers is used to help diagnose, monitor, and manage people with suspected ACS and cardiac ischemia. The current biomarker test of choice for detecting heart damage is troponin (see below). Other cardiac biomarkers (e.g., CK, CK-MB, myoglobin) are less specific for the heart and may also be elevated in skeletal muscle injury, liver disease, or kidney disease (Lab Tests Online, 2015).</para>
<para><emphasis role="strong">Coronary artery disease (CAD): </emphasis>Disease in which there is a narrowing or blockage of the coronary arteries that carry blood and oxygen to the heart muscle.</para>
<para><emphasis role="strong">Metabolic syndrome: </emphasis>A cluster of metabolic disorders that increases risk for cardiovascular disease, especially when three or more conditions are present: (1) abdominal obesity (waist circumference of 40 inches or above in men and 35 inches or above in women), (2) triglyceride level of &gt;150 (mg/dL), (3) HDL cholesterol of less than 40 mg/dL in men or less than 50 mg/dL in women, (4) systolic blood pressure of 130 mm Hg or greater or diastolic blood pressure of 85 mm Hg or greater, and (5) fasting glucose of 100 mg/dL or greater.</para>
<para><emphasis role="strong">Myocardial infarction (MI): </emphasis>An occlusion or blockage of arteries supplying the muscles of the heart, resulting in injury or necrosis of the heart muscle (heart attack).</para>
<para><emphasis role="strong">Occlusive thrombus: </emphasis>Blood clot that completely blocks a coronary artery.</para>
<para><emphasis role="strong">Percutaneous coronary interventions (PCIs), also known as angioplasty: </emphasis>A nonsurgical procedure used to treat stenotic coronary arteries of the heart found in coronary heart disease. During PCI, a cardiologist feeds a deflated balloon or other device on a catheter from the inguinal femoral artery or radial artery up through blood vessels until it reaches the site of blockage in the heart. X-ray imaging is used to guide the catheter threading. At the blockage, the balloon is inflated to open the artery, allowing blood to flow. A stent is often placed at the site of blockage to permanently open the artery.</para>
<para><emphasis role="strong">Non-ST-segment elevation myocardial infarction (NSTEMI): </emphasis>Development of heart muscle necrosis without the ECG change of ST-segment elevation, resulting from an acute interruption of blood supply to a part of the heart and demonstrated by an elevation of cardiac markers (CK-MB or troponin) in the blood. NSTEMI involves less than full-thickness damage of heart muscle and is, therefore, a less severe type of heart attack than <emphasis role="strong">STEMI </emphasis>(see below) (&ldquo;NSTEMI,&rdquo; 2017).</para>
<para><emphasis role="strong">ST-segment elevation myocardial infarction (STEMI): </emphasis>Occurs by complete occlusion of a major coronary artery that produces an entire thickness damage of heart muscle (transmural). This damage of heart muscle produces an ECG change of ST-segment elevation.</para>
<para><emphasis role="strong">Troponin (also known as cardiac-specific troponin I [cTn I] and troponin T [cTn T]): </emphasis>Blood test used to help diagnose a heart attack, to detect and evaluate mild to severe heart injury, and to distinguish chest pain that may be due to other causes.</para>
<para><emphasis role="strong">Unstable angina (UA): </emphasis>Chest pain produced when the heart muscle is not getting enough blood flow is considered &ldquo;unstable&rdquo; when it no longer follows the predictable patterns typical of &ldquo;stable angina.&rdquo; Unstable angina is called &ldquo;unstable&rdquo; for two reasons: (1) symptoms occur in a more random and unpredictable fashion, and (2) it is most often caused by the actual rupture of a plaque in a coronary artery, resulting in clot formation, with impairment of free blood flow to tissues. The imminent risk of a complete myocardial infarction is very high in unstable angina. Such a condition is quite &ldquo;unstable&rdquo; and for this reason is a medical emergency (Fogoros, 2011b).</para></note>
<sect2 id="ch0002s0033"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Client may have a short hospitalization during acute stage for stabilization and possible cardiac revascularization. The client who has sustained a STEMI or is judged to be at intermediate or high risk for MI will be hospitalized for further evaluation and therapeutic intervention.</para>
</sect2>
<sect2 id="ch0002s0034"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0037">Angina: chronic/stable</link></para>
<para><link linkend="ch0002s0053">Cardiac surgery</link></para>
<para><link linkend="ch0002s0047">Dysrhythmias</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<table frame="top" id="ch0002s0032ta0023"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Sedentary lifestyle</para></listitem>
<listitem><para>Weakness, feeling incapacitated after exercise</para></listitem>
<listitem><para>Fatigue</para></listitem>
<listitem><para>Activities and sleep disrupted by pain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Exertional dyspnea</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of heart disease, hypertension in self</para></listitem>
<listitem><para>Palpitations</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachycardia, dysrhythmias</para></listitem>
<listitem><para>Blood pressure (BP) may be normal, elevated, or decreased</para></listitem>
<listitem><para>Heart sounds may be normal, late S<subscript>4</subscript> or transient late systolic murmur may be evident during pain</para></listitem>
<listitem><para>Moist, cool, pale skin in presence of vasoconstriction</para></listitem>
<listitem><para>Orthostatic blood pressure changes</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Stressors of work, family, others, and financial concerns</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Apprehension, uneasiness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Nausea, &ldquo;heartburn,&rdquo; or epigastric distress</para></listitem>
<listitem><para>Diet high in cholesterol and fats, salt, caffeine, liquor</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of dizziness, fainting spells, transient numbness, tingling in extremities</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis>Note:</emphasis> Ischemia anywhere in the body can produce transient neurological symptoms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis>Note:</emphasis> Reports of pain location and severity differ between men and women.</para>
<itemizedlist mark="&bull;">
<listitem><para>Substernal or anterior chest pain that may radiate to jaw, neck, shoulders, and upper extremities, often to left side more than right. Women may report pain between shoulder blades, back pain.</para></listitem>
<listitem><para><emphasis role="bi">Quality:</emphasis> Varies from transient and mild to moderate, heavy pressure, tightness, squeezing, burning. Women may report dull aching pain.</para>
</listitem>
<listitem><para><emphasis role="bi">Duration:</emphasis> Usually more than 15 minutes</para></listitem>
<listitem><para><emphasis role="bi">Precipitating factors:</emphasis> May be unpredictable or occur during rest or sleep</para></listitem>
<listitem><para><emphasis role="bi">Relieving factors:</emphasis> Pain may not be responsive to relief mechanisms, such as rest and antianginal medications</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Placing fist over midsternum</para></listitem>
<listitem><para>Rubbing left arm, muscle tension</para></listitem>
<listitem><para>Autonomic responses, for example, tachycardia, blood pressure changes</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Exertional dyspnea, which may resolve with rest or pain relief</para></listitem>
<listitem><para>Smoking history</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Increased rate and rhythm, alteration in depth</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history or risk factors of CAD: obesity, sedentary lifestyle, hypertension, stroke, diabetes, smoking, and hyperlipidemia</para></listitem>
<listitem><para>Use or misuse of cardiac, antihypertensive, and over-the-counter (OTC) drugs</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Assistance with physical care, medication management, homemaker or maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0032ta0024"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart to detect dysrhythmias, to identify any myocardial ischemia present or any damage to myocardial tissue from the past.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In the emergency setting, ECG is the most important diagnostic test. It may show changes during symptoms and in response to treatment; confirms a cardiac basis for symptoms.</para>
<para>It also may demonstrate preexisting structural or ischemic heart disease (left ventricular hypertrophy, Q waves).</para>
<para>ECG changes associated with unstable angina (UA) include ST-segment depression, transient ST-segment elevation, and T-wave inversion or some combination of these factors (Coven et al, 2016). <emphasis>Note:</emphasis> Unstable angina may be associated with new electrocardiographic changes but can be present in the absence of ECG changes (Manesh et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Echocardiography (also called two-dimensional echocardiogram and Doppler ultrasound):</emphasis> Provides visual of working heart and structures.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May play an important role in the setting of ACS as it identifies regional wall motion abnormalities associated with myocardial ischemia.</para>
<para>An echocardiogram can also help in defining the extent of an infarction when muscle damage occurs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac catheterization with angiography:</emphasis> Assesses patency of coronary arteries, reveals abnormal heart and valve size or shape, and evaluates ventricular contractility.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac catheterization defines coronary anatomy and the extent of a client&rsquo;s disease. Client in early stages of an acute heart attack or client with intractable angina (despite medication) should immediately undergo cardiac catheterization and stent placement to stop damage to heart muscle and/or to stabilize plaque (Coven et al, 2016; Fogoros, 2016a).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Coronary computed tomography angiography (CTA) (also called CT angiography or fast CT):</emphasis> High-resolution, three-dimensional pictures of the moving heart and great vessels.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Scanners can do a full cardiac scan in 10 seconds and produce high-resolution images that allow fine details of coronary arteries to be seen. This technology allows for noninvasive and early diagnosis of CAD and thus earlier treatment before the coronary arteries become more or completely occluded.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Documents heart size and visualizes infiltrates that may be present in the lung.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps in assessing cardiomegaly and pulmonary edema, or it may reveal complications of ischemia, such as pulmonary edema.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac enzymes, including troponin I and troponin T. Also CK-MB:</emphasis> Substances released from heart muscle when it is damaged.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac-specific troponins are not detectable in the blood of healthy individuals; therefore, they provide high specificity for detecting injury to cardiac contractile muscle. Troponins are also more sensitive than CK-MB for myocardial necrosis and therefore improve early detection of small myocardial infarctions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis>Note:</emphasis> Some research has supported the use of point-of-care testing for cardiac troponin (PoCT-cTn). Results are rapidly available and can be used to rule out or rule in ACS, thereby facilitating timely treatment (Chew et al, 2011; Li et al, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">C-reactive protein (CRP):</emphasis> A marker for inflammation.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Growing numbers of studies suggest that elevation of high-sensitive CRP (hs-CRP) levels predict clinical outcomes in ACS and may be used in conjunction with troponin I or T levels to identify high-risk patients for more aggressive management with antiplatelet agents and statins (Shrivastava et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Metabolic profile, including blood glucose electrolytes BUN/Cr</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Important for client with new-onset angina. Close monitoring of potassium and magnesium levels is important in client with ACS because low levels may predispose to ventricular dysrhythmias. Creatinine levels must be considered before using an angiotensin-converting enzyme (ACE) inhibitor and particularly if cardiac catheterization is considered.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum lipids, including total lipids, lipoprotein electrophoresis, isoenzymes, cholesterols (HDL, LDL, very low-density lipoprotein [VLDL]), triglycerides, and phospholipids:</emphasis> A group of tests that make up a lipid profile.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The presence of lipid abnormalities increases the risk of CAD. <emphasis>Note:</emphasis> Recently, an elevated triglyceride (Tg) has been identified as an <emphasis>independent</emphasis> risk factor for development of coronary artery disease (Van Leeuwen &amp; Bladh, 2015).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Coagulation studies, including partial thromboplastin time (PTT), activated partial thromboplastin time (aPPT), and platelets:</emphasis> Injury to a vessel wall or the tissue initiates the coagulation cascade and formation of a thrombus.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Thrombus formation can potentiate ischemic damage to the myocardium as blood flow is blocked.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0035"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Relieve or control pain.</para></listitem>
<listitem><para>Prevent or minimize development of myocardial complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment.</para></listitem>
<listitem><para>Support client or significant other (SO) in initiating necessary lifestyle or behavioral changes.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0036"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Desired activity level achieved, with return to activity baseline, and self-care needs met with minimal or no pain.</para></listitem>
<listitem><para>Remains free of complications.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Participates in treatment program and behavioral changes.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0002s0032note0043"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Biological agents (tissue ischemia, increased cardiac workload and oxygen consumption, decreased myocardial blood flow)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbal/coded reports of pain</para>
<para>Expressive behaviors (such as moaning, crying, pacing, or restlessness)</para>
<para>Diaphoresis; changes in blood pressure, heart rate, respiratory rate, pupillary dilation</para>
<para>Self-focus</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report pain is relieved or controlled.</para>
<para>Demonstrate relief of pain as evidenced by stable vital signs and absence of muscle tension and restlessness.</para></note>
<note role="none" id="ch0002s0032note0044"><table frame="top" id="ch0002s0032ta0025"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client to notify nurse immediately when chest pain occurs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain and decreased cardiac output may stimulate the sympathetic nervous system to release excessive amounts of norepinephrine, which increases platelet aggregation, and release of thromboxane A2. This potent vasoconstrictor causes coronary artery spasm, which can precipitate, complicate, and prolong an anginal attack. Unbearable pain may cause vasovagal response, thus decreasing BP and heart rate.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify precipitating event, if any; identify frequency, duration, intensity, and location of pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps differentiate chest pain and aids in evaluating possible progression or process. Pain associated with UA, NSTEMI, and STEMI is usually intense, occurs unpredictably, may last a longer period of time, and is not usually relieved by nitroglycerine (NTG) or rest.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate reports of pain in jaw, neck, shoulder, arm, or hand (typically on left side).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac pain may radiate; for example, pain is often referred to more superficial sites served by the same spinal cord nerve level.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess and document client response and effects of medication.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about progression of coronary blockage. Aids in evaluating effectiveness of interventions and may indicate need for change in therapeutic regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs every 5 minutes during initial pain attack.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>BP may initially rise because of sympathetic stimulation and then fall if cardiac output is compromised. Tachycardia also develops in response to sympathetic stimulation and may be sustained as a compensatory response if cardiac output falls.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor heart rate and rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with unstable angina has an increased risk of acute life-threatening dysrhythmias, which occur in response to ischemic changes and stress hormones. (Refer to ND: <link linkend="ch0002s0022note0013">risk for decreased Cardiac Output</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Place client at complete rest during anginal episodes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces myocardial oxygen demand to minimize risk of tissue injury and necrosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Elevate head of bed if client is short of breath.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates gas exchange to decrease hypoxia and resultant shortness of breath.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for associated symptoms, such as dyspnea, nausea, vomiting, dizziness, palpitations, and desire to urinate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased cardiac output (which may occur during ischemic myocardial episode) stimulates sympathetic or parasympathetic nervous system, causing a variety of vague sensations that client may not identify as related to anginal episode.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Stay with client who is experiencing pain or appears anxious.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anxiety releases catecholamines, which increase myocardial workload and can escalate or prolong ischemic pain. Presence of nurse can reduce feelings of fear and helplessness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain quiet, comfortable environment; restrict visitors as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mental or emotional stress increases myocardial workload.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate in treatment of condition.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Initial therapy for ACS should focus on stabilizing the client&rsquo;s condition, relieving ischemic pain, and providing antithrombotic therapy to reduce myocardial damage and prevent further ischemia. (Refer to NDs: <link linkend="ch0002s0032note0045">risk for decreased cardiac Tissue Perfusion</link>, and <link linkend="ch0002s0032note0047">risk for decreased Cardiac Output</link>, for discussion of additional medications.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide supplemental oxygen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases oxygen available for myocardial uptake to relieve ischemic pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer analgesics, such as morphine sulfate (MS) or fentanyl (Duragesic) by appropriate route.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potent opioid analgesic may be used in acute angina because of its beneficial side effects. Such effects include peripheral vasodilation and reduced myocardial workload; sedation, which produces relaxation; and interrupted flow of vasoconstricting catecholamines, thereby effectively relieving severe chest pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer antianginal medication(s) promptly, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sublingual and/or IV nitroglycerin</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nitrates do not improve mortality. However, they provide symptomatic relief by means of several mechanisms, including coronary vasodilation, improved collateral myocardial blood flow, and reduction of cardiac workload (Fogoros, 2016a).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Calcium channel blockers, such as bepridil (Vascor), amlodipine (Norvasc), nicardipine (Cardene), nifedipine (Procardia), felodipine (Plendil), isradipine (DynaCirc), and diltiazem (Cardizem)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Produce relaxation of coronary vascular smooth muscle, dilate coronary arteries, and decrease peripheral vascular resistance.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0032note0045"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased cardiac Tissue Perfusion</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by Risk Factors of</emphasis></para>
<para>Hypoxemia, hypertension; coronary artery spasm</para>
<para>Elevated C-reactive protein; hyperlipidemia</para>
<para>Family history of cardiac disease</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate adequate coronary perfusion as appropriate (e.g., vital signs within client&rsquo;s normal range; free of chest pain or discomfort).</para>
<para>Participate in behaviors and activities that reduce the workload of the heart.</para>
</note>
<note role="none" id="ch0002s0032note0046"><table frame="top" id="ch0002s0032ta0026"><title/>
<tgroup colsep="0" rowsep="0" cols="4">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<colspec colnum="4" colname="4" align="left" colsep="0"/>
<spanspec spanname="1-3" namest="1" nameend="3"/>
<spanspec spanname="2-3" namest="2" nameend="3"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-3">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="strong">Hemodynamic Regulation <inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Maintain bedrest or chair rest in position of comfort during acute episode.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases oxygen consumption and demand, reducing myocardial workload and risk of decompensation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Monitor vital signs and cardiac rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia and changes in blood pressure (hypotension or hypertension) may be present because of pain, anxiety, hypoxemia, and circulating stress hormones.</para>
<para>ECG changes reflecting ischemia and dysrhythmias indicate need for additional evaluation and therapeutic intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Auscultate breath sounds and heart sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>S<subscript>3</subscript>, S<subscript>4</subscript> may occur with cardiac decompensation or pulmonary complication.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Monitor for and document effects of and adverse response to medications, noting BP, heart rate, and rhythm (especially when giving combination of calcium antagonists, beta blockers, and nitrates).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Desired effect is to decrease myocardial oxygen demand by decreasing cardiac stress. Drugs with negative inotropic properties can decrease perfusion to an already ischemic myocardium.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Encourage immediate reporting of pain for prompt administration of medications, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Timely interventions can reduce oxygen consumption and myocardial workload and may prevent or minimize cardiac complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Assess for signs and symptoms of heart failure.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angina is only a symptom of underlying pathology causing myocardial ischemia. Progression of disorder may compromise cardiac function to point of decompensation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Monitor serial ECG, noting ST-segment changes associated with ischemia.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ischemia associated with NSTEMI or UA may cause transient ST-segment depression or elevation and T-wave inversion. Serial tracings verify ischemic changes, which may disappear when client is pain free. They also provide a baseline against which to compare later pattern changes. If ST-segment is elevated or other ECG changes occur over a short time, STEMI myocardial infarction is most likely evolving. Refer to CP: <link linkend="ch0002s0042">Myocardial Infarction</link>.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Administer supplemental oxygen as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases oxygen available for myocardial uptake to improve contractility and reduce ischemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Monitor pulse oximetry or arterial blood gases (ABGs), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oxygen saturation may decrease as oxygen demands increase for heart muscle and systemic circulation. Monitoring determines adequacy of respiratory function and O<subscript>2</subscript> therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Statins, such as atorvastatin (Lipitor), simvastatin (Zocor), and others</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Statins may be given emergently to lower circulating cholesterol and to stabilize plaque deposits, reducing the likelihood of plaque rupture (Mayo Clinic Staff, 2016a).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Beta blockers, such as metoprolol (Lopressor), nadolol (Corgard), and esmolol (Brevibloc)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers have antiarrhythmic and antihypertensive properties, as well as the ability to reduce ischemia. They minimize the imbalance between myocardial supply and demand by reducing afterload and wall stress (Coven et al, 2016; Mayo Clinic Staff, 2016a).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Antiplatelet therapy, including aspirin (Anacin, Bayer aspirin)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aspirin remains a first-line therapy for managing patients with UA/NSTEMI and is often given in prehospital transport or emergency room (Anderson, 2013; Mayo Clinic Staff, 2016a).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Other drugs (such as ticagrelor [Brilinta], clopidogrel [Plavix], and prasugrel [Effient])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aspirin plus an anticoagulant (e.g., heparin) may be followed by a second antiplatelet agent (e.g., clopidogrel, ticagrelor) or an intravenous glycoprotein IIb/IIIa agent before angiography (Anderson, 2013; Vallerand et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Glycoprotein IIb/IIIa receptor antagonists such as abciximab (ReoPro), eptifibatide (Integrilin), and tirofiban (Aggrastat)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These agents prevent the binding of fibrinogen, thereby blocking platelet aggregation, and in combination with aspirin are considered standard antiplatelet therapy for client at high risk for unstable angina. Tirofiban has been approved for use in combination with heparin for patients with UA who are being treated medically and for patients undergoing PCI (Coven et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="2-3">
<para>Anticoagulants, such as heparin, and low-molecular-weight heparins (LMWHs), such as enoxaparin (Lovenox) and dalteparin (Fragmin)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An IV bolus of heparin, followed by continuous infusion, is recommended to help reduce risk of subsequent MI by reducing the thrombotic complications of plaque rupture for clients diagnosed with intermediate or high-risk UA.</para>
<para>Use of low-molecular-weight heparins is increasing because they are more predictable, have fewer adverse effects, and do not require anticoagulation monitoring (Anderson, 2013; Vallerand et al, 2017).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-3">
<para>Prepare for interventions such as angioplasty (with or without intracoronary stent placement) or bypass/grafting, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Angioplasty, also called percutaneous coronary intervention (PCI) or transluminal coronary angioplasty (PTCA), is a procedure carried out to improve coronary blood flow. Angioplasty opens coronary arteries narrowed or blocked by atherosclerotic plaque and may be used to relieve symptoms of ACS or to reduce heart damage during or after a heart attack.</para>
<para>Intracoronary stents may be placed to provide structural support within the coronary artery and improve the odds of long-term patency. Some stents (called drug-eluting stents) are coated with slow-releasing drugs to prevent fibrosis that, together with clots, could block the stented artery, a process called restenosis (Beckerman, 2016).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0032note0047"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by</emphasis></para>
<para>Alteration in heart rate or rhythm</para>
<para>Altered contractility, stroke volume</para>
<para>Altered preload</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain hemodynamic stability, such as BP, cardiac output within normal range, adequate urinary output, decreased frequency or absence of dysrhythmias.</para>
<para>Report/demonstrate decreased episodes of dyspnea and angina.</para>
</note>
<note role="none" id="ch0002s0032note0048"><table frame="top" id="ch0002s0032ta0027"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Cardiac Care: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obtain blood pressure (BP) readings. Compare both arms and obtain lying, sitting, and standing pressures when able.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypotension may occur related to ventricular dysfunction, hypoperfusion of the myocardium, and vagal stimulation. However, hypertension is also a common phenomenon, possibly related to pain, anxiety, catecholamine release, and preexisting vascular problems.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor heart rate and rhythm. Document dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dysrhythmias, especially premature ventricular contractions or heart blocks, can compromise cardiac function or increase ischemic damage. Acute or chronic atrial flutter or fibrillation may be seen with coronary artery involvement and may or may not be pathological.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate heart sounds. Note development of S<subscript>3</subscript> and S<subscript>4</subscript>.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>S<subscript>4</subscript> may be associated with myocardial ischemia, ventricular stiffening, and pulmonary or systemic hypertension. S<subscript>3</subscript> is usually associated with heart failure, but it may also be noted with left ventricular overload that can accompany infarction in STEMI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Crackles reflect pulmonary congestion; may develop because of depressed myocardial function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Have emergency equipment and medications available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sudden coronary occlusion, lethal dysrhythmias, extension of infarct, and unrelenting pain are situations that may precipitate cardiac arrest, requiring immediate life-saving therapies or transfer to the critical care unit (CCU).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases amount of oxygen available for myocardial uptake, reducing ischemia and resultant cellular irritation and dysrhythmias.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review serial ECGs, noting onset or resolution of dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information regarding progression or resolution of ischemia and status of coronary perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review chest x-ray.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reflect pulmonary edema related to ischemia and ventricular dysfunction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory data, such as cardiac enzymes, arterial blood gases (ABGs), and electrolytes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enzymes monitor resolution or extension of infarction. Presence of hypoxia indicates need for supplemental oxygen. Electrolyte imbalances, such as hypo- or hyperkalemia, adversely affect cardiac rhythm and contractility.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain IV or saline-lock access, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Patent line is important for administration of fluids to support circulation and to administer emergency drugs in the presence of persistent lethal dysrhythmias or chest pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angiotensin-converting enzyme inhibitors (ACEIs) such as benazepril (Lotensin), enalapril (Vasotec), and lisinopril (Zestril)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Given to expand blood vessels, allowing heart to work more easily and efficiently, and improving cardiac output/systemic perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angiotensin receptor blockers (ARBs), such as isosartan (Cozaar), valsartan (Diovan), and irbesartan (Avapro)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps lower blood pressure, alone or in combination with other agents, in order to reduce systemic vascular resistance and improve organ perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antidysrhythmic drugs (refer to CP: <link linkend="ch0002s0047">Dysrhythmias</link>)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dysrhythmias are usually treated symptomatically but have the potential for becoming lethal; therefore, must be monitored diligently and treated promptly.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to CP: <link linkend="ch0002s0042">Myocardial Infarction</link> for additional interventions.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>If STEMI is occurring, many more supportive interventions may be needed.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0032note0049"><title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, postprocedural care, potential complications</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information</para>
<para>Alteration in cognitive functioning or memory</para>
<para>Insufficient knowledge of resources</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instruction</para>
<para>Development of preventable complication</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Coronary Artery Disease</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, postprocedure needs, and potential complications.</para>
<para>Identify individual risk factors.</para>
<para>Initiate necessary lifestyle changes.</para>
</note>
<note role="none" id="ch0002s0032note0050"><table frame="top" id="ch0002s0032ta0028"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Cardiac Risk Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reinforce explanation of ACS incident, associated procedures and treatment provided, and self-care needs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individually specific information creates knowledge base for management of condition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Begin with information client already knows and move to what client does not know, progressing from simple to complex. Use short simple sentences and concepts initially. Repeat and summarize as needed. Avoid giving too much information in one setting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This client has often come into acute care because of a sudden-onset chest pain and experienced all the chaos of a life-threating medical emergency. In addition to the &ldquo;brain fog&rdquo; of being very sick initially, the client is subjected to overwhelming demands of major healthcare decisions in a short period. Teaching must be geared to the client&rsquo;s cognitive and physical abilities of the moment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Deal with client&rsquo;s/family&rsquo;s anxiety or other strong emotions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anxiety can interfere with ability to learn or retain information. The nurse may need to adjust timing or sequence of teaching to improve client/family retention comprehension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide written information or guidelines for client/caregiver to refer to as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reinforces the learning process and allows client to proceed at own pace.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage identification and reduction of individual risk factors such as smoking, alcohol consumption, and obesity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These behaviors and lifestyle factors have direct adverse effects on cardiovascular function, may impede recovery, and increase risk for complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss appropriate activity/exercise guidelines and limitations (e.g., avoiding long periods of standing; not lifting heavy objects).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individual capabilities and expectations depend on type of procedure performed, location of the catheter insertion (e.g., femoral or radial artery), underlying cardiac function, and prior physical conditioning.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Remind client to rest as needed. Encourage setting of realistic goals for activities and/or cardiac rehabilitation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These needs vary per individual. Client may feel weak and fatigued after procedure (typical) or be feeling effects of recent ACS and ongoing heart issues.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review medication regimen, including new drugs as well as drugs client was taking prior to incident. Discuss schedule for taking each medication, as well special instructions (e.g., don&rsquo;t take NSAIDs while on anticoagulants).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment regimen may be complex with numerous drugs, addition of/removal of certain medications, etc. The age and severity of client&rsquo;s current illness can interfere with full understanding of treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide medication list in writing. Discuss expected drug effects, as well as potential side effects and interactions. Review potential problems that need reporting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client/caregiver understand medication plan, and know when to contact a healthcare professional.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of checking with physician before taking OTC drugs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>OTC drugs may potentiate or negate effects of prescribed medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss use of herbals such as ginseng, garlic, ginkgo, hawthorn, and bromelain, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some herbals can affect bleeding and clotting, especially when added to medications such as Plavix or Coumadin, which increase bleeding. Others, such as hawthorn, can increase the effects of certain heart medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review catheter insertion site care and reportable symptoms, as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instructions may include such things as when to take the dressing off, what the site may look like (e.g., bruised, swollen, slightly pink), when to shower/bathe, and use of lotions/ointments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize symptoms to be reported to physician, particularly recurrence of chest pain, development of hematoma, or bleeding at catheter site; changes in response to medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge of expectations can not only avoid undue concern for insignificant events but also prevent delay in treatment of worrisome symptoms.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify services and resources available after discharge.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provides for ongoing monitoring, continuation of prescribed therapies, and support for lifestyle changes.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0032note0051"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following discharge from care setting (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">acute Pain</emphasis>&mdash;biological agents (decreased myocardial blood flow, tissue ischemia)</para></listitem>
<listitem><para><emphasis role="bi">Activity Intolerance</emphasis>&mdash;imbalance between oxygen supply and demand, sedentary lifestyle</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, perceived barriers, economic difficulties</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0002s0037"><title><emphasis role="strong">ANGINA: CHRONIC/STABLE</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology (Fihn et al, 2012; Mayo Clinic Staff, 2016c; National Guideline Clearinghouse [NCG], 2012; Roth, 2015)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Chronic/stable angina is an episodic clinical manifestation of ischemic heart disease due to transient myocardial ischemia. May be called &ldquo;angina pectoris,&rdquo; &ldquo;stable ischemic heart disease&rdquo; (SIHD), or &ldquo;ischemic heart disease&rdquo; (IHD).</para></listitem>
<listitem><para>Stable means no increase in frequency or severity of attacks over a prolonged period of time.</para></listitem>
<listitem><para>Usually presents as chest discomfort precipitated by stress or exertion that rapidly resolves with rest or nitrates.</para></listitem>
<listitem><para>Pain follows a trackable, predictable pattern (e.g., occurs when climbing stairs, during exposure to cold, after heavy meals, when feeling rushed or angry) and is similar in nature to previous chest pain.</para></listitem>
<listitem><para>Most commonly caused by atherosclerotic coronary artery disease (CAD).</para></listitem>
<listitem><para>Atypical presentations of angina are more common in women than in men. Heart disease in men is more often due to blockages in the coronary arteries, referred to as <emphasis role="strong">obstructive </emphasis>CAD. Women more frequently develop heart disease within the very small arteries that branch out from the coronary arteries. This is referred to as <emphasis role="strong">microvascular disease </emphasis>(MVD) and occurs particularly in younger women (American Heart Association [AHA], 2015b)</para></listitem>
<listitem><para>Many people experience anginal attacks despite revascularization and pharmacological antianginal treatments. This is sometimes classified as refractory angina. See <link linkend="ch0002s0037note0052">Glossary</link> (Mannheimer et al, 2002).</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Etiology (Mozaffarian et al, 2016; NCG, 2012; Snow et al, 2004)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Conditions that create increased myocardial oxygen demand (including hyperthyroidism, hyperthermia, stimulant use (e.g., cocaine and others), valvular disease such as aortic stenosis, and severe uncontrolled hypertension</para></listitem>
<listitem><para>Conditions that create diminished myocardial oxygen supply, such as anemia, or hypoxemia secondary to pulmonary disease</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Diagnosis and Management</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>A diagnosis of stable angina can be based on clinical assessment alone or with the addition of diagnostic testing such as stress testing.</para></listitem>
<listitem><para>Management of stable angina includes (1) lifestyle changes (a key aspect of angina management), namely in the areas of diet, exercise, smoking, diabetes, hypertension, and psychological issues, and (2) medical therapy, the aim of which is to help reduce symptoms and prevent cardiovascular events (Bellchambers et al, 2016; Montalescot et al, 2013).</para></listitem>
<listitem><para>Complications of angina pectoris include unstable angina, MI, cardiogenic shock, heart failure, cardiac arrest, and death.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Statistics:</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Prevalence: Stable angina affects more than 8 million people in the United States each year (Mozaffarian et al, 2016). The prevalence of chronic stable angina (as reported in 2010) increases with age for women but peaks between 55 and 65 years of age for men and then declines (Lloyd-Jones et al, 2010).</para></listitem>
<listitem><para>Morbidity: A recent study reported that patients with stable CAD and angina have higher rates of future cardiovascular events compared with patients without angina, especially heart failure, cardiovascular hospitalization, and coronary revascularization (Eisen et al, 2016).</para></listitem>
<listitem><para>Mortality: There were 614,348 deaths from heart disease in 2014 (includes ischemic heart disease, inclusive of but not specifically angina) (Heron, 2016)).</para>
<para>Cost: Direct and indirect costs of coronary artery disease were estimated to have topped $177 billion in 2010 (includes but is not specific to angina) (Kohan &amp; Annex, 2015).</para></listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0037note0052"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Angina: </emphasis>Chest pain or discomfort that occurs if an area of heart muscle doesn&rsquo;t get enough oxygen-rich blood. Angina isn&rsquo;t a disease; it&rsquo;s a symptom of an underlying heart problem, usually <emphasis role="strong">coronary heart disease </emphasis>(National Institutes of Health [NIH], 2011a).</para>
<para><emphasis role="strong">Angioplasty (also called percutaneous transluminal coronary angioplasty or PTCA or percutaneous coronary intervention [PCI]): </emphasis>Procedure that increases coronary blood flow by compression of atheromatous lesions and dilation of the vessel lumen in an occluded coronary artery.</para>
<para><emphasis role="strong">Cardiovascular disease (CVD): </emphasis>Diseases of the heart and blood vessels.</para>
<para><emphasis role="strong">Coronary artery disease (CAD): </emphasis>A disease in which there is a narrowing or blockage of the coronary arteries that carry blood and oxygen to the heart muscle.</para>
<para><emphasis role="strong">Hypertension (HTN): </emphasis>High blood pressure.</para>
<para><emphasis role="strong">Metabolic syndrome: </emphasis>Name for a group of risk factors (e.g., fasting hyperglycemia and insulin resistance, hypertension, central obesity, decreased high-density lipoprotein [HDL] and elevated low-density lipoprotein [LDL] cholesterol, elevated triglycerides) that raises the risk of heart disease.</para>
<para><emphasis role="strong">Refractory angina: </emphasis>A chronic condition characterized by the presence of angina caused by coronary insufficiency in the presence of CAD, which is not amenable to a combination of medical therapy, angioplasty, or coronary bypass surgery in a patient with evidence of ischemia (Mannheimer et al, 2002).</para></note>
<sect2 id="ch0002s0038"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Client may be seen in community physician offices or emergency department. Clients judged to be at intermediate or high risk for MI are often hospitalized for further evaluation and therapeutic intervention.</para>
</sect2>
<sect2 id="ch0002s0039"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0032">Acute coronary syndrome</link></para>
<para><link linkend="ch0002s0053">Cardiac surgery</link></para>
<para><link linkend="ch0002s0047">Dysrhythmias</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<table frame="top" id="ch0002s0037ta0029"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Sedentary lifestyle</para></listitem>
<listitem><para>Weakness, feeling incapacitated after exercise</para></listitem>
<listitem><para>Fatigue</para></listitem>
<listitem><para>Activities and sleep disrupted by pain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Exertional dyspnea</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of heart disease in self or family (especially early age onset)</para></listitem>
<listitem><para>Hypertension in self or family</para></listitem>
<listitem><para>History of MI or revascularization procedure</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Tachycardia, dysrhythmias</para></listitem>
<listitem><para>Blood pressure (BP) normal, elevated, or decreased</para></listitem>
<listitem><para>Heart sounds may be normal, late S<subscript>4</subscript>, or transient late systolic murmur that may be evident during pain</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Stressors of work, family, others, and financial concerns</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Apprehension, uneasiness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Diet high in cholesterol and fats, salt, caffeine, liquor</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis>Note:</emphasis> Individual with chronic stable angina is usually not surprised by pain episodes as they tend to be similar in character and precipitated by predictable factors.</para>
<itemizedlist mark="&bull;">
<listitem><para>Substernal or anterior chest pain that may radiate to jaw, neck, shoulders, and upper extremities, often to left side more than right. Women may report pain between shoulder blades, back pain.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain that is outside of client&rsquo;s usual experience can be indicative of developing a complication.</para>
<itemizedlist mark="&bull;"><listitem><para>Facial grimacing, restlessness</para></listitem>
<listitem><para>Placing fist over midsternum</para></listitem>
<listitem><para>Rubbing left arm, muscle tension</para></listitem>
<listitem><para>Autonomic responses; for example, tachycardia, blood pressure changes</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Quality:</emphasis> Varies from transient and mild to moderate; may describe heavy pressure, tightness, squeezing, burning. Women may report dull aching pain.</para></listitem>
<listitem><para><emphasis role="bi">Duration:</emphasis> Usually less than 15 minutes</para></listitem>
<listitem><para><emphasis role="bi">Precipitating factors:</emphasis> Physical exertion or great emotion, such as anger or sexual arousal; exercise in weather extremes</para></listitem>
<listitem><para><emphasis role="bi">Relieving factors:</emphasis> Pain usually responsive to relief mechanisms, such as rest and antianginal medications</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>If pain is unrelieved by usual means or is worsening, prompt medical evaluation is indicated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dyspnea associated with activity</para></listitem>
<listitem><para>Smoking currently or in the past</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Increased rate and rhythm, alteration in depth</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of falls, fainting spells, or lightheadedness</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Chest pain during sex</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history or risk factors of CAD: obesity, sedentary lifestyle, hypertension, stroke, diabetes, smoking, hyperlipidemia</para></listitem>
<listitem><para>Use or misuse of cardiac, antihypertensive, and over-the-counter (OTC) drugs</para></listitem>
<listitem><para>History of hormone replacement therapy (HRT) in postmenopausal women</para></listitem>
<listitem><para>Use of vitamins or herbal supplements, such as niacin, coenzyme Q10, ginger, bilberry, comfrey, garlic, or L-carnitine</para></listitem>
<listitem><para>Use or misuse of alcohol or illicit drug use, such as cocaine or amphetamines</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Assistance with homemaker or maintenance tasks</para></listitem>
<listitem><para>Changes in physical layout of home</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0037ta0030"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac enzymes, including troponin I and cardiac troponin T, CPK, CK and CK-MB, LDH, and isoenzymes LD<subscript>1</subscript>, LD<subscript>2</subscript>:</emphasis> Substances released from heart muscle when it is damaged.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually within normal limits. Any elevation indicates myocardial damage.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum lipids, including total lipids, lipoprotein electrophoresis, isoenzymes, cholesterols (HDL, LDL, very low-density lipoprotein [VLDL]), triglycerides (TGs), phospholipids:</emphasis> A group of tests that make up a lipid profile.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The presence of lipid abnormalities can increase the risk of CAD and complications. <emphasis>Note:</emphasis> Recent studies suggest that elevated triglyceride is an independent risk <emphasis role="strong">factor </emphasis>for development of CAD (Scordo &amp; Pickett, 2017; Van Leeuwen &amp; Bladh, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">C-reactive protein (CRP):</emphasis> A marker for inflammation.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>CRP levels have been shown to predict risk of both recurrent ischemia and death among those with stable and unstable angina (Jiang et al, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart to detect dysrhythmias, to identify electrolyte imbalance, to identify any myocardial ischemia present or any damage to myocardial tissue from the past.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Often normal when patient at rest or when pain free; depression of the ST-segment or T-wave inversion signifies ischemia. Dysrhythmias and heart block may also be present. Significant Q waves are consistent with a prior MI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Exercise or pharmacological stress electrocardiography (also called stress test, exercise treadmill, or exercise ECG):</emphasis> Raises heart rate and blood pressure using exercise. The heart can also be stressed with drugs such as dobutamine or persantine.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can determine whether pain episodes correlate to ECG or change during exercise or activity. <emphasis>Note:</emphasis> Stress imaging (not exercise ECG) is recommended in (1) client with previous cardiac catheterization and (2) client with a previous revascularization now showing significant change in anginal pattern suggestive of ischemia (Snow et al, 2004; Belleza, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Myocardial perfusion imaging (MPI) scans, which may include stress MPI and single-photon emission computed tomography (SPECT):</emphasis> Scans the heart using radioactive dyes to show areas of increased metabolic activity and decreased blood flow.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>MPI is the most widely used imaging test for the evaluation of suspected myocardial ischemia. SPECT can assess cardiovascular risk with a high degree of accuracy, measuring both ventricular function and relative regional perfusion at rest and with stress.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Calcium scoring (also called coronary artery calcium scoring computed tomography, or CT, scan):</emphasis> Ultrafast CT scan that measures the amount of calcium in the coronary arteries.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Elevated calcium scoring in a client with other risk factors, such as family history, hypertension, diabetes, or hypercholesterolemia, is an indication of some level of CAD.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0040"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Relieve or control pain.</para></listitem>
<listitem><para>Prevent or minimize development of myocardial complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment.</para></listitem>
<listitem><para>Support client or significant other (SO) in initiating necessary lifestyle or behavioral changes.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0041"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Desired activity level achieved, with a return to activity baseline, and self-care needs met with minimal or no pain.</para></listitem>
<listitem><para>Remains free of complications.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Participates in treatment program and behavioral changes.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0002s0037note0053"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">Related to:</emphasis></para>
<para>Biological injury agent (e.g., tissue ischemia)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Self-report of pain characteristics and intensity</para>
<para>Guarding behavior; positioning to ease pain</para>
<para>Changes in physiological parameter (e.g., blood pressure, heart, and respiratory rate)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report relief of chest pain.</para>
<para>Demonstrate relief of pain as evidenced by stable vital signs and absence of muscle tension and restlessness.</para>
<para>Report decrease in frequency, severity of anginal pain, or equivalents over time (specify).</para></note>
<note role="none" id="ch0002s0037note0054"><table frame="top" id="ch0002s0037ta0031"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Perform thorough pain assessment with each reported pain episode, using appropriate pain scale, when client is in acute healthcare setting. Discuss pain episodes client has been experiencing when client is reporting in from home/community (e.g., phone call to office). Identify precipitating event, if any; identify frequency, duration, intensity, and location of pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helpful in identifying changes from client&rsquo;s usual angina discomfort, which has certain typical characteristics in location, duration, or intensity. If nature of angina is changing, angina may become unstable or new-onset coronary occlusion may be occurring.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Ascertain if client has any angina equivalents.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Patient with stable angina may report typical and regularly recurrent symptoms (pain equivalent) rather than chest pain. For example, older patients, those with diabetes, and women often have fatigue and shortness of breath as angina equivalents rather than outright pain (NIH, 2011a &amp; 2011b).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor for changes in vital signs during pain episode if it is different from usual pattern of angina.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>BP may initially rise because of sympathetic stimulation and then fall if cardiac output is compromised. Tachycardia also develops in response to sympathetic stimulation and may be sustained as a compensatory response if cardiac output falls.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate heart rate and rhythm, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with changes may now have unstable angina, with an increased risk of acute life-threatening dysrhythmias, which occur in response to ischemic changes and stress.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess and document client response to and effects of usual medication. Evaluate need for change in medication regimen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with established CAD and/or history of cardiac reperfusion procedures will likely be on a regimen of various medications, including beta blockers, ACE inhibitors, and other drugs, including nitrates, for control of persistent angina discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage client to maintain pain diary documenting frequency, severity, duration, precipitating factors.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows evaluation over time to assess appropriateness of therapeutic regimen, progression of disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate in treatment and monitoring of underlying conditions and status of stable angina, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Management may include changes in medications (e.g., antianginals, antihypertensive, diabetic medications) or may require evaluation for/treatment of new-onset heart problems. Guideline recommendations in 2012 noted that patients with stable ischemic heart disease should receive periodic follow-up at least annually to (1) evaluate symptoms and clinical function; (2) observe for complications of stable angina, including heart failure and dysrhythmias; and (3) monitor risk factors and adequacy of/adherence to recommended lifestyle changes and medical therapy (Qaseem et al, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide supplemental oxygen, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases oxygen available for myocardial uptake and reversal of ischemia. Patient may benefit from periodic oxygen therapy such as during exercise or when dyspnea is occurring.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications as indicated, for example, antiplatelet agents (such as aspirin or clopidogrel [Plavix])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Guideline recommendations for prevention of complications (including MI and death) include 75 to 162 mg daily, continued indefinitely in the absence of contraindications in patients with stable angina (NGC, 2012). Other antiplatelet medications may also be used.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antianginal medication(s) as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nitrates: NTG sublingual (Nitrostat, NitroQuick), metered-dose spray (Nitrolingual, Nitromist), transdermal patch (Minitran, Nitrodisc), and isosorbide (Isordil, Imdur)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nitrate can be used as chronic therapy to help prevent episodes of angina. The biggest problem is &ldquo;tolerance,&rdquo; where chronic exposure to nitrates causes a diminished effect, and the antianginal effect of the drug disappears. Nitrate tolerance can be prevented by scheduling dosing in such a way as to guarantee daily nitrate-free intervals. If client is still experiencing pain after following prescribed nitrate use, further assessment of chest pain and additional interventions may be required.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Miscellaneous anti-ischemic agents (e.g., ranolazine [Ranexa])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardioselective anti-ischemic agent for chronic angina unresponsive to other antianginal treatments (Alaeddini, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers, such as atenolol (Tenormin), carteolol (Cartrol), labetalol (Toprol, Lopressor), and bisoprolol (Zebeta)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The benefits provided by beta blockers have made them the drugs of first choice in treating patients with CAD and angina. In client with angina, beta blockers are effective in improving the amount of exercise that can be performed without developing ischemia or angina. Also, beta blockers are the only antiangina drugs that have been shown to lower the risk of having another myocardial infarction in patients who have already had a heart attack (Fogoros, 2011b).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calcium channel blockers, such as diltiazem (Cardizem, Dilacor), amlodipine (Norvasc), and verapamil (Calan, Covera)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>By reducing calcium influx into muscle cells, calcium channel blockers cause the muscle cells to &ldquo;relax.&rdquo; This relaxing effect results in the dilation of blood vessels and a reduced force of contraction of the heart muscle. In treating angina, the most commonly used calcium blockers are the longer-acting forms of diltiazem and verapamil, Norvasc, or Plendil.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review ECG, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ischemia during an anginal attack may cause transient ST-segment depression or elevation and T-wave inversion. Serial tracings verify ischemic changes, which may disappear when client is pain free or may reveal a new-onset cardiac blockage.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for/assist with additional diagnostic studies, procedures, or interventions, as indicated. (Refer to CPs: <link linkend="ch0002s0032">Acute Coronary Syndrome</link>; <link linkend="ch0002s0053">Cardiac Surgery</link>, for related interventions.)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>If angina is atypical or unrelenting, complications may be occurring, such as MI, new-onset occlusion, coronary artery restenosis, or blockage of stent in client who has had past revascularization procedures. <emphasis>Note: </emphasis>Revascularization may be required (usually CABG) when testing confirms myocardial ischemia due to left main coronary artery disease or symptomatic three-vessel disease, especially in those with left ventricular dysfunction.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0037note0055"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Activity Intolerance</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by</emphasis></para>
<para>Circulatory problem [imbalance between oxygen supply and demand]</para>
<para>Altered heart rate, rhythm</para>
<para>Physical deconditioning (weakness, sedentary lifestyle; aging) [side effects of medications]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate increased activity tolerance.</para>
<para>Report or display decreased episodes of dyspnea, angina, and dysrhythmias.</para>
<para>Participate in behaviors and activities that reduce the workload of the heart.</para>
</note>
<note role="none" id="ch0002s0037note0056"><table frame="top" id="ch0002s0037ta0032"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Hemodynamic Regulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate client&rsquo;s level of physical activity when not experiencing angina.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides a baseline for determining activity tolerance and future needs. <emphasis>Note:</emphasis> Client may be frail from age, comorbid conditions, or has self-limited activities to avoid anginal episodes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs and cardiac rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia and changes in blood pressure (hypotension or hypertension) may be present because of pain, anxiety, hypoxemia, and reduced cardiac output. ECG changes reflecting ischemia and dysrhythmias indicate need for additional evaluation and therapeutic intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess BP before, during, and after activities, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps in identifying actions/activities that can affect blood pressure. Changes in or timing of activities and medications may improve client&rsquo;s tolerance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide for and encourage adequate rest periods interspersed with activity. Assist with or perform self-care activities, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rest between activities conserves energy and reduces cardiac workload.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Remind client to keep antianginal pills close by or on person or to use prophylactically when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Patient with stable and predictable angina can help manage anginal responses to desired/required activities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note and discuss with client emotional response to limitations. Offer additional support/referrals as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depression over the inability to perform desired activities can be a source of stress to both client/caregiver.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate need for support at home.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client might benefit from certain services (e.g., homemaker, shopping, laundry, additional care assistance) to cope with limitations and conserve energy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for signs and symptoms of heart failure.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angina is only a symptom of underlying pathology causing myocardial ischemia. Disease may compromise cardiac function to the point of decompensation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases oxygen available for myocardial uptake to reduce ischemia and improve activity tolerance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor chest x-ray.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies new or worsening congestive heart failure (often associated with refractory angina).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer/remind client to take medications, as indicated. Refer to ND: <link linkend="ch0002s0037note0053">acute Pain</link>, above.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Adherence to medication regimen is important for managing symptoms or well-being, reducing the risk of preventable complications.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0037note0057"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity or insufficient knowledge of therapeutic regimen</para>
<para>Perceived barriers, economic difficulties</para>
<para>Family pattern of healthcare</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports difficulty with prescribed regimen</para>
<para>Failure to include treatment regimen in daily living or to take action to reduce risk factors</para>
<para>Ineffective choices in daily living for meeting health goals</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Coronary Artery Disease Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, disease process, and potential complications.</para>
<para>Verbalize understanding of and participate in therapeutic regimen.</para>
<para>Initiate necessary lifestyle changes.</para>
</note>
<note role="none" id="ch0002s0037note0058"><table frame="top" id="ch0002s0037ta0033"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Cardiac Risk Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss the pathophysiology of condition. Emphasize need for preventing and managing anginal attacks.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clients with stable angina need to learn why it occurs and what they can do to manage it. This focus on therapeutic management aims to reduce the likelihood of MI, heart failure, and sudden death and to promote a heart-healthy lifestyle.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage avoidance of factors or situations that may precipitate anginal episodes, such as emotional stress, extensive or intense physical exertion, use of recreational drugs, ingestion of a large or heavy meal (especially close to bedtime), and exposure to extremes of environmental temperature.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This is a crucial step in limiting or preventing anginal attacks.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review importance of cessation of smoking, weight control, dietary changes, and exercise.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge of the significance of risk factors provides client with the opportunity to make needed changes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review significance of cholesterol and triglyceride levels in heart disease and address the benefits of lowering lipid levels and triglycerides. Emphasize importance of periodic laboratory measurements and use of cholesterol-lowering (statins) drugs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In patients with stable angina, an intensive lipid-lowering therapy has shown to provide significant clinical benefit and improve prognosis (LaRosa et al, 2005). Many patients will require both pharmacologic and nonpharmacologic interventions to reach target goals: (1) LDL: less than 100 mg/dL for all patients, ideal less than 70 mg/dL, especially for high-risk patients; (2) HDL: 40 mg/dL or greater; and (3) triglycerides: less than 150 mg/dL (NGC, 2013; Scordo &amp; Pickett, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to follow prescribed reconditioning or cardiac rehabilitation program.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fear of triggering attacks may cause client to avoid participation in activity that has been prescribed to enhance recovery. Cardiac rehabilitation programs provide a phased approach to increasing client&rsquo;s activity and exercise tolerance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrate how and encourage client to monitor own pulse and BP during and after activities, when appropriate, and to schedule and simplify activities and take rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows client to identify those activities that can be modified to avoid cardiac stress and stay below the anginal threshold.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ask client/caregiver about client&rsquo;s emotional status. Discuss means of acquiring support (e.g., counseling, medications) as needed/desired.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This patient may be anxious, feel emotional and out of control of situation, and overwhelmed by self-care requirements. These factors can bring on or worsen depression. Many studies have correlated depression with heart disease. Predictors of depression include remote history of depression, female sex, and more symptomatic angina (Szpakowski et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss impact of condition on desired lifestyle and activities, including work, driving, sexual activity, and hobbies. Provide information, privacy, or consultation, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may be reluctant to resume or continue certain activities because of fear of anginal attack or death. If symptoms have worsened or the client has decreased physical activity to avoid precipitating angina, then he or she should be reevaluated and treated accordingly. <emphasis>Note: </emphasis>Erectile dysfunction (ED) can be a sign of CAD or diabetes in men. Use of Viagra, or similar drugs, is contraindicated with nitrates, which are usually used for angina.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review prescribed medications for control and prevention of anginal attacks. (Refer to ND: <link linkend="ch0002s0042note0061">acute Pain</link> in this care plan, and CP: <link linkend="ch0002s0032">Acute Coronary Syndrome</link>, ND <link linkend="ch0002s0042note0063">risk for decreased cardiac Tissue Perfusion</link> for discussion of drugs.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angina is a complicated condition that often requires the use of many drugs to decrease myocardial workload, improve coronary circulation, and control the occurrence of attacks.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of checking with physician before taking OTC drugs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>OTC drugs may potentiate or negate effects of prescribed medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss use of herbals such as ginseng, garlic, ginkgo, hawthorn, and bromelain, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some herbals, such as ginkgo, ginseng, and bromelain, can affect bleeding and clotting, especially when added to medications such as Plavix or Coumadin, which increase bleeding. Others, such as hawthorn, can increase the effects of certain heart medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review symptoms to be reported to physician, particularly an increase in frequency and duration of attacks and changes in response to medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge of expectations can avoid undue concern for insignificant events or prevent delay in treatment of worrisome symptoms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss importance of follow-up appointments (e.g., physician evaluation, laboratory monitoring, etc.).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angina is a symptom of CAD that can be progressive, should be monitored, and may require occasional adjustment of treatment regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to wear medical alert bracelet or necklace.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alerts care, providers of client&rsquo;s diagnosis when an emergency occurs.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Recommend that SO/caregivers have ready access to emergency phone numbers and encourage them to take CPR classes.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Helps family to be prepared for emergency actions when needed.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0037note0059"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following discharge from care setting (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for decreased cardiac Tissue Perfusion</emphasis>&mdash;coronary artery spasm</para></listitem>
<listitem><para><emphasis role="bi">Activity Intolerance</emphasis>&mdash;imbalance between oxygen supply and demand, sedentary lifestyle</para></listitem>
<listitem><para><emphasis role="bi">ineffective Denial</emphasis>&mdash;lack of control of life situation, anxiety</para></listitem>
<listitem><para><emphasis role="bi">interrupted Family Processes</emphasis>&mdash;situational transition or crisis, shift in health status of family member</para></listitem>
<listitem><para><emphasis role="bi">impaired Home Maintenance</emphasis>&mdash;impaired functioning, inadequate support systems, unfamiliarity with neighborhood resources</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0002s0042"><title><emphasis role="strong">MYOCARDIAL INFARCTION</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Marked reduction or loss of blood flow through one or more of the coronary arteries, resulting in cardiac muscle ischemia, and over a finite period, resulting in necrosis.</para></listitem>
<listitem><para>Occurs most often due to coronary artery disease (CAD).</para></listitem>
<listitem><para>Cellular ischemia and necrosis can affect the heart&rsquo;s rhythm, pumping action, and blood circulation.</para></listitem>
<listitem><para>Other problems may also ensue, such as heart failure, life-threatening arrhythmias, and death.</para></listitem>
<listitem><para>Delay in seeking treatment is the largest barrier to receiving therapy quickly.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Classification</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Types of myocardial infarction (MI) can be identified on the electrocardiogram (ECG).</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>ST-segment elevation (also called STEMI)</para></listitem>
<listitem><para>Non-ST elevation (NSTEMI)</para></listitem></orderedlist>
</listitem>
<listitem><para>Location of MI can be identified on the ECG.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Anterior wall of the ventricle</para></listitem>
<listitem><para>Inferior wall of the ventricle</para></listitem>
<listitem><para>Posterior wall of the ventricle</para></listitem>
<listitem><para>Lateral wall of the ventricle</para></listitem></orderedlist>
</listitem>
<listitem><para>Infarcts are usually classified by size.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Microscopic (focal necrosis)</para></listitem>
<listitem><para>Small (&lt;10% of the left ventricle)</para></listitem>
<listitem><para>Medium (10% to 30% of the left ventricle)</para></listitem>
<listitem><para>Large (&gt;30% of the left ventricle)</para></listitem></orderedlist>
</listitem>
<listitem><para>Point of time can be identified on the ECG by the Q wave and the client&rsquo;s history.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Acute or evolving infarction is characterized by the presence of polymorphonuclear leukocytes unless the interval between the onset of infarction and death is brief (e.g., 6 hours), minimal, or no polymorphonuclear leukocytes may be seen.</para></listitem>
<listitem><para>Old or healed infarction is manifested as scar tissue without cellular infiltration, a process usually requiring 5 to 6 weeks or more.</para></listitem></orderedlist>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>A common cause of coronary artery disease (CAD) is plaque buildup on the wall of the arteries, causing narrowing of the blood vessels and increased risk of pieces of plaque breaking off, creating emboli.</para></listitem>
<listitem><para>Nonatherosclerotic causes include the following: coronary occlusion secondary to vasculitis, ventricular hypertrophy, coronary artery emboli (secondary to cholesterol, air, or the products of sepsis), coronary trauma, drug use (e.g., cocaine, amphetamines), aortic dissection and aneurysms of coronary arteries, factors that increase oxygen requirement (e.g., heavy exertion, fever, hyperthyroidism), and factors that decrease oxygen delivery (e.g., hypoxemia of severe anemia, carbon monoxide poisoning, or acute pulmonary disorders) (Zafari &amp; Abdou, 2017).</para></listitem>
<listitem><para>Risk factors&mdash;age, being overweight or obese, smoking, hyperlipidemia, family history.</para></listitem>
<listitem><para>Greater risk in presence of kidney problems, peripheral arterial disease, or prior MI.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: About 750,000 people in the United States have heart attacks each year (Benjamin et al, 2017).</para></listitem>
<listitem><para>Mortality: Coronary heart disease is the most common type of heart disease, killing about 365,000 people in the United States in 2014 (Mozaffarian et al, 2016).</para>
<para>Acute myocardial infarction (MI) is associated with a 30% mortality rate; about 50% of the deaths occur prior to arrival at the hospital. Additional 5% to 10% die within the first year after their myocardial infarction (Zafari &amp; Abdou, 2017). CAD is a leading killer of both men and women in the United States.</para>
</listitem>
<listitem><para>Cost: MI ($11.5 billion) and coronary heart disease (CHD) ($10.4 billion) were 2 of the 10 most expensive hospital principal discharge diagnoses in 2011 (Pfuntner et al, 2013).</para></listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0042note0060"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Atherosclerosis: </emphasis>Abnormal accumulation of lipid deposits and fibrous tissue within the arterial walls and lumen.</para>
<para><emphasis role="strong">Cardiac biomarkers: </emphasis>Substances that are released into the blood when the heart is damaged or stressed. Measurement of these biomarkers is used to help diagnose, monitor, and manage people with suspected cardiac ischemia. The current biomarker test of choice for detecting heart damage is troponin (see below). Other cardiac biomarkers (e.g., CK, CK-MB, myoglobin) are less specific for the heart and may also be elevated in skeletal muscle injury, liver disease, or kidney disease (Lab Tests Online, 2015).</para>
<para><emphasis role="strong">Coronary artery bypass graft (CABG): </emphasis>Surgical procedure in which a blood vessel from another part of the body is grafted onto the occluded coronary artery above and below the occlusion in such a way that blood flow bypasses the blockage.</para>
<para><emphasis role="strong">Coronary artery disease (CAD): </emphasis>Narrowing or blockage of the arteries and vessels that provide oxygen and nutrients to the heart, caused by atherosclerosis. The resulting blockage restricts blood flow to the heart. When the blood flow is completely cut off, the result is a heart attack (also called a myocardial infarction, MI).</para>
<para><emphasis role="strong">Ejection fraction (EF): </emphasis>An EF is a percentage of blood that is pumped out of the heart during each beat. In a healthy heart, each beat should pump out at least 50% of the blood in the left ventricle. A EF range between 50% and 75% indicates the heart is pumping well and able to deliver an adequate supply of blood to the body and brain. Poor pumping and a low EF can occur if the heart muscle has been damaged due to a heart attack, a diseased heart valve, or heart failure.</para>
<para><emphasis role="strong">Myocardial infarction (MI, also called acute MI, or AMI): </emphasis>An occlusion or blockage of arteries supplying the muscles of the heart, resulting in injury or necrosis of the heart muscle (heart attack).</para>
<para><emphasis role="strong">Non-ST-segment elevation myocardial infarction (NSTEMI): </emphasis>Development of heart muscle necrosis without the ECG change of ST-segment elevation, resulting from an acute interruption of blood supply to a part of the heart and demonstrated by an elevation of cardiac markers (CK-MB or troponin) in the blood. NSTEMI involves less than full-thickness damage of heart muscle and is, therefore, a less severe type of heart attack than STEMI (see below) (&ldquo;NSTEMI,&rdquo; 2017).</para>
<para><emphasis role="strong">Percutaneous coronary interventions (PCIs): </emphasis>A nonsurgical procedure used to treat the stenotic coronary arteries found in coronary heart disease. During PCI, a cardiologist feeds a deflated balloon or other device on a catheter from the femoral artery or radial artery up through blood vessels until it reaches the site of blockage in the heart. X-ray imaging is used to guide the catheter threading. At the blockage, the balloon is inflated to open the artery, allowing blood to flow. A stent is often placed at the site of blockage to permanently open the artery.</para>
<para><emphasis role="strong">ST-segment elevation myocardial infarction (STEMI): </emphasis>Occurs by complete occlusion of a major coronary artery that produces an entire thickness damage of heart muscle (transmural). This damage of heart muscle produces an ECG change of ST-segment elevation.</para>
<para><emphasis role="strong">Stent: </emphasis>Woven mesh that provides structural support to a coronary vessel, preventing its closure.</para>
<para><emphasis role="strong">Thrombolytic: </emphasis>Agent or process that breaks down blood clots.</para>
<para><emphasis role="strong">Troponin (also known as cardiac-specific troponin I [cTn I] and troponin T [cTn T]): </emphasis>Blood test used to help diagnose a heart attack, to detect and evaluate mild to severe heart injury, and to distinguish chest pain that may be due to other causes.</para>
</note>
<sect2 id="ch0002s0043"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Myocardial infarctions are treated in the emergency room, inpatient acute hospital, critical care unit (CCU), intensive care unit (ICU), step-down unit, or medical unit.</para>
</sect2>
<sect2 id="ch0002s0044"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0032">Acute coronary syndrome</link></para>
<para><link linkend="ch0002s0037">Angina: chronic/stable</link></para>
<para><link linkend="ch0002s0047">Dysrhythmias</link></para>
<para><link linkend="ch0002s0027">Heart failure: chronic</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0002s0064">Venous thromboembolism (VTE): deep vein thrombosis (DVT) and pulmonary embolism (PE)</link></para>
<table frame="top" id="ch0002s0042ta0034"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of sedentary lifestyle, sporadic exercise schedule</para></listitem>
<listitem><para>Weakness, fatigue, intolerance to usual activities</para></listitem>
<listitem><para>Women often report unusual fatigue</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Chest pain with activity or rest</para></listitem>
<listitem><para>Tachycardia, dyspnea with rest or activity</para></listitem>
<listitem><para>Fatigue with normal daily activities</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of previous MI, CAD, heart failure, hypertension, diabetes mellitus, hypercholesterolemia</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Color:</emphasis> Pallor or cyanosis; mottling of the skin, nail beds, mucous membranes, and lips</para></listitem>
<listitem><para><emphasis role="bi">Blood pressure (BP):</emphasis> May be increased or decreased; orthostatic changes may occur</para></listitem>
<listitem><para><emphasis role="bi">Pulses:</emphasis> May be normal, full, bounding, or having a weak or thready quality with delayed capillary refill</para></listitem>
<listitem><para>Tachycardia, bradycardia, other irregularities may be noted</para></listitem>
<listitem><para><emphasis role="bi">Heart sounds:</emphasis> S<subscript>3</subscript> and S<subscript>4</subscript>, reflecting a pathological condition such as cardiac failure, decreased ventricular contractility, or compliance</para></listitem>
<listitem><para>Murmurs reflecting valvular insufficiency or papillary muscle dysfunction</para></listitem>
<listitem><para>Friction rub (suggests pericarditis)</para></listitem>
<listitem><para><emphasis role="bi">Edema:</emphasis> Signs of jugular vein distention (JVD), peripheral edema, dependent edema, generalized edema</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Denial of significance of symptoms and presence of condition</para></listitem>
<listitem><para>Fear of dying, feelings of impending doom</para></listitem>
<listitem><para>Anger at inconvenience of illness and the &ldquo;unnecessary&rdquo; attention and hospitalization</para></listitem>
<listitem><para>Worry about family, employment, finances, childcare, elders at home, and pets at home</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Withdrawal, anxiety, lack of eye movements</para></listitem>
<listitem><para>Irritability, anger, combative behavior; may refuse emergent care</para></listitem>
<listitem><para>Focus on self and pain</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of/current obesity</para></listitem>
<listitem><para>Diet high in cholesterol, saturated fats, salt, caffeine</para></listitem>
<listitem><para>Nausea, vomiting, belching, heartburn</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Vomiting</para></listitem>
<listitem><para>Decreased urine output</para></listitem>
<listitem><para>Poor skin turgor, dry or diaphoretic skin</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of dizziness, fainting spells, falling</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weakness</para></listitem>
<listitem><para>Mentation changes such as disorientation, poor memory, changes in thought processes</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>***Reports of pain location and severity differ between men and women. Pain is sometimes absent in postoperative clients, those with prior stroke or heart failure, diabetes, hypertension, or an older person.</para>
<itemizedlist mark="&bull;"><listitem><para>Sudden onset of chest pain unrelieved by rest or nitroglycerin (common symptom, particularly in men)</para></listitem>
<listitem><para><emphasis role="bi">Location:</emphasis> Substernal or anterior chest pain that may radiate to jaw, neck, shoulders, and upper extremities, often to left side more than right. Women may report pain between shoulder blades, back pain.</para>
<para>(May have atypical location, such as pain in epigastric or abdominal area, elbow, jaw, back, neck, between shoulder blades, or throat)</para></listitem>
<listitem><para><emphasis role="bi">Quality:</emphasis> Crushing, constricting, squeezing, heavy, steady pain. Women may report dull aching pain.</para></listitem>
<listitem><para><emphasis role="bi">Intensity:</emphasis> Usually a 10 on a scale of 0 to 10 or the &ldquo;worst pain ever experienced&rdquo;</para></listitem>
<listitem><para><emphasis role="bi">Duration:</emphasis> Usually more than 15 minutes</para></listitem>
<listitem><para><emphasis role="bi">Precipitating factors:</emphasis> May or may not be associated with activity or increased stress</para></listitem>
<listitem><para><emphasis role="bi">Relieving factors:</emphasis> Pain is not responsive to relief mechanisms, such as rest and antianginal medications</para></listitem>
</itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Facial grimacing, changes in body posture; crying, groaning, squirming, stretching</para></listitem>
<listitem><para>May place clenched fist on midsternum when describing pain</para></listitem>
<listitem><para>Autonomic responses: Changes in heart rate and rhythm, blood pressure, respirations, skin color and moisture, and level of consciousness</para></listitem>
</itemizedlist></entry>
</row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Recent history of dyspnea with or without exertion, nocturnal dyspnea, unable to sleep flat</para></listitem>
<listitem><para>Recent history of cough with or without sputum production</para></listitem>
<listitem><para>History of smoking, chronic respiratory disease</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Increased respiratory rate, shallow and labored breathing</para></listitem>
<listitem><para><emphasis role="bi">Color:</emphasis> Pallor or cyanosis</para></listitem>
<listitem><para>Decreased oxygen saturation on pulse oximetry</para></listitem>
<listitem><para><emphasis role="bi">Breath sounds:</emphasis> May be clear or crackles and wheezes present</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SOCIAL INTERACTION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Recent history of stressors such as work, family, financial, caretaking</para></listitem>
<listitem><para>Difficulty coping with recent or current stressors</para></listitem>
<listitem><para>May be worried about current hospitalization&rsquo;s effect on self and family and question coping abilities</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Difficulty resting quietly</para></listitem>
<listitem><para>Overemotional responses such as intense anger or fear</para></listitem>
<listitem><para>Withdrawal from family</para></listitem>
<listitem><para>Not willing to cooperate with treatment recommendations; not responsive to teaching</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Postmenopausal; history of hormone replacement therapy</para></listitem>
<listitem><para>Erectile dysfunction (ED): May be associated with hypertension or antihypertensive medications</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of heart disease, MI, diabetes, stroke, hypertension, peripheral vascular disease, hypercholesterolemia</para></listitem>
<listitem><para>Use of tobacco; may express desire or attempts at smoking cessation</para></listitem>
<listitem><para>Use of alcohol or other drugs</para></listitem>
<listitem><para>Use or misuse of cardiac medications, over-the-counter (OTC) preparations</para></listitem>
<listitem><para>Use of vitamins and herbal supplements such as vitamin E, ginseng, garlic, ginkgo, hawthorn, bromelain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with activities of daily living (ADLs), food preparation, shopping, transportation, homemaking or maintenance tasks, modifications of physical layout of home</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0042ta0035"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart to detect dysrhythmias, to identify any myocardial ischemia present or any damage to myocardial tissue from the past.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In the emergency setting, the ECG is the most important diagnostic test. High probability of myocardial infarction is indicated by ST-segment elevation greater than 1 mm in two anatomically contiguous leads (indicates acute MI in 90% of people, as confirmed by serial measurements of cardiac biomarkers) or by the presence of new Q waves (Kumar &amp; Cannon, 2009). A new-onset left bundle branch block (LBBB) in ECG is also considered as STEMI (&ldquo;NSTEMI,&rdquo; 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac catheterization:</emphasis> Assesses patency of coronary arteries, reveals abnormal heart and valve size or shape, and evaluates ventricular contractility. May be combined with angiography (a procedure performed to view blood vessels after injecting them with a radiopaque dye that outlines them on x-ray).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac catheterization defines coronary anatomy and the extent of a client&rsquo;s disease. Client with intractable angina (despite medication) should immediately undergo cardiac catheterization and possibly angiography with revascularization interventions (Coven et al, 2016; Fogoros, 2016a). (Refer to CP: <link linkend="ch0002s0032">Acute Coronary Syndrome</link> for related interventions.)</para>
<para><emphasis>Note:</emphasis> A left ventricular ejection fraction (LVEF, or simply EF) of 50% or lower in the setting of acute MI demonstrates loss of ventricular pumping ability due to myocardial damage, dysrhythmias, and/or valvular involvement. Reduced EF is associated with greater mortality among patients with coronary artery disease and predicts increased risks of early all-cause mortality, as well as sudden cardiac death after acute MI (Mankad, 2017; Miller et al, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Echocardiogram:</emphasis> Sound waves produce images of the heart, including structures and blood circulation.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Regional ventricular wall motion abnormalities are suggestive of a myocardial infarction. <emphasis>Note:</emphasis> Echocardiogram is a common noninvasive method used to assess ejection fraction if cardiac catheterization is delayed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Procedure used to evaluate organs and structures within the chest.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Visualize changes in heart size and any infiltrates that may be present in the lung.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac enzymes, including troponin I and troponin T, also possibly CPK, CK, and CK-MB:</emphasis> Substances released from heart muscle when it is damaged.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac-specific troponins are not detectable in the blood of healthy individuals; therefore, they provide high specificity for detecting injury to cardiac muscle. Troponins are also more sensitive than CK-MB for myocardial necrosis and therefore improve early detection of small myocardial infarctions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Complete blood count (CBC), including red blood cell (RBC) and white blood cell (WBC) counts, hemoglobin/hematocrit (Hgb/Hct), platelets</emphasis></para>
</listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be done to rule out anemia as a cause of decreased myocardial oxygen supply and/or prior to giving thrombolytics.</para>
<para>Elevated white blood cell count (leukocytosis) is also common but not universal, signifying an acute inflammatory state.</para>
<para>The platelet count is necessary if a IIb/IIIa agent is considered or may become dangerously low after the use of heparin.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Metabolic profile, including blood glucose, electrolytes, and BUN/Cr</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Important for client with new-onset angina. Close monitoring of potassium and magnesium levels is important because low levels may predispose to dysrhythmias. Creatinine levels must be considered before using an angiotensin-converting enzyme (ACE) inhibitor and particularly if cardiac catheterization is considered.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum lipids, including total lipids, lipoprotein electrophoresis, isoenzymes, cholesterols (HDL, LDL, very low-density lipoprotein [VLDL]), triglycerides (Tg), phospholipids:</emphasis> A group of tests that make up a lipid profile.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The presence of lipid abnormalities increases the risk of CAD. <emphasis>Note:</emphasis> Recently, an elevated triglyceride (Tg) has been identified as an <emphasis>independent</emphasis> risk factor for development of coronary artery disease (Van Leeuwen &amp; Bladh, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Coagulation studies, including partial thromboplastin time (PTT), activated partial thromboplastin time (aPPT), and platelets:</emphasis> Injury to a vessel wall or the tissue initiates the coagulation cascade and formation of a thrombus.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Thrombus formation can potentiate ischemic damage to the myocardium as blood flow is blocked.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Pulse oximeter oxygen saturation or arterial blood gases (ABGs):</emphasis> Assessment of levels of oxygen (PaO<subscript>2</subscript>) and carbon dioxide (PaCO<subscript>2</subscript>).</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Should be monitored constantly in early stages of MI. Hypoxemia may result from pulmonary congestion, atelectasis, or ventilatory impairment secondary to complications of MI.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0045"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Relieve pain.</para></listitem>
<listitem><para>Reduce myocardial workload.</para></listitem>
<listitem><para>Prevent, detect, and assist in treatment of life-threatening dysrhythmias or complications.</para></listitem>
<listitem><para>Promote cardiac health and self-care.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0046"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Chest pain absent or controlled.</para></listitem>
<listitem><para>Heart rate and rhythm sufficient to sustain adequate cardiac output and tissue perfusion.</para></listitem>
<listitem><para>Achievement of activity level sufficient for basic self-care.</para></listitem>
<listitem><para>Anxiety reduced and managed.</para></listitem>
<listitem><para>Disease process, treatment plan, and prognosis understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge, including follow-up appointments.</para></listitem></orderedlist>
<note id="ch0002s0042note0061"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Biological agents (tissue ischemia, increased cardiac workload and oxygen consumption, decreased myocardial blood flow)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbal/coded reports of pain</para>
<para>Expressive behaviors (such as moaning, crying, pacing, self-focus, or restlessness)</para>
<para>Diaphoresis; changes in blood pressure, heart rate, respiratory rate, pupillary dilation</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize relief or control of chest pain within appropriate period for administered medications.</para>
<para>Demonstrate relief of pain as evidenced by stable vital signs and absence of muscle tension and restlessness.</para>
</note>
<note role="none" id="ch0002s0042note0062"><table frame="top" id="ch0002s0042ta0036"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor and document characteristics of pain, noting verbal reports, nonverbal cues, for example, moaning, crying, restlessness, diaphoresis, clutching chest, rapid breathing, and hemodynamic response (BP and heart rate changes).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Variation of appearance and behavior of clients in pain may present a challenge in assessment. For example, men and women consistently present differently or an individual may present differently from one episode to another.</para>
<para>However, most clients with an acute MI appear ill, distracted, and focused on pain. Respirations may be increased because of pain and associated anxiety.</para>
<para>Release of stress-induced catecholamines increases heart rate and BP.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Obtain full description of pain from client, including location, intensity (using 0 to 10 or similar scale), duration, characteristics (dull or crushing), and radiation. Assist client to quantify pain by comparing it to other experiences.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain is a subjective experience and must be described by client. Provides baseline for comparison to aid in determining effectiveness of therapy, resolution, or progression of problem.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note history of previous angina, anginal equivalent, or MI pain. Discuss family history if pertinent.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May differentiate current pain from preexisting patterns as well as identify complications, such as extension of infarction, pulmonary embolus, or pericarditis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client to report pain immediately.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Delays in reporting pain hinder pain relief and may necessitate increased dosage of medication to achieve relief. In addition, severe pain may induce shock by stimulating the sympathetic nervous system, thereby creating further damage and interfering with diagnostics and relief of pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for associated symptoms, such as dyspnea, nausea, vomiting, dizziness, palpitations, and desire to urinate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased cardiac output (which may occur during ischemic myocardial episode) stimulates sympathetic or parasympathetic nervous system, causing a variety of vague sensations that client may not identify as related to current situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs every 5 minutes during initial pain attack.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>BP may initially rise because of sympathetic stimulation and then fall if cardiac output is compromised. Tachycardia also develops in response to sympathetic stimulation and may be sustained as a compensatory response if cardiac output falls.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor heart rate and rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with MI has an increased risk of acute life-threatening dysrhythmias (especially during first 24 hours), which occurs in response to ischemic changes and stress hormones.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Place client at complete rest during initial evaluation and treatment of MI.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reducing myocardial oxygen demand and stress-related catecholamine reactions is beneficial in achieving relief of ischemic pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Allow for uninterrupted periods of rest and sleep.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain quiet, comfortable environment; restrict visitors as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Schedule lab tests, EKGs, x-rays, and other diagnostic tests to be done within the same time frame, where possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Elevate head of bed if client is short of breath.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates gas exchange to decrease hypoxia and associated ischemic pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Stay with client who is experiencing pain or appears anxious.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anxiety typically accompanies severe chest pain and may increase due to unfamiliarity of the surroundings and procedures. Refer to ND: <link linkend="ch0002s0042note0067">Anxiety (specify level)</link> following.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Check vital signs before and after administration of opioid medication.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypotension and respiratory depression can occur because of opioid administration. These problems may increase myocardial damage in the presence of ventricular insufficiency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer supplemental oxygen by appropriate route.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases amount of oxygen available for myocardial uptake and thereby may relieve discomfort associated with tissue ischemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated; for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antianginals, such as nitroglycerin (Nitro-Bid, Nitrostat, Nitro-Dur), isosorbide dinitrate (Isordil), and mononitrate (Imdur)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nitrates do not improve mortality. However, they provide symptomatic relief by means of several mechanisms, including coronary vasodilation, improved collateral myocardial blood flow, and reduction of cardiac workload (Fogoros, 2016a).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Analgesics, such as morphine sulfate (MS) or fentanyl (Duragesic), by appropriate route</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Potent opioid analgesic may be used in acute chest pain/evolving MI because of beneficial side effects. Such effects include peripheral vasodilation, reduced myocardial workload; sedation (which produces relaxation); and interrupted flow of vasoconstricting catecholamines, thereby effectively relieving severe chest pain.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0042note0063"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased cardiac Tissue Perfusion</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by</emphasis></para>
<para>Hypoxemia, hypertension; coronary artery spasm</para>
<para>Elevated C-reactive protein; hyperlipidemia</para>
<para>Family history of cardiac disease</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate adequate coronary perfusion as appropriate (e.g., vital signs within client&rsquo;s normal range; free of chest pain or discomfort).</para>
<para>Participate in behaviors and activities that reduce the workload of the heart.</para>
</note>
<para><emphasis role="strong">***Refer to CP: <link linkend="ch0002s0032">ACUTE CORONARY SYNDROME (ACS)</link>, ND: <link linkend="ch0002s0042note0063">risk for decreased cardiac Tissue Perfusion</link> for related nursing and collaborative interventions.</emphasis></para>
<note id="ch0002s0042note0064"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by</emphasis></para>
<para>Alteration in heart rate or rhythm</para>
<para>Altered contractility [infarcted myocardial muscle], diminished stroke volume</para>
<para>Altered preload [e.g., decreased venous return]</para>
<para>Altered afterload [e.g., systemic vascular resistance]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain hemodynamic stability, such as vital signs and cardiac output within normal range, adequate urinary output, decreased frequency or absence of dysrhythmias; absence of venous stasis complications.</para>
</note>
<note role="none" id="ch0002s0042note0065"><table frame="top" id="ch0002s0042ta0037"><title/>
<tgroup colsep="0" rowsep="0" cols="4">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<colspec colnum="4" colname="4" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<spanspec spanname="3-4" namest="3" nameend="4"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="3-4">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Cardiac Care: Acute <inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor mental status. Investigate sudden changes or continued alterations in mentation, such as anxiety, confusion, lethargy, and stupor.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Cerebral perfusion is directly related to cardiac output and is influenced by electrolyte and acid-base variations, hypoxia, and systemic emboli.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Inspect for pallor, cyanosis, mottling, and cool or clammy skin.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Systemic vasoconstriction resulting from diminished cardiac output may be evidenced by decreased skin perfusion and diminished pulses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor respirations, noting work of breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Cardiac pump failure and ischemic pain may precipitate respiratory distress.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Crackles reflect pulmonary congestion; may develop because of depressed myocardial function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate quality and equality of pulses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Decreased cardiac output results in diminished, weak, or thready pulses. Irregularities suggest dysrhythmias, which may require further evaluation and monitoring.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate heart sounds. Note development of S<subscript>3</subscript> and S<subscript>4</subscript>.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>S<subscript>4</subscript> may be associated with myocardial ischemia, ventricular stiffening, and pulmonary or systemic hypertension. S<subscript>3</subscript> is usually associated with heart failure, but it may also be noted with left ventricular overload that can accompany infarction in STEMI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note presence of murmurs and rubs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Indicates disturbances of normal blood flow within the heart, such as incompetent valve, septal defect, or vibration of papillary muscle and chordae tendineae (complication of MI). Presence of rub with an infarction is also associated with inflammation, such as pericardial effusion and pericarditis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Obtain frequent BP readings. Monitor hemodynamic pressures when invasive lines/devices are available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Hypertension is a common phenomenon initially, possibly related to pain, anxiety, catecholamine release, or preexisting vascular problems. However, with right ventricular MI or severe left ventricular dysfunction, hypotension and cardiogenic shock can be seen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor heart rate and rhythm. Document dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Heart rate and rhythm can be affected by the presence of coronary artery blockage, myocardial necrosis, impairment of ventricular contractility, electrolyte and acid-base imbalances, and circulating catecholamines. Common dysrhythmias that may develop in STEMI are ventricular tachycardia or fibrillation, premature ventricular ectopics, atrial tachycardia or fibrillation, and atrioventricular block and sinus bradycardia. <emphasis>Note:</emphasis> Life-threatening dysrhythmias are a major cause of death during the first 24 hours after an attack. (Refer to CP: <link linkend="ch0002s0047">Dysrhythmias</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor output, noting changes in urine output. Record urine specific gravity, as indicated. Calculate fluid balance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Decreased output may reflect systemic perfusion problems and may reflect heart failure. Inotropic drugs may be needed for support of circulation or additional fluids to enhance circulating volume and kidney function. <emphasis>Note: </emphasis>Specific gravity measurements reflect hydration status and renal function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for sudden or progressing changes in vital signs, such as hypotension, diminished mentation, cool clammy skin, or weight gain, swelling of extremities, and progressive shortness of breath.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Signs of poor ventricular function and/or impending complications, including cardiogenic shock or congestive heart failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Elevate legs when in sitting position and avoid prolonged sitting when extremities are edematous.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Helps reduce venous congestion, thus reducing risk of thromboembolic complications due to venous stasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Apply antiembolic hose or sequential compression devices as indicated, being sure they are individually fitted and appropriately applied.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>These enhance venous return to promote cardiac output and systemic circulation, thus reducing risk of venous stasis complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Have emergency equipment and medications available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Sudden coronary occlusion, lethal dysrhythmias, extension of infarct, and unrelenting pain are situations that may precipitate cardiac arrest, requiring immediate life-saving therapies or transfer to CCU.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer supplemental oxygen by appropriate route, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Supplemental oxygen is indicated for patients who are breathless, hypoxic (oxygen saturation &lt;90%), or who present with heart failure (Cabello et al, 2013; Zafari &amp; Abdou, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Measure cardiac output and other functional parameters as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Cardiac index, preload and afterload, contractility, and cardiac work can be measured noninvasively with thoracic electrical bioimpedance (TEB) technique. Useful in evaluating response to therapeutic interventions and identifying need for more aggressive or emergency care.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review serial ECGs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Provides information regarding progression or resolution of infarction, status of ventricular function, electrolyte balance, and effect of drug therapies.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory data, such as cardiac enzymes, arterial blood gases (ABGs), and electrolytes, and blood urea nitrogen (BUN), creatinine, and coagulation studies (prothrombin time [PT], activated prothrombin time [aPTT], clotting times).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Enzymes monitor resolution or extension of infarction. Presence of hypoxia indicates need for supplemental oxygen. Electrolyte imbalances, such as hypo- or hyperkalemia, adversely affect cardiac rhythm and contractility. BUN and creatinine are indicators of organ perfusion and function. Abnormalities in coagulation may occur as a result of therapeutic measures, such as heparin or Coumadin use and some cardiac drugs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain IV or saline-lock access, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Patent line is important for administration of fluids to support circulation and to administer emergency drugs in the presence of persistent lethal dysrhythmias or chest pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer fluids, diuretics, inotropic drugs, vasopressors, and/or vasodilators as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>These treatments support systemic circulation and organ function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with reperfusion interventions, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>As a rule, initial therapy is directed toward restoration of perfusion as soon as possible to salvage as much myocardium as possible. Early mechanical intervention (PCI, PTCA, surgery) or pharmacologic reperfusion should be performed as soon as possible for patients with clinical presentation of STEMI (Zafari &amp; Abdou, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Percutaneous coronary interventions (PCIs), including percutaneous transluminal coronary angioplasty (PTCA), with or without stenting</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Regarding STEMI, PCI may be performed either as a primary intervention or after thrombolysis failure. The advantage of performing primary PTCA in MI is the ability to achieve reperfusion of the infarcted vessel with a lower risk of bleeding than that associated with thrombolytic therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with medical therapies as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Certain classes of medications may be given short-term or long-term in both STEMI and NSTEMI, including nitrates, thrombolytics, antiplatelet agents, anticoagulants, beta blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Thrombolytic agents, for example, streptokinase (Streptase): tissue plasminogen activator (tPA) and recombinant forms (alteplase [Activase], reteplase [Retavase], tenecteplase [TNKase]) (Rivera-Bou et al, 2016)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Thrombolytic (clot-buster) therapy prevents the formation of thrombi associated with myocardial infarction and has been shown to improve survival rates by 29% in STEMI (Reed et al, 2016). Later-generation drugs have clot sensitivity without causing a systemic lytic state and should be administered as soon as possible after onset of acute MI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antiplatelet agents, including aspirin (ASA), and P2Y<subscript>12</subscript> inhibitors</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>In initial management, inhibition of the coagulation cascade is essential to limit thrombus propagation in patient with acute MI, whether managed invasively or conservatively. Giving aspirin as soon as possible inhibits platelet activity at the site of plaque rupture&mdash;a key mechanism in the unfolding acute MI. <emphasis>Note:</emphasis> Aspirin is a mainstay blood thinner and may be combined with newer anticlotting drugs (P2Y<subscript>12</subscript> inhibitors like clopidogrel [Plavix] or prasugrel [Effient]). This is often referred to as dual antiplatelet therapy (DAPT) (Reed et al, 2016). <emphasis>Note:</emphasis> DAPT is also a long-term therapy after PCI stent placement.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Beta-adrenergic blockers are of benefit when given intravenously within 4 hours of the onset of pain and continued on a long-term basis. The American Heart Association (AHA) recommends the initiation of beta blockers to all patients with STEMI, unless beta blockers are contraindicated (Zafari &amp; Abdou, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angiotensin-converting enzyme (ACE) inhibitors</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>ACE inhibitors are useful for long-term therapy and also appear to benefit client who has no evidence of hypotension if administration is begun within the first 24 hours after the onset of MI. May be given to reduce risk of developing heart failure in client with diminished ventricular EF and in those with hypertension, diabetes, or chronic kidney disease, unless contraindicated (Reed et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Angiotensin receptor blockers (ARBs)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Helps lower blood pressure, alone or in combination with other agents, in order to reduce systemic vascular resistance and improve organ perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antidysrhythmic drugs (refer to CP: <link linkend="ch0002s0047">Dysrhythmias</link>)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dysrhythmias are usually treated symptomatically. Early inclusion of ACE inhibitor therapy, especially in the presence of large anterior MI, ventricular aneurysm, or heart failure, enhances ventricular output, increases survival, and may slow progression of heart failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for surgery, as indicated. (Refer to CP: <link linkend="ch0002s0053">Cardiac Surgery</link>.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Emergent or urgent CABG surgery may be indicated if angioplasty fails or client develops mechanical complications, such as a ventricular septal defect or left ventricular or papillary muscle rupture.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with insertion and maintain pacemaker or automatic internal cardiac defibrillator (AICD) when used. (Refer to CP: <link linkend="ch0002s0047">Dysrhythmias</link>.)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="3-4">
<para>Pacing may be a temporary support measure during acute phase or may be needed permanently if infarction severely damages conduction system, impairing systolic function. Use of AICD is currently advocated in client who had ventricular fibrillation or tachycardia resulting in arrest.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0042note0066"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Activity Intolerance</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by</emphasis></para>
<para>Circulatory problem [imbalance between oxygen supply and demand]</para>
<para>Altered heart rate, rhythm</para>
<para>Physical deconditioning (weakness, sedentary lifestyle; aging) [side effects of medications]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate increased activity tolerance.</para>
<para>Report or display decreased episodes of dyspnea, angina, and dysrhythmias.</para>
<para>Participate in behaviors and activities that reduce the workload of the heart.</para>
</note>
<para><emphasis role="strong">****Refer to CP: <link linkend="ch0002s0037">Angina, Chronic/Stable</link>, ND: <link linkend="ch0002s0042note0066">risk for Activity Intolerance</link> for related nursing and collaborative interventions.</emphasis></para>
<note id="ch0002s0042note0067"><title><emphasis role="strong">NURSING DIAGNOSIS: Anxiety [specify level]</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Situational crisis; environment</para>
<para>Major change (e.g., threat to or change in health, economic status; threat of death)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Fearful attitude</para>
<para>Apprehension, increased tension, restlessness, facial tension</para>
<para>Uncertainty, feelings of inadequacy</para>
<para>Reports concern due to change in life events</para>
<para>Focus on self, worried</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Anxiety Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Recognize and verbalize feelings.</para>
<para>Identify causes and contributing factors.</para>
<para>Verbalize reduction of anxiety or fear.</para>
<para>Demonstrate positive problem-solving skills.</para>
<para>Identify and use resources appropriately.</para>
</note>
<note role="none" id="ch0002s0042note0068"><table frame="top" id="ch0002s0042ta0038"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Anxiety Reduction</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify and acknowledge client&rsquo;s perception of threat or situation. Encourage expressions of, and avoid denying feelings of, anger grief, sadness, and fear.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Coping with the pain and emotional trauma of an MI is difficult. Client may fear death or be anxious about immediate environment. Ongoing anxiety related to concerns about impact of heart attack on future lifestyle, matters left unattended or unresolved, and effects of illness on family may be present in varying degrees for some time and may be manifested by symptoms of depression.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence of hostility, withdrawal, and denial&mdash;inappropriate affect or refusal to comply with medical regimen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Research into survival rates between personality types in individuals and the impact of denial has been ambiguous; however, studies show some correlation between degree and expression of anger or hostility and an increased risk for MI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain confident manner, without false reassurance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client and SO may be affected by the anxiety or uneasiness displayed by health team members. Honest explanations can alleviate anxiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Orient client and SO to routine procedures and expected activities. Promote participation when possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Predictability and information can decrease anxiety for client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for verbal and nonverbal signs of anxiety, and stay with client. Intervene if client displays destructive behavior.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may not express concern directly, but words or actions may convey sense of agitation, aggression, and hostility. Intervention can help client regain control of own behavior.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Accept but do not reinforce use of denial. Avoid confrontations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Denial can be beneficial in decreasing anxiety but can postpone dealing with the reality of the current situation. Confrontation can promote anger and increase use of denial, reducing cooperation, and possibly impeding recovery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Answer all questions factually. Provide consistent information; repeat as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Accurate information about the situation reduces fear, strengthens nurse-client relationship, and assists client and SO to deal realistically with situation. Attention span may be short, and repetition of information helps with retention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client and SO to communicate with one another, sharing questions and concerns.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sharing information elicits support and comfort and can relieve tension of unexpressed worries.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide privacy for client and SO.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows needed time for personal expression of feelings; may enhance mutual support and promote more adaptive behaviors.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide rest periods and uninterrupted sleep time and quiet surroundings, with client controlling type and number of external stimuli.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Conserves energy and enhances coping abilities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Support normality of grieving process, including time necessary for resolution.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can provide reassurance that feelings are normal response to situation and perceived changes. Helps client and SO identify realistic goals, thereby reducing risk of discouragement in face of the reality of limitations of condition and pace of recuperation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage independence, self-care, and decision making within accepted treatment plan.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased independence from staff promotes self-confidence and reduces feelings of abandonment that can accompany transfer from coronary unit and discharge from hospital.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage discussion about postdischarge expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client and SO identify realistic goals, thereby reducing risk of discouragement in face of the reality of limitations of condition and pace of recuperation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer antianxiety or hypnotics, as indicated, such as alprazolam (Xanax) and lorazepam (Ativan).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Promotes relaxation and rest and reduces feelings of anxiety.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0042note0069"><title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding cause and treatment of condition, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information or interest in learning, information misperception</para>
<para>Insufficient knowledge of resources</para>
<para>Lack of recall</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports the problem</para>
<para>Inaccurate follow-through of instructions</para>
<para>Development of preventable complications</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Cardiac Disease Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, potential complications, individual risk factors.</para>
<para>Verbalize understanding of therapeutic regimen.</para>
<para>List desired action and possible adverse side effects of medications.</para>
<para><emphasis role="strong">Self-Management: Cardiac Disease</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Correctly perform necessary procedures and explain reasons for actions.</para>
<para>Keep follow-up appointments.</para>
</note>
<note role="none" id="ch0002s0042note0070"><table frame="top" id="ch0002s0042ta0039"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Individual</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
<para><emphasis role="bi">Independent</emphasis></para>
<para>Assess client and SO level of knowledge and ability or desire to learn.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Necessary for creation of individual instruction plan. Reinforces expectation that this will be a &ldquo;learning experience.&rdquo; Verbalization identifies misunderstandings and allows for clarification.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be alert to signs of avoidance, such as changing subject away from information being presented or extremes of behavior, such as withdrawal or euphoria.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Natural defense mechanisms, such as anger or denial of significance of situation, can block learning, affecting client&rsquo;s response and ability to assimilate information. Changing to a less formal or structured style may be more effective until client and SO are ready to accept or deal with current situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Present information in varied learning formats, such as programmed books, audiovisual tapes, question-and-answer sessions, and group activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Using multiple learning methods enhances retention of material.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Cardiac Care: Rehabilitation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para>
<para>Reinforce explanations of risk factors, dietary and activity restrictions, medications, and symptoms requiring immediate medical attention.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity for client to retain information and to assume control and participate in rehabilitation program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review activity limitations, such as refraining from strenuous activities until first checking with provider. Avoid exertion in extreme heat or cold. Stop any activity if chest pain, unusual shortness of breath, dizziness, lightheadedness, or nausea occurs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>During healing phase, restrictions may be needed to limit amount of myocardial workload and oxygen consumption.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain rationale of dietary regimen, diet low in sodium, saturated fats, and cholesterol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excess saturated fats, cholesterol, calories, and sodium increase BP and risk for heart disease. Excess of cholesterol builds plaque in arteries.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client to consult healthcare provider before taking other prescription or OTC medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many drugs may contain sympathetic nervous stimulants and may increase BP or counteract other medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss use of herbals, such as ginseng, garlic, ginkgo, hawthorn, and bromelain, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use of supplements or herbal remedies can result in alterations in blood clotting, especially when anticoagulant therapy, such as Plavix or ASA, is prescribed. Hawthorn can increase the effect of certain cardiac medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage identification and reduction of individual risk factors, such as smoking and alcohol consumption and obesity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These behaviors and chemicals have direct adverse effects on cardiovascular function and may impede recovery and increase risk for complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Warn against isometric activity, Valsalva&rsquo;s maneuver, and activities requiring arms positioned above head.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These activities greatly increase cardiac workload and myocardial oxygen consumption and may adversely affect myocardial contractility and output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review programmed increases in levels of activity. Educate client regarding resumption of activities, such as walking, work, and recreational and sexual activity. Provide guidelines for gradually increasing activity and instruction regarding target heart rate and pulse taking, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gradual increase in activity increases strength and prevents overexertion, may enhance collateral circulation, and promotes return to normal lifestyle. <emphasis>Note:</emphasis> Sexual activity can be safely resumed once client can accomplish activity equivalent to climbing two flights of stairs without adverse cardiac effects.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify alternative activities for &ldquo;bad weather&rdquo; days, such as measured walking in house or shopping mall.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides for continuing daily activity program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review signs and symptoms requiring reduction in activity and notification of healthcare provider. Differentiate between increased heart rate that normally occurs during various activities and worsening signs of cardiac stress: chest pain, dyspnea, palpitations, increased heart rate lasting more than 15 minutes after cessation of activity, and excessive fatigue the following day.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pulse elevations beyond established limits, development of chest pain, or dyspnea may require changes in exercise and medication regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of follow-up care, and identify community resources and support groups, such as cardiac rehabilitation programs, &ldquo;coronary clubs,&rdquo; and smoking cessation clinics.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reinforces that this is an ongoing or continuing health condition for which support and assistance are available after discharge. <emphasis>Note:</emphasis> After discharge, client may encounter limitations in physical functioning and often incurs difficulty with emotional, social, and role functioning, requiring ongoing support.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend client receive annual influenza and periodic pneumonia vaccination unless otherwise contraindicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps protect against viral and bacterial cardiorespiratory illnesses that can negatively impact client&rsquo;s heart health.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of contacting physician if chest pain, change in anginal pattern, or other symptoms recur.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Timely evaluation and intervention may prevent complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stress importance of reporting development of fever in association with diffuse or atypical chest pain (pleural, pericardial) and joint pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Post-MI complication of pericardial inflammation (Dressler syndrome) requires further medical evaluation and intervention.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Encourage client and SO to share concerns and feelings. Discuss signs of pathological depression versus transient feelings frequently associated with major life events. Recommend seeking professional help if feelings of depression persist.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Depressed clients have a greater risk of dying 6 to 18 months following a heart attack (Glassman, 2007). Timely intervention may be beneficial. <emphasis>Note:</emphasis> Selective serotonin reuptake inhibitors (SSRIs), such as paroxetine (Paxil), have been found to be as effective as tricyclic antidepressants but with significantly fewer adverse cardiac complications.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0042note0071"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following discharge from care setting (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Activity Intolerance</emphasis>&mdash;imbalance between oxygen supply and demand</para></listitem>
<listitem><para><emphasis role="bi">Grieving</emphasis>&mdash;loss of significant object (e.g., general well-being, required changes in lifestyle)</para></listitem>
<listitem><para><emphasis role="bi">Decisional Conflict</emphasis>&mdash;multiple or divergent sources of information; support system deficit</para></listitem>
<listitem><para><emphasis role="bi">interrupted Family Processes</emphasis>&mdash;situational transition or crisis; shift in health status of a family member</para></listitem>
<listitem><para><emphasis role="bi">impaired Home Maintenance</emphasis>&mdash;disease/illness, impaired functioning, inadequate support systems, unfamiliarity with neighborhood resources</para></listitem></itemizedlist></note>
</sect2></sect1>
<sect1 id="ch0002s0047"><title><emphasis role="strong">DYSRHYTHMIAS</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Abnormal formation or conduction of the electrical impulses within the heart. Dysrhythmias are usually classified as originating from above the atrioventricular (AV) node (supraventricular) or below, from the ventricle. They are fast, slow, or irregular; and persistent or intermittent.</para></listitem>
<listitem><para>Bradyarrhythmias: decreased intrinsic pacemaker function or block in conduction, often at AV junction or His-Purkinje system</para></listitem>
<listitem><para>Tachyarrhythmias: caused by reentry, often due to enhanced or abnormal automaticity</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Causes abnormalities of the heart rate, rhythm, or both</para></listitem>
<listitem><para>Change in conduction may alter pumping action of heart, affecting blood pressure and perfusion of body organs.</para></listitem></orderedlist>
</listitem>
</orderedlist></listitem>
<listitem><para><emphasis role="strong">Classification: Types of Dysrhythmias (Wedro, 2016)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Named according to the site of origination and the mechanism of conduction involved:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Sinus or sinoatrial (SA) node</para></listitem>
<listitem><para>AV node</para></listitem>
<listitem><para>Involved heart chamber&mdash;atrial or ventricular</para></listitem>
<listitem><para>Between the atria and ventricles&mdash;supraventricular or junctional dysrhythmias</para></listitem></orderedlist>
</listitem>
<listitem><para>Differentiated by rate</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Slow: bradycardia, pulse below 60 in adult</para></listitem>
<listitem><para>Fast: tachycardia, pulse above 100 in adult</para></listitem></orderedlist>
</listitem>
<listitem><para>Rhythm disturbances can be regular (e.g., sinus tachycardia) or irregular (e.g., atrial fibrillation).</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Primary cardiac disorder: coronary artery disease (CAD), myocardial infarction (MI), heart valve dysfunction, coronary artery bypass (CABG) surgery, or valve replacement surgery</para></listitem>
<listitem><para>Systemic conditions: hypothyroidism and hyperthyroidism; fever and dehydration; sepsis; shock states (hypovolemic, cardiogenic); anemia; pulmonary diseases; brain injury; catecholamine release, such as occurs in intense emotional stress or vigorous exercise; anxiety disorders and panic attacks</para></listitem>
<listitem><para>Electrolyte imbalances, such as with potassium</para></listitem>
<listitem><para>Effects of drugs and drug toxicity, such as with digoxin, aminophylline, atropine, and caffeine</para></listitem>
<listitem><para>Illicit drug use, such as cocaine, methamphetamines</para></listitem></orderedlist>
</listitem></orderedlist>
</sect1>
<sect1 id="ch0002s0048"><title><emphasis role="strong">COMMON DYSRHYTHMIAS (BYRG, 2016; WEDRO, 2016)</emphasis></title>
<para><emphasis role="strong">Tachycardias</emphasis></para>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Sinus Tachycardia</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Sinus node creates rate that is faster than normal (greater than 100).</para></listitem>
<listitem><para>Associated with physiological or psychological stress; medications, such as catecholamines, aminophylline, atropine, stimulants, and illicit drugs; enhanced automaticity; and autonomic dysfunction.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Atrial Flutter</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Occurs in the atrium and creates regular atrial rates between 250 and 400. Because AV node cannot keep up with conduction of all these impulses, not all atrial impulses are conducted into the ventricle, causing a block at the AV node (usually 2:1 or 3:1).</para></listitem>
<listitem><para>Approximately 60% of patients with atrial flutter have coronary artery disease (CAD) or hypertensive heart disease while 30% have no underlying cardiac disease (Ali, 2017).</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Atrial Fibrillation (AF)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Rapid, irregular twitching of the atrial musculature with an atrial rate of 300 to 600 and a ventricular rate of 120 to 200 if untreated. The atria do not beat and pump blood to the ventricles. Instead, blood flows into the ventricles by gravity alone. This lack of atrial kick can decrease the heart&rsquo;s efficiency and cardiac output by 10% to 15% (Wedro, 2016).</para></listitem>
<listitem><para>Associated with advanced age, thyroid disorders, obesity, pulmonary disorders, alcohol ingestion (&ldquo;holiday heart syndrome&rdquo;), hypertension, diabetes, sleep apnea, coronary artery or valvular disease, or after open heart surgery.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Paroxysmal Supraventricular Tachycardia (PSVT, also called SVT)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Pathways in the AV node or atrium allow an altered conduction of electricity, causing a regular and fast rate of sometimes more than 150 to 200.</para></listitem>
<listitem><para>Ventricle, sensing the electrical activity coming through the AV node, beats along with each stimulation.</para></listitem>
<listitem><para>Rarely a life-threatening event, but most people feel uncomfortable when PSVT occurs.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Ventricular Tachycardia (VT)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Rapid heartbeat initiated within the ventricles, characterized by three or more consecutive premature ventricular beats with elevated and regular heart rate (such as 160 to 240 beats per minute).</para></listitem>
<listitem><para>Heart rate sustained at a high rate causes symptoms such as weakness, fatigue, dizziness, fainting, or palpitations.</para></listitem>
<listitem><para>Potentially lethal disruption of normal heartbeat that can degenerate to ventricular fibrillation.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Ventricular Fibrillation (VF)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Aside from myocardial ischemia, other causes of ventricular fibrillation may include severe weakness of the heart muscle, electrolyte disturbances, drug overdose, and poisoning.</para></listitem>
<listitem><para>Electrical signal is sent from the ventricles at a very fast and erratic rate, impairing the ability of ventricles to fill with blood and pump it out, markedly decreasing cardiac output and resulting in very low blood pressure and loss of consciousness.</para></listitem>
<listitem><para>Sudden death will occur if VF not corrected.</para></listitem></orderedlist>
</listitem></orderedlist>
<para><emphasis role="strong">Bradycardias</emphasis></para>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Sinus Bradycardia</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Rarely symptomatic until heart rate drops below 50, then fainting or syncope may be reported.</para></listitem>
<listitem><para>Causes include hypothyroidism, athletic training, sleep, vagal stimulation, increased intracranial pressure, MI, hypovolemia, hypoxia, acidosis, hypokalemia and hyperkalemia, hyperglycemia, hypothermia, toxins, tamponade, tension pneumothorax, thrombosis (cardiac or pulmonary), and trauma.</para></listitem>
<listitem><para>Medications, such as beta blockers, calcium channel blockers, and amiodarone, also slow the heart.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Sick Sinus Syndrome (SSS)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Variety of conditions affecting SA node function, including bradycardia, sinus arrest, sinoatrial block, episodes of tachycardia, and carotid hypersensitivity.</para></listitem>
<listitem><para>Signs and symptoms related to cerebral hypoperfusion.</para></listitem>
<listitem><para>May be associated with rapid rate (tachycardia) or alternate between too fast and too slow (bradycardia-tachycardia syndrome). A long pause (asystole) may occur between heartbeats, especially after an episode of tachycardia.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Heart Blocks</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>First-degree AV block</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Asymptomatic; usually an incidental finding on electrocardiogram (ECG)</para></listitem>
</orderedlist>
</listitem>
<listitem><para>Second-degree AV (type I and type II)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Usually asymptomatic, although some clients can feel irregularities (palpitations) of the heartbeat, or syncope may occur, which usually is observed in more advanced conduction disturbances such as Mobitz II AV block.</para></listitem>
<listitem><para>Medications affecting AV node function, such as digoxin, beta blockers, and calcium channel blockers, may contribute.</para></listitem></orderedlist>
</listitem>
<listitem><para>Third-degree AV block (also called complete heart block)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>May be associated with acute MI, either causing the block or related to reduced cardiac output from bradycardia in the setting of advanced atherosclerotic CAD.</para></listitem>
<listitem><para>Symptomatic with fatigue, dizziness, and syncope and possible loss of consciousness.</para></listitem>
<listitem><para>Can be life-threatening, especially if associated with heart failure.</para></listitem></orderedlist>
</listitem></orderedlist></listitem></orderedlist>
<para><emphasis role="strong">Other Dysrhythmias</emphasis></para>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Premature Atrial Complex (PAC)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Electrical impulse starts in the atrium before the next normal impulse of the sinus node.</para></listitem>
<listitem><para>Causes include caffeine, alcohol, and nicotine use; stretched atrial myocardium; anxiety; hypokalemia; and hypermetabolic states (pregnancy) or may be related to atrial ischemia, injury, or infarction.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Premature Ventricular Contraction (PVC)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Electrical signal originates in the ventricles, causing them to contract before receiving the electrical signal from the atria.</para></listitem>
<listitem><para>PVCs not uncommon and are often asymptomatic.</para></listitem>
<listitem><para>Increase to several per minute may cause symptoms such as weakness, fatigue, dizziness, fainting, or palpitations.</para></listitem>
<listitem><para>Irritability of the heart demonstrated by frequent and/or multiple back-to-back PVCs can lead to VF.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Long QT Syndrome (LQTS) (Mayo Clinic Staff, 2016d; National Heart, Lung, and Blood Institute [NHLB], 2011)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>May be inherited or acquired.</para></listitem>
<listitem><para>Of the seven types of inherited LQTS, three are common:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>In types 1 and 2, the flow of potassium through ion channels in heart cells is abnormal. This may occur when client exercises or experiences strong emotions and can cause a rapid, uncontrollable heart rhythm that can be fatal if it&rsquo;s not quickly brought under control.</para></listitem>
<listitem><para>In type 3, problems usually occur when the heart beats slower than normal, such as during sleep.</para></listitem></orderedlist>
</listitem>
<listitem><para>Acquired types may be medication induced or have other causes:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Medications may include (or are not limited to) antihistamines, diuretics, some antiarrhythmia agents, certain antidepressants, and cholesterol-lowering drugs.</para></listitem>
<listitem><para>Other causes include severe vomiting and diarrhea, eating disorders (e.g., bulimia), and where sodium or potassium losses affect electrical activity of the heart.</para></listitem></orderedlist>
</listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0048note0072"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Arrhythmias (also called dysrhythmias): </emphasis>Heart rhythm disturbances classified by rate (normal, tachycardia, bradycardia), mechanism (automaticity, reentry, fibrillation), and site of origin (atrial, ventricular, junctional). <emphasis>Note:</emphasis> &ldquo;Heart rhythm disorders are often referred to as cardiac arrhythmias (cardiac = heart; a = lack of) but this is technically incorrect, since in most cases there is a heart rhythm, but it is abnormal. Cardiac dysrhythmia (dys = abnormal or faulty + rhythm) might be a better term&rdquo; (Wedro, 2016).</para>
<para><emphasis role="strong">AV node: </emphasis>The electrical relay station between the atria (the upper) and the ventricles (the lower chambers of the heart).</para>
<para><emphasis role="strong">Bigeminal pulse: </emphasis>Irregular strong beat alternating with weak beat.</para>
<para><emphasis role="strong">Bradycardias: </emphasis>Abnormally slow rhythms may be ascribed to two general mechanisms&mdash;failure of the sinoatrial (SA) node to generate impulses, such as in sinus bradycardia, or failure of the impulses to conduct normally to the ventricles, such as in heart blocks.</para>
<para><emphasis role="strong">Pacemaker: </emphasis>A system that sends electrical impulses to the heart in order to set the heart rhythm. The pacemaker can be the natural pacemaker of the heart or it can be an artificial electronic device.</para>
<para><emphasis role="strong">Palpitations: </emphasis>Sensation that the heart is beating too quickly, too slowly, beating irregularly, or skipping a beat. An increased awareness of the heartbeat and palpitations can result from many dysrhythmias. Palpitations associated with dizziness, near-syncope, or syncope suggest tachyarrhythmia and are potentially more serious.</para>
<para><emphasis role="strong">Pulse deficit: </emphasis>Difference between apical pulse and radial pulse.</para>
<para><emphasis role="strong">Pulsus alternans: </emphasis>Regular strong beat, alternating with weak beat.</para>
<para><emphasis role="strong">Sinoatrial (SA) node: </emphasis>One of the major elements in the cardiac conduction system that controls the heart rate. The SA node generates electrical impulses and conducts them throughout the muscle of the heart, stimulating the heart to contract and pump blood.</para>
<para><emphasis role="strong">Sudden cardiac death (also known as sudden cardiac arrest [SCA]): </emphasis>A sudden, unexpected death caused by loss of heart function. Most sudden cardiac deaths are caused by dysrhythmias, such as ventricular fibrillation (VF). The only treatment is defibrillation with an electrical shock.</para>
<para><emphasis role="strong">Tachycardias: </emphasis>Rapid heart rates originating from either the atrium or the ventricle.</para></note>
<sect2 id="ch0002s0049"><title><emphasis role="strong">CARE SETTINGS</emphasis></title>
<para>Generally, minor dysrhythmias are monitored and treated in the community setting; however, potential life-threatening situations (including heart rates above 150 beats per minute) may require a short inpatient stay.</para>
</sect2>
<sect2 id="ch0002s0050"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0032">Acute coronary syndrome</link></para>
<para><link linkend="ch0002s0037">Angina, chronic/stable</link></para>
<para><link linkend="ch0002s0027">Heart failure: chronic</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<table frame="top" id="ch0002s0048ta0040"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Generalized weakness</para></listitem>
<listitem><para>Exertional fatigue</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Changes in heart rate/blood pressure (BP) with activity or exercise</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of previous or acute MI (90% to 95% experience dysrhythmias), cardiac surgery, cardiomyopathy, rheumatic heart disease and heart failure (HF), valvular heart disease, long-standing hypertension, use of pacemaker</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>BP changes (hypertension or hypotension) during episodes of dysrhythmia</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Pulse:</emphasis> Fast, slow, or irregular; palpitations, skipped beats</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Pulses may be irregular, for example, skipped beats, pulsus alternans, bigeminal pulse</para></listitem>
<listitem><para>Pulse deficit</para></listitem>
<listitem><para><emphasis role="bi">Heart sounds:</emphasis> Irregular rhythm, extra sounds, dropped beats</para></listitem>
<listitem><para>Skin color and moisture changes, such as pallor, cyanosis, diaphoresis (HF, shock)</para></listitem>
<listitem><para>Edema dependent, generalized, jugular vein distention (JVD) (in presence of HF)</para></listitem>
<listitem><para>Urine output decreased if cardiac output is severely diminished</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Feeling nervous (certain tachydysrhythmias), sense of impending doom</para></listitem>
<listitem><para>Stressors related to current medical problems</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Anxiety, fear, withdrawal, anger, irritability, crying</para></listitem>
<listitem><para>Denial of health problems</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Loss of appetite, anorexia</para></listitem>
<listitem><para>Food intolerance (with certain medications)</para></listitem>
<listitem><para>Nausea or vomiting</para></listitem>
<listitem><para>Changes in weight</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weight gain or loss</para></listitem>
<listitem><para>Edema</para></listitem>
<listitem><para>Changes in skin moisture or turgor</para></listitem>
<listitem><para>Lung sounds have crackles</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dizzy spells, sudden fainting</para></listitem>
<listitem><para>Headaches</para></listitem>
<listitem><para>Numbness or tingling of fingers or toes</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Mental status or sensorium changes, such as disorientation, confusion, loss of memory; changes in usual speech pattern and consciousness, stupor, coma</para></listitem>
<listitem><para>Behavioral changes, such as combativeness, lethargy, hallucinations</para></listitem>
<listitem><para>Pupil changes (equality and reaction to light)</para></listitem>
<listitem><para>Loss of deep tendon reflexes with life-threatening dysrhythmias (VT, severe bradycardia)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Chest pain (mild to severe) that may or may not be relieved by antianginal medication</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Distraction behaviors, such as restlessness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath</para></listitem>
<listitem><para>Chronic lung disease</para></listitem>
<listitem><para>History of or current tobacco use</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Changes in respiratory rate and depth during dysrhythmia episode</para></listitem>
<listitem><para><emphasis role="bi">Breath sounds:</emphasis> Adventitious sounds such as crackles, rhonchi, or wheezing, indicating respiratory complications, such as left-sided heart failure (pulmonary edema) or pulmonary thromboembolic phenomena</para></listitem>
<listitem><para>Coughing with or without sputum production</para></listitem>
<listitem><para>Abnormal pulse oximetry or blood gases</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fever</para></listitem>
<listitem><para>Skin: Rashes (medication reaction)</para></listitem>
<listitem><para>Loss of muscle tone and strength</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Familial risk factors, such as heart disease, stroke</para></listitem>
<listitem><para>Use or misuse of prescribed medications, such as heart medications, anticoagulants, or over-the-counter (OTC) medications, for example, cough syrup, analgesics containing aspirin (ASA), and decongestants</para></listitem>
<listitem><para>Use of vitamins and herbal supplements for heart rhythm, such as belladonna, camphor, dong quai, ginseng, goldenseal</para></listitem>
<listitem><para>Stimulant abuse, including caffeine and nicotine; street drugs, including cocaine derivatives, methamphetamines, ecstasy, inhalants</para></listitem>
<listitem><para>Lack of understanding about disease process and therapeutic regimen</para></listitem>
<listitem><para>Evidence of failure to improve, such as recurrent or intractable dysrhythmias that are life-threatening</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Alteration of medication use and therapy</para></listitem>
<listitem><para>Anticoagulant or digitalis toxicity precautions</para></listitem>
<listitem><para>Teaching regarding pacemaker or other device</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0048ta0041"><title><emphasis role="strong">DIAGNOSTIC STUDIES (AMERICAN HEART ASSOCIATION [AHA], 2016B)</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Records electrical activity of the heart (snapshot view of one point in time).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measures how long it takes for impulses to travel through the atria, the conduction system, and the ventricles. Identifies when hypoxia (e.g., due to coronary artery obstruction or myocardial muscle damage) and imbalance of electrolytes (e.g., potassium, magnesium, and calcium) are affecting cardiac rhythm and contractility. <emphasis>Note:</emphasis> Exercise ECG reveals dysrhythmias occurring only when client is not at rest (can be diagnostic for cardiac cause of syncope).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Holter monitor:</emphasis> Extended ECG tracing (24 hours to weeks).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used to determine which dysrhythmias occur intermittently or may be causing specific symptoms (e.g., sudden fainting [syncope] or bradycardia only when client is at rest). May also be used to evaluate pacemaker function, antidysrhythmic drug effect, or effectiveness of cardiac rehabilitation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Trans-telephonic event monitor:</emphasis> (may be either implantable [loop memory] or external [transient symptoms event] recorder).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps diagnose why a person may be having palpitations or fainting spells, especially if these symptoms don&rsquo;t happen often. Results are transmitted telephonically or downloaded to a remote computer for rapid interpretation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Signal-averaged ECG (SAECG):</emphasis> Multiple ECG tracings are obtained over a period of approximately 20 minutes evaluating several hundred cardiac cycles.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be done to detect subtle cardiac abnormalities that increase risk for dysrhythmias or for further evaluation of dysrhythmias noted on resting ECG.</para>
<para>Can help identify irregularities that can lead to sudden cardiac death in patients at risk, such as those with hypertrophic cardiomyopathy.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Transthoracic echocardiography (TTE):</emphasis> Employs ultrasound waves to show heart&rsquo;s size, structure, and motion.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can rapidly provide visual information about dysrhythmia&rsquo;s location and effect on cardiac function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">STUDIES THAT MAY BE USED TO PROVOKE/REPRODUCE DYSRHYTHMIAS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrophysiological (EP) mapping:</emphasis> Test that records the spread of electrical activity with each heartbeat and maps the electrical pathways of the heart.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>EP study is valuable for provoking known but infrequent dysrhythmias and for unmasking or triggering suspected dysrhythmias. This diagnostic tool then becomes a treatment modality (e.g., induced tachycardia can usually be stopped by rapid pacing via the electrode catheters).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Stress tests (e.g., treadmill exercise or pharmacological-induced stress test)</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provokes dysrhythmias and makes diagnosis easier. A treadmill test may be used for stable client whose suspected dysrhythmias are clearly exercise related. Drug-induced testing helps identify dysrhythmias that may be from ischemia in client who cannot physically perform treadmill.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Tilt table test:</emphasis> Shows heart rate and blood pressure response to change in position from lying down to standing up.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An infrequently utilized test but may be done to find cause for recurrent syncope by reproducing symptoms under controlled conditions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrolytes:</emphasis> Substances that, in solution, conduct an electric current and are decomposed by its passage. Sodium, potassium, calcium, and magnesium are common electrolytes.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Imbalance of electrolytes, such as potassium, magnesium, and calcium, adversely affects cardiac rhythm and contractility.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Drug screen:</emphasis> Laboratory procedure that checks blood or urine sample for presence or therapeutic levels of certain medications or drugs of abuse.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May reveal therapeutic or toxic levels of prescription medications, suggest interaction of drugs, or detect presence of street drugs that can affect or contribute to dysrhythmias.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0051"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Prevent or treat life-threatening dysrhythmias.</para></listitem>
<listitem><para>Support client and significant other (SO) in dealing with anxiety and fear of potentially life-threatening situation.</para></listitem>
<listitem><para>Assist in identification of cause or precipitating factors.</para></listitem>
<listitem><para>Review information regarding condition, prognosis, and treatment regimen.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0052"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Free of life-threatening dysrhythmias and complications of impaired cardiac output and tissue perfusion.</para></listitem>
<listitem><para>Anxiety reduced and managed.</para></listitem>
<listitem><para>Disease process, therapy needs, and prevention of complications understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0002s0048note0073"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in heart rate or rhythm</para>
<para>Altered contractility</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain or achieve adequate cardiac output as evidenced by BP and pulse within normal range, adequate urinary output, palpable pulses of equal quality, and usual level of mentation.</para>
<para>Display reduced frequency or absence of dysrhythmia(s).</para>
<para>Participate in activities that reduce myocardial workload.</para>
</note>
<note role="none" id="ch0002s0048note0074"><table frame="top" id="ch0002s0048ta0042"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Dysrhythmia Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Palpate radial, carotid, femoral, and dorsalis pedis pulses, noting rate, regularity, amplitude (full or thready), and symmetry. Document presence of pulsus alternans, bigeminal pulse, or pulse deficit.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Differences in equality, rate, and regularity of pulses are indicative of the effect of altered cardiac output on systemic and peripheral circulation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate heart sounds, noting rate, rhythm, presence of extra heartbeats, and dropped beats.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Specific dysrhythmias are more clearly detected audibly than by palpation. Hearing extra heartbeats or dropped beats helps identify dysrhythmias in the unmonitored client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs. Assess adequacy of cardiac output and tissue perfusion, noting significant variations in BP, pulse rate equality, respirations, changes in skin color and temperature, level of consciousness and sensorium, and urine output during episodes of dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although not all dysrhythmias are life-threatening, immediate treatment may be required to terminate dysrhythmia in the presence of alterations in cardiac output and tissue perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine type of dysrhythmia and document with rhythm strip if cardiac or telemetry monitoring is available:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in determining need and type of intervention required.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sinus tachycardia</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia can occur in response to stress, pain, fever, infection, coronary artery blockage, valvular dysfunction, hypovolemia, hypoxia, or because of decreased vagal tone or increased sympathetic nervous system activity associated with the release of catecholamines. Although it generally does not require treatment, persistent tachycardia may worsen underlying pathology in clients with ischemic heart disease because of shortened diastolic filling time and increased oxygen demands. These clients may require medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sinus bradycardia</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bradycardia is common in clients with acute MI (especially anterior and inferior) and is the result of excessive parasympathetic activity, blocks in conduction to the SA or AV nodes, or loss of automaticity of the heart muscle. Clients with severe heart disease may not be able to compensate for a slow rate by increasing stroke volume; therefore, decreased cardiac output, HF, and potentially lethal ventricular dysrhythmias may occur.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Atrial dysrhythmias, such as PACs, atrial flutter, AF, and atrial supraventricular tachycardia (SVT) (i.e., paroxysmal atrial tachycardia [PAT], multifocal atrial tachycardia [MAT])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>PACs can occur as a response to ischemia and are normally harmless but can precede or precipitate AF. Acute and chronic atrial flutter or fibrillation (the most common dysrhythmia) can occur with coronary artery or valvular disease and may or may not be pathological. Rapid atrial flutter or fibrillation reduces cardiac output because of incomplete ventricular filling (shortened cardiac cycle) and increased oxygen demand.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ventricular dysrhythmias, such as premature ventricular contractions (PVCs) or ventricular premature beats (VPBs), ventricular tachycardia (VT), and ventricular flutter and fibrillation (VF)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>PVCs or VPBs reflect cardiac irritability and are commonly associated with MI, digoxin toxicity, coronary vasospasm, and misplaced temporary pacemaker leads. Frequent, multiple, or multifocal PVCs result in diminished cardiac output and may lead to potentially lethal dysrhythmias, such as VT or sudden death or cardiac arrest from ventricular flutter or VF. <emphasis>Note:</emphasis> Intractable ventricular dysrhythmias unresponsive to medication may reflect ventricular aneurysm. Polymorphic VT (torsades de pointes) is recognized by inconsistent shape of QRS complexes and is often related to use of certain medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Heart blocks</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reflect altered transmission of impulses through normal conduction channels (slowed, altered) and may be the result of MI or CAD with reduced blood supply to SA or AV nodes, drug toxicity, and sometimes cardiac surgery. Progressing heart block is associated with slowed ventricular rates, decreased cardiac output, and potentially lethal ventricular dysrhythmias or cardiac standstill.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide calm and quiet environment. Review reasons for limitation of activities during acute phase.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces stimulation and release of stress-related catecholamines, which can cause or aggravate dysrhythmias and vasoconstriction, increasing myocardial workload.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Demonstrate and encourage use of stress management behaviors such as relaxation techniques; guided imagery; and slow, deep breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes client participation in exerting some sense of control in a stressful situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate reports of chest pain, documenting location, duration, intensity (0 to 10 scale), and relieving or aggravating factors. Note nonverbal pain cues, such as facial grimacing, crying, and changes in BP and heart rate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reasons for chest pain are variable and depend on underlying cause. However, chest pain may indicate ischemia due to altered electrical conduction, decreased myocardial perfusion, or increased oxygen need, such as impending or evolving MI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be prepared to initiate cardiopulmonary resuscitation (CPR), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Development of life-threatening dysrhythmias requires prompt intervention to prevent ischemic damage or death.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Electrolytes</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Imbalance of electrolytes, such as potassium, magnesium, and calcium, adversely affects cardiac rhythm and contractility.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Medication and drug levels</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reveal therapeutic and toxic level of prescription medications or street drugs that may affect or contribute to presence of dysrhythmias.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer supplemental oxygen, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases amount of oxygen available for myocardial uptake, reducing irritability caused by hypoxia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for and assist with diagnostic and treatment procedures such as EP studies, radiofrequency ablation (RFA), and cryoablation (CA).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment for several tachycardia dysrhythmias, including SVT, atrial flutter, Wolff-Parkinson-White (WPW) syndrome, AF, and VT, is often carried out as first-line treatment via heart catheterization or angiographic procedures. After rhythm is confirmed with EP study, the client will then often have either an RFA or a CA to terminate or disrupt the dysfunctional pattern. Medications may be tried first or added after ablation for increased treatment success. <emphasis>Note:</emphasis> Catheter ablation has a success rate of 95% and recurrence rate of less than 5%. It is the preferred treatment for symptomatic patients with WPW syndrome (Helton, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Insert and maintain intravenous (IV) access.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Patent access line may be required for administration of emergency drugs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Correction of hypokalemia may be sufficient to terminate some ventricular dysrhythmias. <emphasis>Note:</emphasis> Potassium imbalance is the number one cause of AF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antidysrhythmics, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antiarrhythmic drugs are used to (1) decrease or increase conduction velocity, (2) alter the excitability of cardiac cells, and (3) suppress abnormal excitability (automaticity). (&ldquo;Antiarrhythmic Agents,&rdquo; 2000&ndash;2017; Levine, 2014; &ldquo;Vaughn&rsquo;s Summaries,&rdquo; update 2017.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class I drugs</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class I drugs block sodium (Na+) channels and are subdivided.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class Ia, such as disopyramide (Norpace), procainamide (Procanabid), quinidine (Cardioquin)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs increase action potential, duration, and effective refractory period and decrease membrane responsiveness, prolonging both QRS complex and QT interval. This also results in decreasing myocardial conduction velocity and excitability in the atria, ventricles, and accessory pathways. They suppress ectopic focal activity. Useful for treatment of atrial and ventricular premature beats and repetitive dysrhythmias, such as atrial tachycardias and atrial flutter and AF. <emphasis>Note:</emphasis> Class Ia antiarrhythmics are used less often now because of their modest effectiveness and adverse effects (Helton, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class Ib, such as lidocaine (Xylocaine), phenytoin (Dilantin, Phenytek), and mexiletine (Mexitil)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs slow conduction by depressing SA node automaticity and decreasing conduction velocity through the atria, ventricles, and Purkinje&rsquo;s fibers. The result is prolongation of the PR interval and lengthening of the QRS complex. They suppress and prevent all types of ventricular dysrhythmias.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class Ic, such as flecainide (Tambocor), propafenone (Rhythmol), and moricizine (Ethmozine)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs inhibit the voltage-dependent sodium channels and prolong the depolarization phase, thus increasing conduction velocity, and have little effect on the repolarization phase. This makes them useful in the treatment of atrial flutter or fibrillation in clients with structurally normal hearts. <emphasis>Note:</emphasis> Flecainide increases risk of drug-induced dysrhythmias post-MI. Propafenone can worsen or cause new dysrhythmias, a tendency called the &ldquo;proarrhythmic effect.&rdquo;</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class II drugs (most used), such as atenolol (Tenormin), carvedilol (Coreg), propranolol (Inderal), nadolol (Corgard), acebutolol (Sectral), and esmolol (Brevibloc)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers have antiadrenergic properties and decrease automaticity. They reduce the rate and force of cardiac contractions, which in turn decrease cardiac output, blood pressure, and peripheral vascular resistance. Therefore, they are useful in the treatment of dysrhythmias caused by SA and AV node dysfunction, including SVTs, atrial flutter, and AF. <emphasis>Note:</emphasis> These drugs may exacerbate bradycardia and cause myocardial depression, especially when combined with drugs that have similar properties.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class III drugs, such as bretylium tosylate (Bretylol), amiodarone (Pacerone, Cordarone), dofetilide (Tikosyn), sotalol (Betapace), and ibutilide (Corvert)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs are potassium channel blockers; they prolong the refractory period and action potential duration, consequently prolonging the QT interval. They decrease peripheral resistance and increase coronary blood flow. They have antianginal and antiadrenergic properties. They are used to terminate VF and other life-threatening ventricular dysrhythmias and sustained ventricular tachyarrhythmias, especially when lidocaine and procainamide are not effective.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class IV drugs, such as amlodipine (Norvasc), verapamil (Adalat, Calan), and diltiazem (Cardizem, Tiazac)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Calcium channel blockers slow conduction time through the AV node, prolonging PR interval to decrease ventricular response in SVTs, atrial flutter, and AF. Calan and Cardizem may be used for bedside conversion of acute AF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Class V drugs, such as electrolytes (e.g., magnesium, potassium), isoproterenol (Isuprel), adosene (Adenocard); inotropic agents (digoxin [Lanoxin, Digitek])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Miscellaneous drugs have antiarrhythmic effects using various mechanisms and are chosen for specific circumstances. For example, isoproterenol may be used to treat certain types of heart block, digitalis (may be used alone to improve cardiac pumping force and ejection fraction), or in combination with other antidysrhythmic drugs to reduce ventricular rate in the presence of uncontrolled or poorly tolerated atrial tachycardias or atrial flutter and AF.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for and assist with elective cardioversion.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used in AF after trials of first-line drugs&mdash;such as atenolol, metoprolol, diltiazem, and verapamil&mdash;have failed to control heart rate or in certain unstable dysrhythmias to restore normal heart rate or relieve symptoms of heart failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with insertion and maintain pacemaker (external or temporary, internal or permanent) function.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Temporary pacing may be necessary to accelerate impulse formation in bradydysrhythmias, synchronize electrical impulsivity, or override tachydysrhythmias and ectopic activity to maintain cardiovascular function until spontaneous pacing is restored or permanent pacing is initiated. These devices may include atrial and ventricular pacemakers and may provide single-chamber or dualchamber pacing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for procedures, such as PCIs, including angiography with possible angioplasty and stent placement; catheter or surgical ablation; or surgery, such as aneurysmectomy or CABG, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment may include revascularization procedures such as stenting or CABG, indicated to enhance circulation to myocardium and conduction system. Ablation therapy destroys a small spot of heart tissue and creates an electrical block along the pathway that stops the dysrhythmia and redirects electrical conduction pathways. Resection of ventricular aneurysm may be required to correct intractable ventricular dysrhythmias unresponsive to medical therapy.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for placement of ICD when indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>This device may be surgically implanted in those clients with recurrent, life-threatening ventricular dysrhythmias (such as might occur with long QT syndrome [LQTS]), or other dysrhythmias unresponsive to tailored drug therapy (NHLB, 2011). The latest generation of devices can provide multilevel or &ldquo;tiered&rdquo; therapy, that is, antitachycardia and antibradycardia pacing, cardioversion, or defibrillation, depending on how each device is programmed.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0048note0075"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Poisoning [Digitalis toxicity]</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inadequate knowledge of pharmacological agents; inadequate knowledge of poisoning prevention</para>
<para>Reduced vision, cognitive limitations</para>
<para>[Limited range of therapeutic effectiveness]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Medication</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of individual prescription, how it interacts with other drugs or substances, and importance of maintaining prescribed regimen.</para>
<para>Recognize signs of digoxin overdose and developing heart failure, and identify what to report to physician.</para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of signs of toxicity; display serum drug level within individually acceptable range.</para>
</note>
<note role="none" id="ch0002s0048note0076"><table frame="top" id="ch0002s0048ta0043"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Medication Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate client need for/use of digitalis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Incidence of digitalis toxicity has declined because of reduced digitalis usage, improvement in drug formulation, increased awareness in drug-to-drug interactions, increased availability of other drugs to treat heart failure, and techniques like catheter ablation therapy for supraventricular tachycardias. However, digitalis toxicity rates remain relatively stable. <emphasis>Note:</emphasis> One study, which used data from the National Electronic Injury Surveillance System&mdash;Cooperative Adverse Drug Event Surveillance Project, the National Ambulatory Medical Care Survey, and the National Hospital Ambulatory Medical Care Survey, estimated that 1% of emergency department visits for adverse drug events in patients aged 40 years or older resulted from digoxin toxicity, with this figure rising to 3.3% for patients aged 85 years or older (See et al, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client not to change dose for any reason, not to omit dose&mdash;unless instructed to, based on pulse rate&mdash;not to increase dose or take extra doses, and to contact physician if more than one dose is omitted.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alterations in drug regimen can reduce therapeutic effects, result in toxicity, and cause complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Advise client that digoxin may interact with <emphasis role="strong">many </emphasis>other drugs and that physician should be informed that digoxin is taken whenever new medications are prescribed. Advise client not to use OTC drugs, such as laxatives, antidiarrheals, antacids, cold remedies, diuretics, and herbals, without first checking with the pharmacist or healthcare provider.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge may help prevent dangerous drug interactions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review importance of dietary and supplemental intake of potassium, calcium, and magnesium.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintaining electrolytes at normal ranges may prevent or limit development of toxicity and correct many associated dysrhythmias.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide information and have the client and SO verbalize understanding of toxic signs and symptoms to report to the healthcare provider.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nausea, vomiting, diarrhea, unusual drowsiness, confusion, very slow or very fast irregular pulse, thumping in chest, double or blurred vision, yellow or green tint or halos around objects, flickering color forms or dots, altered color perception, and worsening HF&mdash;such as dependent or generalized edema, dyspnea, decreased amount or frequency of voiding&mdash;indicate need for prompt evaluation and intervention. <emphasis>Note:</emphasis> In severe or refractory heart failure, altered cardiac binding of digoxin may result in toxicity even with previously appropriate drug doses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss necessity of periodic laboratory evaluations, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Drug levels are evaluated in conjunction with clinical manifestations and ECG to determine individual&rsquo;s response.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum digoxin level</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Digoxin has a narrow therapeutic serum range (0.6&ndash;1.3 to 2.6 ng/mL). Levels associated with toxicity overlap between therapeutic and toxic ranges and are dependent on individual response. <emphasis>Note:</emphasis> Cardiac glycosides (includes digoxin) accounted for 2.6% of toxic plant exposures in the United States in 2008 (Bronstein et al, 2009).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Electrolytes, blood urea nitrogen (BUN), creatinine, and liver function studies</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Abnormal levels of potassium, calcium, or magnesium increase the heart&rsquo;s sensitivity to digoxin. Impaired kidney function can cause digoxin (mainly excreted by the kidney) to accumulate to toxic levels. Digoxin levels (mainly excreted by the bowel) are affected by impaired liver function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review ECG, noting rate and rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alterations in cardiac rate and rhythm from digitalis toxicity may simulate almost every known type of dysrhythmia (Patel &amp; James, 2017). Effective management relies on early recognition that a dysrhythmia may be related to digitalis intoxication.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist in providing supportive therapy, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depending on the severity of the toxicity, treatment ranges from simply holding or discontinuing to treatment with IV fluids, oxygenation and support of ventilatory function, and correction of electrolyte imbalances.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as appropriate, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Digoxin immune Fab (Digibind)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Digibind is currently considered first-line treatment for severe digoxin toxicity accompanied by significant dysrhythmias (e.g., severe bradyarrhythmia, second- or third-degree heart block, ventricular tachycardia or fibrillation) from digitalis. Onset of action ranges from 20 to 90 minutes; complete response generally occurs within several hours (Patel &amp; James, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate serum electrolyte levels (especially potassium, magnesium, and calcium) and renal and hepatic functions periodically during detoxification therapy. Replace electrolytes as prescribed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypokalemia, hypomagnesemia, or hypercalcemia may make the patient more susceptible to digitalis toxicity.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare client for transfer to critical care unit (CCU), as indicated, such as for dangerous dysrhythmias, exacerbation of heart failure.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>In the presence of digoxin toxicity, clients frequently require intensive monitoring until therapeutic levels have been restored. Because all digoxin preparations have long serum half-lives, stabilization can take several days.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0048note0077"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity of/insufficient knowledge of therapeutic regimen</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports difficulty with prescribed regimen</para>
<para>Failure to take action to reduce risk factors</para>
<para>[Unexpected acceleration of disease condition]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Dysrhythmias</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of therapeutic regimen.</para>
<para>List desired action and possible adverse side effects of medications.</para>
<para>Demonstrate behaviors and changes in lifestyle necessary to maintain therapeutic regimen.</para>
</note>
<note role="none" id="ch0002s0048note0078"><table frame="top" id="ch0002s0048ta0044"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Individual</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess client and SO level of knowledge and ability and desire to learn.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Necessary for creation of individual instruction plan. Reinforces expectation that this will be a &ldquo;learning experience.&rdquo; Verbalization identifies misunderstandings and allows for clarification.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be alert to signs of avoidance, such as changing subject away from information being presented or extremes of behavior (withdrawal or euphoria).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Natural defense mechanisms, such as anger or denial of significance of situation, can block learning, affecting client&rsquo;s response and ability to assimilate information. Changing to a less formal or structured style may be more effective until client and SO are ready to accept and deal with current situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Present information in varied learning formats, for example, programmed books, audiovisual tapes, question-and-answer sessions, and group activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Multiple learning methods may enhance retention of material.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide information in written form for client and SO to take home.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Follow-up reminders may enhance client&rsquo;s understanding and cooperation with the desired regimen. Written instructions are a helpful resource when client is not in direct contact with healthcare team.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Disease Process</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Explain and reinforce specific dysrhythmia problem and therapeutic measures to client and SO.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ongoing and updated information (such as whether the problem is resolving or may require long-term control measures) can decrease anxiety associated with the unknown and prepare client and SO to make necessary lifestyle adaptations. Educating the SO may be especially important if client is elderly, visually or hearing impaired, or unable or even unwilling to learn or follow instructions. Repeated explanations may be needed because anxiety and bulk of new information can block or limit learning.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reinforce explanations of risk factors, dietary and activity restrictions, medications, and symptoms requiring immediate medical attention.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity for client to retain information and to assume control and participate in rehabilitation program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage identification and reduction of individual risk factors, such as smoking and alcohol consumption and obesity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These behaviors and chemicals have direct adverse effect on cardiovascular function and may impede recovery and increase risk for complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify adverse effects and complications of specific dysrhythmias, such as fatigue, dependent edema, progressive changes in mentation, vertigo, and psychological manifestations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dysrhythmias may decrease cardiac output, manifested by symptoms of developing cardiac failure and altered cerebral perfusion. Tachydysrhythmias may also be accompanied by debilitating anxiety and feelings of impending doom.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct and document teaching regarding medications. Include the desired action, how and when to take the drug, what to do if a dose is forgotten (dosage and usage information), and expected side effects or possible adverse reactions or interactions with other prescribed and OTC drugs or substances (alcohol, tobacco, herbal remedies), as well as what and when to report to the healthcare provider.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Information necessary for client to make informed choices and to manage medication regimen. <emphasis>Note:</emphasis> Use of herbal remedies in conjunction with drug regimen may result in adverse effects, for example, cardiac stimulation and impaired clotting, necessitating evaluation of product for safe use.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review signs and symptoms of digitalis toxicity with patient and family, where indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Teaching is tailored for individual situation (e.g., reason for digoxin toxicity is unknown [as in person with heart failure confused about dosing] or patient is just beginning digoxin therapy). Reportable symptoms may include (and not be limited to) fatigue, headache, weakness; blurred vision, yellow or green vision; new or worsening dysrhythmias; anorexia, nausea, vomiting, diarrhea (Vallerand et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage development of regular exercise routine, avoiding overexertion. Identify signs and symptoms requiring immediate cessation of activities, such as dizziness, lightheadedness, dyspnea, and chest pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When dysrhythmias are properly managed, normal activity should not be affected. Exercise program is useful in improving overall cardiovascular well-being.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review individual dietary needs and restrictions, such as potassium and caffeine.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depending on specific problem, client may need to increase dietary potassium, such as when potassium-depleting diuretics are used. Caffeine may be limited to prevent cardiac excitation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Demonstrate proper pulse-taking technique. Recommend weekly checking of pulse for 1 full minute or daily recording of pulse before medication and during exercise as appropriate. Identify situations requiring immediate medical intervention, for example, dizziness or irregular heartbeat, fainting, and chest pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Continued self-observation or monitoring provides for timely intervention to avoid complications. Medication regimen may be altered or further evaluation may be required when heart rate varies from desired rate or pacemaker&rsquo;s preset rate.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review safety precautions, techniques to evaluate and maintain pacemaker or ICD function, when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes self-care, provides for timely interventions to prevent serious complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review symptoms requiring medical intervention; for example, report pulse rate below set limit for demand pacing or less than low-limit rate for rate-adaptive pacers and prolonged hiccups.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instructions or concerns depend on function and type of device as well as client&rsquo;s condition and presence or absence of family or caregivers.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend wearing medical alert bracelet or necklace and carrying pacemaker ID card.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows for appropriate evaluation and timely intervention, especially if client is unable to respond in an emergency situation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Discuss monitoring and environmental safety concerns in presence of pacemaker or ICD; for example, microwave ovens and other electrical appliances (including electric blankets, razors, radio/TV) can be safely operated if they are properly grounded and in good repair. There is no problem with metal detectors, although pacemaker may trigger sensitive detectors. Cordless phones are safe, although cellular phones held directly over pacemaker may cause interference; it is recommended that client not carry phone in shirt pocket when phone is on. High-voltage areas, magnetic fields, and radiation can interfere with optimal pacemaker function, so client should avoid high-tension electric wires, arc welding, and large industrial magnets, such as demolition sites and magnetic resonance imaging (MRI).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Aids in clarifying misconceptions and fears and encourages client to be proactive in avoiding potentially harmful situations.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0048note0079"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following discharge from care setting (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Activity Intolerance</emphasis>&mdash;imbalance between oxygen supply and demand</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, decisional conflicts, economic difficulties, inadequate number of cues to action</para></listitem></itemizedlist></note>
</sect2></sect1>
<sect1 id="ch0002s0053"><title><emphasis role="strong">CARDIAC SURGERY: CORONARY ARTERY BYPASS GRAFT (CABG), AND VALVE REPLACEMENT: POSTOPERATIVE CARE</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Purpose: </emphasis>To maximize cardiac output by improving blood flow and myocardial muscle function. Procedures are carried out on patients with coronary artery and/or valvular disorders to improve their quality of life and to reduce cardiac-related mortality.</para></listitem>
<listitem><para><emphasis role="strong">Types</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Reparative: Closure of atrial or ventricular septal defect or repair of stenotic mitral valve; reparative surgeries more likely to produce cure or prolonged improvement</para></listitem>
<listitem><para>Reconstructive: Coronary artery bypass grafting (CABG), restructure of incompetent valve leaflets</para></listitem>
<listitem><para>Substitutional: Valve replacement, heart transplant</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Procedures</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Procedures requiring use of cardiopulmonary bypass (CPB)</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="bi">Coronary artery bypass grafting (CABG)</emphasis> is the most common type of open heart surgery in the United States (Bilal et al, 2014; Diodato &amp; Chedrawy, 2014). Traditional CABG surgery requires a large incision dividing the breastbone and use of the heart-lung machine. During CABG, a healthy artery or vein from the body is connected (grafted) into one or more blocked coronary arteries, creating a new path for blood flow to the heart muscle. Grafts usually come from the client&rsquo;s own arteries (e.g., internal mammary artery [IMA] or internal thoracic artery [ITA]) or veins located in the legs (saphenous vein). CABG may be performed as an emergency procedure in the context of an ST-segment elevation MI (STEMI) where it has not been possible to perform percutaneous coronary intervention (PCI) or where PCI has failed and there is persistent pain and ischemia threatening a significant area of myocardium.</para></listitem>
<listitem><para><emphasis role="bi">Port-access coronary artery bypass (PACAB)</emphasis> is a minimally invasive option in certain conditions, such as single bypass from left mammary artery to left anterior descending coronary artery. PACAB combines the benefits of conventional CABG (use of the heart-lung machine and cardioplegia) with minimally invasive direct coronary bypass (MIDCAB). The patient is hooked to the heart-lung machine without opening the chest, and the procedure is carried out using modified instruments to fashion the connection between the graft and coronary artery inside the chest cavity.</para></listitem>
<listitem><para><emphasis role="bi">Aortic or mitral valve repair and replacement</emphasis>. The aortic valve and the mitral valve are the most commonly replaced valves. Valves may be mechanical (synthetic materials) or tissue (human or animal donor tissue). The procedure chosen will depend on the valve that needs replacement, the severity of symptoms, and the risk of surgery. With limited-access techniques for valve repair or replacement, the sternum does not need to be opened to gain access to the heart. For example, an aortic valve can be replaced through a small incision between the ribs on the side of the chest or through a 3-inch incision made in the middle of the chest. The mitral valve can be repaired or replaced through a 3-inch incision between the ribs, on the side of the chest. Robotic-assisted surgery may be employed (American Heart Association [AHA], 2016c; Texas Heart Institute, 2016).</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Procedures that do not require the use of a CBP machine (sometimes called beating heart surgery [BHS]).</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="bi">Off-pump coronary artery bypass (OPCAB)</emphasis> requires full sternotomy or limited access incisions. Surgeons use special equipment to hold parts of the beating heart still while they are constructing bypass grafts. Meanwhile, the rest of the heart keeps pumping blood to the body.</para></listitem>
<listitem><para><emphasis role="bi">Minimally invasive direct coronary bypass (MIDCAB)</emphasis> requires that several small incisions are made in the chest to access only the sections of coronary arteries that require grafts. <emphasis>Note:</emphasis> The limited number of small incisions made using MIDCAB makes it hard to treat more than two coronary arteries during the same surgery.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="bi">Robotic-assisted coronary artery bypass (RACAB),</emphasis> also called closed-chest heart surgery, may or may not require cardiopulmonary bypass. Robotic surgeries have been used for several different heart-related procedures, including valve surgery, coronary artery bypass, cardiac tissue ablation, heart defect repair, and tumor removal.</para></listitem>
<listitem><para><emphasis role="bi">Endoscopic coronary bypass (ECAB)</emphasis> enables the performance of bypass surgery in difficult spaces using a port access, which may be video and robotic assisted. This procedure is rare and typically reserved for one vessel revascularization.</para></listitem>
<listitem><para><emphasis role="bi">Transmyocardial laser revascularization (TMR)</emphasis> uses lasers to create channels in heart muscle to improve direct blood flow. This treatment is aimed at improving blood flow to areas of the heart that were not treated by angioplasty or surgery. A special carbon dioxide (CO<subscript>2</subscript>) laser is used to create small channels in the heart muscle, improving blood flow to the heart muscle.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Nearly 400,000 coronary artery bypass graft (CABG) surgery procedures are performed annually in the United States (Go et al, 2014). In 2010, 106,000 valve replacements were performed in the United States (Go et al, 2013).</para></listitem>
<listitem><para>One-year mortality is similar between CABG and percutaneous coronary interventions (PCI), but 5-year survival is significantly better for CABG (Go et al, 2013; Verma et al, 2013).</para></listitem>
<listitem><para>Cost: According to the Centers for Disease Control and Prevention (CDC), National Centers for Health Statistics (2014) reporting for 2012 total hospital costs for heart bypass were $6,170,000, with total hospital costs for heart valve replacement at $5,481,000.</para></listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0053note0080"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Anastomosis: </emphasis>Surgical connection created between tubular structures, such as blood vessels, that are grafted into the coronary arteries to create a bypass channel for circulation around a blocked artery.</para>
<para><emphasis role="strong">Cardioplegia: </emphasis>The intentional and temporary cessation of cardiac activity, primarily for cardiac surgery.</para>
<para><emphasis role="strong">Cardiopulmonary bypass (CPB) (also called heart-lung machine): </emphasis>Mechanical means of circulating and oxygenating the blood through the body when it&rsquo;s diverted from the heart and lungs. The heart&rsquo;s beating is stopped so the surgeon can perform the bypass procedure on a still heart.</para>
<para><emphasis role="strong">Coronary artery bypass grafting (CABG): </emphasis>Procedure in which one or more blocked coronary arteries are bypassed by a blood vessel graft to restore normal blood flow to the heart. These grafts usually come from the client&rsquo;s own arteries and veins located in the leg (saphenous vein), internal mammary artery (IMA), or internal thoracic artery (ITA). The graft goes around the blocked artery (or arteries) to create new pathways for oxygen-rich blood to flow to the heart.</para>
<para><emphasis role="strong">Minimally invasive direct coronary bypass (MIDCAB): </emphasis>Requires a smaller incision and may be done for CABG and some valve remodeling and replacement procedures.</para>
<para><emphasis role="strong">Off-pump coronary artery bypass (OPCAB) (also called off-pump coronary revascularization): </emphasis>Off-pump procedures can offer certain advantages in low-risk populations, such as decreased cost, reduced length of stay, reduced postoperative complications, and avoidance of blood transfusions. They also reduce surgical trauma to the client as well as risk of stroke and kidney failure.</para>
<para><emphasis role="strong">Percutaneous transmyocardial revascularization (PTMR) (also called transmyocardial laser revascularization, or TMR): </emphasis>Laser surgery that opens tiny new pathways within the heart muscle to treat the symptoms of angina in a client who cannot withstand more conventional treatments such as bypass surgery or balloon angioplasty.</para>
<para><emphasis role="strong">Robotic-assisted coronary artery bypass (RACAB): </emphasis>Surgeon views the procedure on a video screen, uses a robot to perform the bypass, and has no direct contact with the client.</para>
<para><emphasis role="strong">Sternotomy: </emphasis>Surgical incision made in the breastbone (mediastinum).</para>
<para><emphasis role="strong">Totally endoscopic coronary artery bypass (TECAB): </emphasis>Robotic-assisted procedure in which small-port incisions are made in intercostal spaces. TECAB is performed on the beating heart using a stabilization device that holds the anastomosis site steady and removes the need for CPB.</para></note>
<sect2 id="ch0002s0054"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Client is cared for at inpatient acute hospital on a surgical or post&ndash;intensive care unit (ICU) step-down unit.</para>
</sect2>
<sect2 id="ch0002s0055"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0037">Angina, chronic/stable</link></para>
<para><link linkend="ch0002s0047">Dysrhythmias</link></para>
<para><link linkend="ch0002s0027">Heart failure</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0003s0084">Pneumothorax/hemothorax</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0014s0348">Surgical interventions</link></para>

<table frame="top" id="ch0002s0053ta0045"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>****The preoperative data presented here depend on the specific disease process and underlying cardiac condition and reserve.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Exercise intolerance</para></listitem>
<listitem><para>Generalized weakness, fatigue</para></listitem>
<listitem><para>Inability to perform expected or usual life activities</para></listitem>
<listitem><para>Insomnia and sleep disturbances</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abnormal heart rate, blood pressure (BP) changes with activity</para></listitem>
<listitem><para>Exertional dyspnea</para></listitem>
<listitem><para>Electrocardiogram (ECG) changes and dysrhythmias with activity</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of recent or acute MI (three or more), vessel coronary artery disease, valvular heart disease, hypertension</para></listitem>
<listitem><para>Current use of antithrombotic drugs, including those that inhibit the production of clotting factors in the liver, such as warfarin (Coumadin); those that interfere with blood clotting by blocking thrombin activity, such as heparin and lepirudin (Refludan); and antiplatelet drugs, such as aspirin, clopidogrel (Plavix), tirofiban (Aggrastat), and eptifibatide (Integrilin), which keep platelets from aggregating into clots. <emphasis>Note:</emphasis> Cardiac patients taking these drugs preoperatively require various interventions to ensure their safety for CPB and to reduce postoperative bleeding complications.</para></listitem>
<listitem><para>Recent use of over-the-counter (OTC) drugs, such as NSAIDs, and dietary supplements, such as vitamin E, garlic, ginseng, and ginkgo (can inhibit clotting)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Variations in BP, heart rate, and rhythm</para></listitem>
<listitem><para>Abnormal heart sounds: S<subscript>3</subscript>/S<subscript>4</subscript>, murmurs</para></listitem>
<listitem><para>Pallor and cyanosis of skin or mucous membranes</para></listitem>
<listitem><para>Cool and clammy skin</para></listitem>
<listitem><para>Edema, jugular vein distention (JVD)</para></listitem>
<listitem><para>Diminished peripheral pulses</para></listitem>
<listitem><para>Restlessness and other changes in mentation or sensorium (severe cardiac decompensation)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Feeling frightened, apprehensive, or helpless</para></listitem>
<listitem><para>Distress over current events</para></listitem>
<listitem><para>Fear of death or eventual outcome of surgery or possible complications</para></listitem>
<listitem><para>Fear about changes in lifestyle and role functioning</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Apprehension, restlessness</para></listitem>
<listitem><para>Facial or general tension</para></listitem>
<listitem><para>Withdrawal and lack of eye contact</para></listitem>
<listitem><para>Focus on self, irritability, anger, crying</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Change in weight</para></listitem>
<listitem><para>Loss of appetite</para></listitem>
<listitem><para>Nausea or vomiting</para></listitem>
<listitem><para>Change in urine frequency or amount</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weight gain or loss</para></listitem>
<listitem><para>Dry skin, poor skin turgor</para></listitem>
<listitem><para>Postural hypotension</para></listitem>
<listitem><para>Edema&mdash;generalized, dependent, pitting</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fainting spells, vertigo</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Changes in orientation or usual response to stimuli</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Chest pain, angina</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dyspnea</para></listitem>
<listitem><para>Abnormal breath sounds, such as crackles</para></listitem>
<listitem><para>Productive cough</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Familial risk factors of diabetes, heart disease, hypertension, strokes</para></listitem>
<listitem><para>Use of various cardiovascular drugs</para></listitem>
<listitem><para>Failure to improve</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">POSTOPERATIVE ASSESSMENT PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Incisional discomfort</para></listitem>
<listitem><para>Pain or paresthesia of shoulders, arms, hands, legs</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Guarding of incisional areas</para></listitem>
<listitem><para>Facial mask of pain, grimacing</para></listitem>
<listitem><para>Distraction behaviors, moaning, restlessness</para></listitem>
<listitem><para>Changes in BP, pulse, respiratory rate</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Respiration:</emphasis> Inability to cough or take a deep breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased chest expansion</para></listitem>
<listitem><para>Dyspnea&mdash;normal response to thoracotomy</para></listitem>
<listitem><para>Areas of diminished or absent breath sounds (atelectasis)</para></listitem>
<listitem><para>Changes in arterial blood gas (ABG) levels or pulse oximetry</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Safety:</emphasis> Oozing or bleeding from chest or donor site incisions</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Modifiable risk factors for sternal wound infection, such as obesity, diabetes, and smoking</para></listitem>
<listitem><para>Postoperative incision care to minimize or prevent infection</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Short-term assistance with food preparation, shopping, transportation, self-care needs, and homemaker and home maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0053ta0046"><title><emphasis role="strong">DIAGNOSTIC STUDIES (POSTOPERATIVE)</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Hemoglobin (Hgb) and hematocrit (Hct):</emphasis> To identify red blood cell (RBC) and fluid replacement needs.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Whether heart surgery is performed on or off CPB equipment, clients develop moderate hemodilution from the fluids given perioperatively, thus lowering the Hct and platelet count. A low Hgb reduces oxygen-carrying capacity and indicates need for RBC replacement. Elevation of Hct suggests dehydration and need for fluid replacement.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Coagulation studies:</emphasis> Various studies may be done, such as platelet count and bleeding and clotting time.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Post-CPB bleeding is caused by various factors, including hemodilution, heparin use, platelet dysfunction due to exposure to the bypass pump, disseminated intravascular coagulation, and induced hypothermia (Shea, 2016). Patients placed on CPB equipment are more likely to bleed excessively than those who have off-bypass cardiac surgery. Risk increases further if the patient remains on bypass for more than 2.5 hours (Steiner &amp; Despotis, 2007).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrolytes:</emphasis> A substance that, in solution, conducts an electric current and is decomposed by its passage. Sodium (Na), potassium (K<superscript>+</superscript>), and calcium (Ca) are common electrolytes.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Imbalances&mdash;hyperkalemia or hypokalemia, hypernatremia or hyponatremia, and hypocalcemia&mdash;can affect cardiac function and fluid balance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Assessment of levels of oxygen (PaO<subscript>2</subscript>) and carbon dioxide (PaCO<subscript>2</subscript>).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Verifies oxygenation status, effectiveness of respiratory function, and acid-base balance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN) and creatinine (Cr):</emphasis> Elevated BUN can occur with dehydration, shock due to blood loss, or any condition that decreases blood flow to the kidneys.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides good evidence of the filtering function of the kidneys and a measure of the degree of systemic hydration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Glucose:</emphasis> Blood glucose levels should be controlled in all patients with diabetes to avoid hyperglycemia perioperatively.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluctuations may occur because of preoperative nutritional status, presence of organ dysfunction, and impact of IV infusions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac enzyme and isoenzymes troponin I (cTnI) and troponin T (cTnT):</emphasis> Contractile proteins with nearly absolute myocardial tissue specificity, as well as high sensitivity. Troponins increase within 3 to 4 hours of myocardial injury.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated in the presence of acute, recent, or perioperative myocardial infarction (MI).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs and structures within the chest.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reveals heart size and position, pulmonary vasculature, and changes indicative of pulmonary complications, such as atelectasis or pulmonary edema. Verifies condition of valve prosthesis and sternal wires, position of pacing leads, and intravascular or cardiac lines.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Identifies changes in electrical and mechanical function such as might occur in immediate postoperative phase, acute or perioperative MI, valve dysfunction, and pericarditis.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0057"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Support hemodynamic stability and ventilatory function.</para></listitem>
<listitem><para>Promote relief of pain and discomfort.</para></listitem>
<listitem><para>Promote healing.</para></listitem>
<listitem><para>Provide information about postoperative expectations and treatment regimen.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0058"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Activity tolerance adequate to meet self-care needs.</para></listitem>
<listitem><para>Pain alleviated or managed.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Incisions healing.</para></listitem>
<listitem><para>Postdischarge medications, exercise, diet, and therapy understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0002s0053note0081"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced by</emphasis></para>
<para>Alteration in heart rate or rhythm</para>
<para>Altered preload [e.g., decreased venous return]</para>
<para>Altered afterload [e.g., systemic vascular resistance]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cardiac Pump Effectiveness</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain hemodynamic stability, such as vital signs and cardiac output within normal range, adequate urinary output, decreased frequency or absence of dysrhythmias; absence of venous stasis complications.</para>
</note>
<note role="none" id="ch0002s0053note0082"><table frame="top" id="ch0002s0053ta0047"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Hemodynamic Regulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and document trends in heart rate and BP, especially noting hypertension. Be aware of specific systolic and diastolic limits defined for client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia is a common response to discomfort, inadequate blood or fluid replacement, and the stress of surgery. However, sustained tachycardia increases cardiac workload and can decrease effective cardiac output. Hypotension may result from fluid deficit, dysrhythmias, heart failure, and shock. Hypertension can occur (fluid excess or preexisting condition), placing stress on suture lines of new grafts and changing blood flow or pressure within heart chambers and across valves, with increased risk for various complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and document cardiac dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypothermia, electrolyte and metabolic disturbances, manual manipulation of the heart, and myocardial ischemia may be factors in postoperative dysrhythmias. The incidence of atrial fibrillation (AF) ranges from 15% to 30% depending on many factors, including preoperative history and medications and type of surgery performed (El-Chami, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe client response to dysrhythmias, such as drop in BP, chest pain, and dyspnea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased cardiac output and hemodynamic compromise that occur with dysrhythmias require prompt intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for bleeding from incisions and chest tube (if in place).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps identify bleeding complications that can reduce circulating volume, organ perfusion, and cardiac function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for changes in usual mental status, orientation, and body movement or reflexes, such as onset of confusion, disorientation, restlessness, reduced response to stimuli, and stupor.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate decreased cerebral blood flow or systemic oxygenation because of diminished cardiac output-sustained or severe dysrhythmias, low BP, heart failure, or thromboembolic phenomena, including perioperative stroke.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Record skin temperature and color and quality and equality of peripheral pulses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Warm, pink skin and strong, equal pulses are general indicators of adequate cardiac output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measure and document intake and output (I&amp;O) and calculate fluid balance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in determining fluid needs or identifying fluid excesses, which can compromise cardiac output and oxygen consumption.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Schedule uninterrupted rest and sleep periods. Assist with self-care activities as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents fatigue or exhaustion and excessive cardiovascular stress.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor graded activity program. Note client response; vital signs before, during, and after activity; and development of dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Regular exercise stimulates circulation and promotes feeling of well-being. Progression of activity depends on cardiac tolerance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect for JVD, peripheral or dependent edema, congestion in lungs, shortness of breath, and change in mental status.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be indicative of acute or chronic heart failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of angina or severe chest pain accompanied by restlessness, diaphoresis, and ECG changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although not a common complication of CABG, perioperative or postoperative MI can occur.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate and report profound hypotension and unresponsiveness to fluid challenge, tachycardia, distant heart sounds, and stupor or coma.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Development of cardiac tamponade can rapidly progress to cardiac arrest because of the heart&rsquo;s inability to fill adequately for effective cardiac output. <emphasis>Note:</emphasis> This is a relatively rare, life-threatening complication that usually occurs in the immediate postoperative period but can occur later in the recovery phase.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review serial ECGs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Most frequently done to follow the progress in normalization of electrical conduction patterns and ventricular function after surgery or to identify complications such as perioperative MI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measure cardiac output and other functional parameters, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in evaluating response to therapeutic interventions and identifying need for more aggressive or emergency care.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor Hgb, Hct, and coagulation studies, such as activated prothrombin time (aPTT), international normalized ratio (INR), activated clotting time (ACT), and platelet count.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help to identify bleeding or clotting problems associated with the surgery. <emphasis>Note:</emphasis> Diverting the client&rsquo;s blood through the CPB machine activates the clotting cascade and decreases the number (as well as the function) of platelets. Hemodilution occurs when the client&rsquo;s blood mixes with the crystalloid solution used to prime the CPB machine. Because blood is being diluted, the Hct drops, as does the concentration of coagulation factors, fibrinogen, and platelets. In addition, the use of hypothermia during surgery to decrease tissue oxygen requirements slows down the process of clotting and decreases platelet function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer intravenous (IV) fluids or blood products as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clients who have surgery on CPB equipment are more likely to bleed excessively than those who have off-bypass cardiac surgery. RBC replacement is often indicated to restore and maintain adequate circulating volume and enhance oxygen-carrying capacity. IV fluids may be discontinued before discharge from the ICU or may remain in place for fluid replacement and emergency cardiac medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes maximal oxygenation to reduce cardiac workload and aid in resolving myocardial irritability and dysrhythmias.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer electrolytes and medications, as indicated, such as potassium, antidysrhythmics, inotropic agents, diuretics, and anticoagulants.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client needs are variable, depending on type of surgery, client&rsquo;s response to surgical intervention, and preexisting conditions, such as general health and type of heart disease. Electrolytes, antidysrhythmics, and other heart medications may be required on a short-term or long-term basis to maximize cardiac contractility and output.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Maintain surgically placed pacing wires (atrial or ventricular) and initiate pacing if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be required to support cardiac output in presence of conduction disturbances (severe dysrhythmias) that compromise cardiac function.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0053note0083"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Injuring physical agents&mdash;surgical incisions, tissue inflammation, edema formation, intraoperative nerve trauma</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbal/coded reports of pain</para>
<para>Guarding behavior</para>
<para>Expressive behaviors&mdash;restlessness, irritability</para>
<para>Changes in heart rate, blood pressure, respiratory rate</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize relief or absence of pain.</para>
<para>Demonstrate relaxed body posture and ability to rest and sleep appropriately.</para>
<para><emphasis role="strong">Pain Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Differentiate surgical discomfort from angina or preoperative heart pain.</para>
</note>
<note role="none" id="ch0002s0053note0084"><table frame="top" id="ch0002s0053ta0048"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note type and location of incision(s).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many CABG clients do not experience severe discomfort in chest incision and may complain more often of donor site incision discomfort. Newer procedures, such as MIDCAB, require smaller chest and leg incisions, with less significant pain. Severe pain in either area should be investigated further for possible complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to report type, location, and intensity of pain, rating it on a scale. Note associated symptoms. Ascertain how this compares with preoperative chest pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain is perceived, manifested, and tolerated individually. It is important for client to differentiate incisional pain from other types of chest pain, such as angina or discomfort from chest tubes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for anxiety, irritability, crying, restlessness, and sleep disturbances.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These nonverbal cues may indicate the presence or degree of pain being experienced.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Heart rate usually increases with acute pain, although a bradycardic response can occur in a severely diseased heart. BP may be elevated slightly with incisional discomfort but may be decreased or unstable if chest pain is severe or myocardial damage is occurring.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify and promote position of comfort, using adjuncts as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pillows or blanket rolls are useful in supporting extremities, maintaining body alignment, and splinting incisions to reduce muscle tension and promote comfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide comfort measures, such as back rubs and position changes; assist with self-care activities; and encourage diversional activities, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May promote relaxation, redirect attention, and reduce analgesic dosage or frequency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Schedule care activities to balance with adequate periods of sleep and rest.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rest and sleep are vital for cardiac healing (balance between oxygen demand and consumption) and can enhance coping with stress and discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify and encourage use of behaviors such as guided imagery, distractions, visualizations, and deep breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Relaxation techniques aid in management of stress, promote sense of well-being, may reduce analgesic needs, and promote healing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tell client to request analgesics as soon as discomfort becomes noticeable.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of pain causes muscle tension, which can impair circulation, slow healing process, and intensify pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Medicate before procedures and activities, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client participation in respiratory treatments, ambulation, and procedures, such as removal of chest tubes, pacemaker wires, and sutures, are facilitated by maximum analgesic blood level.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of pain in unusual areas&mdash;for instance, calf of leg or abdomen&mdash;or vague complaints of discomfort, especially when accompanied by changes in mentation, vital signs, and respiratory rate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be an early manifestation of developing complication, such as thrombophlebitis, infection, and gastrointestinal dysfunction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note reports of pain or numbness in ulnar area (fourth and fifth digits) of the hand, often accompanied by pain and discomfort of the arms and shoulders. Tell client that the problem usually resolves with time.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicative of a stretch injury of the brachial plexus because of the position of the arms during surgery. No specific treatment is currently useful.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer analgesic medications (e.g., opioids, NSAIDs) by appropriate route (e.g., IV, patch, by mouth) as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provides for control of pain and inflammation and reduces muscle tension, which improves client comfort and promotes healing. <emphasis>Note:</emphasis> IV narcotics will be used during the immediate postoperative period. Oral narcotics will most likely still be required for some time after extubation. Narcotic-induced respiratory depression is a risk during this time, requiring vigilant monitoring of client&rsquo;s respiratory status.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0053note0085"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for ineffective Breathing Pattern</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Pain</para>
<para>Musculoskeletal impairment [surgical incision; chest tube]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Ventilation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain an effective respiratory pattern free of cyanosis and other signs and symptoms of hypoxia, with breath sounds equal bilaterally, lung fields clearing.</para>
<para>Display complete re-expansion of lungs with absence of pneumothorax and hemothorax.</para>
</note>
<note role="none" id="ch0002s0053note0086"><table frame="top" id="ch0002s0053ta0049"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate respiratory rate and depth. Note respiratory effort; for example, presence of dyspnea, use of accessory muscles, and nasal flaring.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client responses are variable. Respiratory rate and effort may be altered by pain, fear, fever, blood or fluid loss, accumulation of secretions, hypoxia, or gastric distention. Respiratory suppression can occur from long time under anesthesia or heavy use of opioid analgesics. Early recognition and treatment of abnormal ventilation may prevent complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds. Note areas of diminished or absent breath sounds and presence of adventitious sounds, such as crackles or rhonchi.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Breath sounds are often diminished in lung bases for a period after surgery because of normally occurring atelectasis. Loss of active breath sounds in an area of previous ventilation may reflect collapse of the lung segment, especially if chest tubes have recently been removed. Crackles or rhonchi may be indicative of fluid accumulation due to interstitial edema, pulmonary edema, or infection, or partial airway obstruction with pooling of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe chest excursion. Investigate decreased expansion or lack of symmetry in chest movement.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Air or fluid in the pleural space prevents complete expansion (usually on one side) and requires further assessment of ventilation status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe character of cough and sputum production.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Frequent coughing may simply be throat irritation from operative endotracheal tube (ET) placement or can reflect pulmonary congestion. Purulent sputum suggests onset of pulmonary infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect skin and mucous membranes for cyanosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cyanosis of lips, nail beds, or earlobes or general duskiness may indicate a hypoxic condition due to heart failure or pulmonary complications. General pallor, commonly present in the immediate postoperative period, may indicate anemia from blood loss or insufficient blood replacement or RBC destruction from CPB pump.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head of bed, place in upright or semi-Fowler&rsquo;s position. Assist with early ambulation and increased time out of bed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances respiratory function and lung expansion. Effective in preventing and resolving pulmonary congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client participation in and responsibility for deep-breathing exercises, use of adjuncts (e.g., incentive spirometer), and coughing, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in lung re-expansion and maintaining patency of small airways, especially after removal of chest tubes. Coughing is not necessary unless wheezes and rhonchi are present, indicating retention of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrate and reinforce splinting chest with pillows during deep breathing or coughing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces incisional tension, promotes maximal lung expansion, and may enhance effectiveness of cough effort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain that coughing and respiratory treatments will not loosen or damage grafts or reopen chest incision.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides reassurance that injury will not occur and may enhance cooperation with therapeutic regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage maximal fluid intake within cardiac reserves.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adequate hydration helps liquefy secretions, facilitating expectoration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Medicate with analgesic before respiratory treatments, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows for easier chest movement and reduces discomfort related to incisional pain, facilitating client cooperation with and effectiveness of respiratory treatments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Record response to deep-breathing exercises or other respiratory treatment, noting breath sounds before and after treatment, as well as cough and sputum production.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Documents effectiveness of therapy or need for more aggressive interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate and report respiratory distress, diminished or absent breath sounds, tachycardia, severe agitation, and drop in BP.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although not a common complication, hemothorax or pneumothorax may occur following removal of chest tubes and requires prompt intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review chest x-ray reports, pulse oximetry, and laboratory studies (such as ABGs, Hgb), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitors effectiveness of respiratory therapy and documents developing complications. A blood transfusion may be needed if blood loss is the reason for respiratory hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct in and encourage use of incentive spirometer.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes lung inflation, reduces atelectasis, and prevents pulmonary complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen by cannula or mask, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances oxygen delivery to the lungs for circulatory uptake, especially in the presence of reduced and altered ventilation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Assist with reinsertion of chest tubes or thoracentesis if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Re-expands lung by removal of accumulated blood and air and restoration of negative pleural pressure.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0053note0087"><title><emphasis role="strong">NURSING DIAGNOSIS: impaired Skin/Tissue Integrity</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Surgical procedure</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Disruption of skin surface/damaged tissue [surgical incisions, puncture wounds]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Wound Healing: Primary Intention</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate behaviors and techniques to promote healing and prevent complications.</para>
<para>Display timely wound healing.</para></note>
<note role="none" id="ch0002s0053note0088"><table frame="top" id="ch0002s0053ta0050"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Incision Site Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect all incisions. Evaluate healing progress. Review expectations for healing with client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Healing begins immediately, but complete healing takes time. Chest incision heals first (minimal muscle tissue), but donor site incision requires more time (more muscle tissue, longer incision, slower circulation). As healing progresses, the incision lines may appear dry, with crusty scabs. Underlying tissue may look bruised and feel tense, warm, and lumpy, suggesting resolving hematoma.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest wearing soft cotton shirts and loose-fitting clothing, leaving incisions open to air as much as possible, covering and padding portion of incisions as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces suture line irritation and pressure from clothing. Leaving incisions open to air promotes healing process and may reduce risk of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Have client shower in warm water, washing incisions gently. Instruct client to avoid tub baths until approved by physician.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keeps incision clean and promotes circulation and healing. <emphasis>Note:</emphasis> Climbing out of tub requires use of arms and pectoral muscles, which can put undue stress on sternotomy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage ankle exercises and elevation of legs when sitting in chair.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes circulation and reduces edema to improve tissue healing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review normal signs of healing, such as itching along wound line, bruising, slight redness, and scabbing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps client understand expected progression of healing and recognize signs of complications or nonhealing requiring further evaluation and intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct to watch for and report to physician places in incision that do not heal; reopening of healed incision; bloody or purulent drainage; localized area that is swollen with redness, feels increasingly painful, and is hot to touch; and temperature greater than 101.5&deg;F (38.6&deg;C) for longer than 24 hours.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Superficial infections and deep sternal wound infection (mediastinitis) occur infrequently but can have a profound effect on patient morbidity, length of stay, and cost of care. <emphasis>Note:</emphasis> This complication affects approximately 1% to 2% of cardiac surgery patients (Mueller &amp; Dacey, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote adequate nutritional and fluid intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps maintain circulating volume for tissue perfusion and meets cellular energy requirements to facilitate tissue regeneration and healing process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Obtain specimen of wound drainage, as indicated. Administer antimicrobials and local treatments, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>If infection occurs, local and systemic treatments may be required.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0053note0089"><title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, postoperative care, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information or interest in learning</para>
<para>Insufficient knowledge of resources</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instructions</para>
<para>Development of preventable complications</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Cardiac Disease</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in learning process.</para>
<para>Assume responsibility for own learning.</para>
<para>Begin to ask questions and look for information.</para>
<para><emphasis role="strong">Knowledge: Treatment Regimen</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, prognosis, and potential complications.</para>
<para>Describe reasons for therapeutic actions.</para>
</note>
<note role="none" id="ch0002s0053note0090"><table frame="top" id="ch0002s0053ta0051"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Individual</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reinforce surgeon&rsquo;s explanation of surgical procedure, providing diagram as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides individually specific information, creating knowledge base for subsequent learning regarding home management. Length of rehabilitation and prognosis are dependent on type of surgical procedure, preoperative physical condition, and duration and severity of any complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss importance of changes in memory or mentation and plans for follow-up with appropriate healthcare providers if client has long-term mental status changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mental status changes after heart surgery have long been reported, including confusion, delirium, seizures, coma, prolonged alteration in mental status, combativeness, and agitation. Many of these changes are transient, occurring in the immediate postoperative period, and client&rsquo;s recovery is complete. Some clients may have slower recovery time or have new-onset and/or worsening mental status. It is believed that some changes can be associated with manipulation of the large blood vessels during heart surgery, as well as preexisting cerebrovascular disease and other comorbidities (Fogoros, 2017b).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Cardiac Care: Rehabilitation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reinforce continuation of breathing exercises, incentive spirometry, and coughing with splinting incision.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes alveolar ventilation, reducing risk of lung congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss routine and prophylactic medications and OTC drug use. Emphasize importance of checking with physician before adding any drugs. Reinforce need for routine laboratory tests, outpatient education, and community resources if client with valve replacement will be taking warfarin (Coumadin).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depending on type of valve replacement (i.e., synthetic), lifelong anticoagulant therapy may be indicated. Potential for drug interactions must be considered before adding therapeutic agents to regimen. <emphasis>Note:</emphasis> Using herbal products, such as ginkgo, garlic, and vitamins, can alter coagulation and have an adverse effect when taken with anticoagulants.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review prescribed cardiac rehabilitation or exercise program and progress to date. Assist client and significant other (SO) to set realistic goals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individual capabilities and expectations depend on type of surgery, underlying cardiac function, and prior physical conditioning. <emphasis>Note:</emphasis> Obesity is a predictor of hospital readmission and may require additional interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage participation in home routines, such as self-care and cooking. Suggest alternating rest periods with activity and light tasks with heavy tasks. Avoid heavy lifting and isometric and strenuous upper-body exercise.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents excessive fatigue and exhaustion. Scheduling rest periods and short naps several times a day enhances coping abilities, reduces nervousness (common in this phase), and promotes healing. <emphasis>Note:</emphasis> Strenuous use of arms can place undue stress on sternotomy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Problem-solve with client and SO ways to continue progressive activity program during temperature extremes and high wind or pollution days, such as walking predetermined distance within own house, in local indoor shopping mall, or on exercise track.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Having a plan forestalls giving up exercise because of interferences such as weather.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reinforce physician&rsquo;s time limitations about lifting, driving, returning to work, resuming sexual activity, and exercising that involves upper extremities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These restrictions are present until after the first postoperative office visit for assessment of sternum healing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist client and SO to develop strategies for dealing with changes during recovery period, such as shifting responsibilities to other family members, friends, or neighbors; acquiring temporary assistance for housekeeping; and investigating avenues for financial assistance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Planning for changes that may occur or be required promotes sense of control and accomplishment without loss of self-esteem.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss issues concerning resumption of sexual activity, such as comparison of stress of sexual intercourse with other activities:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Concerns about sexual activity often go unexpressed, but clients usually desire information about what to expect. In general, client can safely engage in sex when activity level has advanced to point at which client can climb two flights of stairs, which is about the same amount of energy expenditure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Position recommendations</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client should avoid positions that restrict breathing (sexual activity increases oxygen demand and consumption). Client with sternotomy should not support self or partner with arms (breast bone healing, support muscles stretched).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Expectations of sexual performance</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Impotence appears to occur with some regularity in postoperative cardiac surgery clients. Although etiology is unknown, condition usually resolves in time without specific intervention. If situation persists, it may require further evaluation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Appropriate timing; for example, avoid sexual intercourse following heavy meal, during periods of emotional distress, when client is fatigued or exhausted</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Timing of activity may reduce occurrence of complications or angina.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pharmacological considerations</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some clients may benefit from prophylactic use of antianginal medications for sexual activity.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify services and resources available after discharge. Provide telephone contact number or schedule follow-up calls as appropriate. Include referral names for home-care services, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Facilitates transition to home and provides for ongoing monitoring, continuation of prescribed therapies, and opportunity to discuss concerns and alleviate anxiety.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0053note0091"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following discharge from care setting (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Activity Intolerance</emphasis>&mdash;generalized weakness, sedentary lifestyle</para></listitem>
<listitem><para><emphasis role="bi">impaired Skin/Tissue Integrity</emphasis>&mdash;mechanical factors (surgical incisions, puncture wounds)</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;broken skin, traumatized tissue, invasive procedures, decreased hemoglobin</para></listitem>
<listitem><para><emphasis role="bi">Self-Care deficit [specify]</emphasis>&mdash;discomfort, weakness, fatigue</para></listitem>
<listitem><para><emphasis role="bi">risk for ineffective Role Performance</emphasis>&mdash;physical illness, body image alteration, fatigue, pain</para></listitem>
<listitem><para><emphasis role="bi">impaired Home Maintenance</emphasis>&mdash;illness, impaired functioning, inadequate support systems, unfamiliarity with neighborhood resources</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0002s0059"><title><emphasis role="strong">AORTIC ANEURYSMS (ABDOMINAL AND THORACIC)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology: </emphasis>Aortic aneurysms (AAs) occur when a weakness develops in part of the wall of the aorta. Any type of aneurysm can lead to circulatory problems (e.g., slowing or blocking of blood flow to tissues and organs with resultant ischemia and potential for tissue damage/organ failure, blood clotting aberrations, and heightened risk of death). Dilation of an abdominal aneurysm becomes significant when the aortic diameter exceeds 3 cm. Surgery is usually recommended when an abdominal aneurysm is growing rapidly, or size exceeds 5 to 5.5 cm (Mayo Clinic Staff, 2016e).</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Three basic pathological conditions are usually found (Gale Encyclopedia of Medicine, 2008):</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>If all three layers of the vessel are affected and weakness develops along an extended area of the vessel, the weakened area will appear as a large, bulging region <emphasis>(fusiform aneurysm).</emphasis></para></listitem>
<listitem><para>If weakness develops between the inner and outer layers of the aortic wall, a bulge results as blood from the interior of the vessel is pushed around the damaged region in the wall and collects between these layers (<emphasis>dissecting aneurysm</emphasis> [DA] because one layer is separated from another).</para></listitem>
<listitem><para>If damage occurs to only the middle (muscular) layer of the vessel, a sack-like bulge can form (<emphasis>saccular aneurysm</emphasis>).</para></listitem></orderedlist>
</listitem>
<listitem><para>Aneurysms can form in any section of the aorta but are most common in the belly area (abdominal aortic aneurysm [AAA]).</para></listitem>
<listitem><para>Thoracic aorta aneurysm (TAA) form in the upper body. These can be <emphasis role="strong">ascending </emphasis>or <emphasis role="strong">descending </emphasis>aneurysms.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Thoracic ascending aortic aneurysms (TAAAs) involve just the aorta proper or include the aortic arch, and can affect blood flow to the head and heart muscle and coronary arteries. Ascending aortic aneurysms tend to cause anterior chest pain, whereas arch aneurysms more likely cause pain radiating to the neck.</para></listitem>
<listitem><para>Descending thoracic aneurysms and thoracoabdominal aneurysms may compress the trachea or bronchus and cause dyspnea, stridor, wheezing, or cough. Descending thoracic aneurysms more likely cause back pain.</para></listitem>
<listitem><para>Thoracic aneurysms are often asymptomatic until an acute (and often catastrophic) complication occurs.</para></listitem></orderedlist>
</listitem>
</orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology: </emphasis>Etiology is multifactorial and may include:</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>The condition occurs in individuals with multiple risk factors. Risk factors include smoking; chronic obstructive pulmonary disease (COPD); hypertension; atherosclerosis; male gender; age over 60; Caucasian race; high body mass index (BMI); congenital heart anomalies (e.g., bicuspid aortic valve); genetic factors (e.g., Marfan syndrome or type 1V Ehlers-Danlos syndrome); family history (especially first-degree relatives); stimulant (e.g., cocaine or methamphetamine) abuse; recent cardiac catheterization or cardiac surgery, especially when surgical complications occur; and pregnancy (especially in women over 40 in third trimester) (Bellomo &amp; Cichminski, 2013; Braverman et al, 2012; Strauss &amp; Davis, 2014; Tseng &amp; Bush, 2016).</para></listitem>
<listitem><para>Aging results in changes in collagen and elastin, which lead to weakening of the aortic wall and aneurysmal dilation.</para></listitem>
<listitem><para>Abdominal aneurysms are usually caused by atherosclerosis but can also occur because of trauma (e.g., shearing forces) or infection (CDC, 2016).</para></listitem>
<listitem><para>Traumatic dissections can occur anywhere in the aorta due to shearing from deceleration (such as might occur in motor vehicle crash or fall from height) (Tseng &amp; Bush, 2016).</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Classifications (Bellomo &amp; Cichminski, 2013; Fogoros, 2016b)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Stanford classification is widely used for types of dissection.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Type A: Dissection of ascending aorta, requiring surgical intervention</para></listitem>
<listitem><para>Type B: Dissection of descending aorta, most often treated medically with monitoring and prescribed medications</para></listitem></orderedlist>
</listitem>
<listitem><para>DeBakey classification is based on site of origin.</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Type I: Originates in ascending aorta and progresses at least to aortic arch and often beyond.</para></listitem>
<listitem><para>Type II: Originates in and is confined to ascending aorta.</para></listitem>
<listitem><para>Type III: Originates in descending aorta and can extend distally (away from origin) or rarely proximally (remains close to point of origin).</para></listitem></orderedlist>
</listitem>
</orderedlist></listitem>
<listitem><para><emphasis role="strong">Complications of Aortic Dissection (White et al, 2013)</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Common: Sudden death, cardiac tamponade, peripheral or mesenteric ischemia due to branch vessel dissection; myocardial ischemia due to coronary artery blockage or dissection; neurological complications (e.g., stroke, partial paralysis)</para></listitem>
<listitem><para>Less common (not a complete list): Left hemothorax, pleural effusion; superior vena cava syndrome; airway obstruction, vocal cord paralysis; hematemesis; spinal cord injury; renal vascular hypertension</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Mortality: Aortic aneurysms were the primary cause of 9,863 deaths in the United States in 2014 (CDC, 2016).</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Aneurysmal rupture is one of the 15 leading causes of death in most lists (Tseng &amp; Bush, 2016).</para></listitem>
<listitem><para>Up to 50% of patients with ruptured abdominal aortic aneurysms do not reach the hospital, and those who do survive to the operating room have a mortality rate as high as 50% (Aggarwal et al, 2011).</para></listitem>
<listitem><para>Early morbidity and mortality are related to bleeding, neurologic injury (e.g., stroke), cardiac failure, and pulmonary failure (e.g., acute respiratory distress syndrome [ARDS]) (Tseng &amp; Bush, 2016).</para></listitem></orderedlist>
</listitem>
<listitem><para>Cost: No recent figures of overall costs in the United States are found, partly owing to the number of reports regarding a particular type of aneurysm and its particular treatment. For example: One clinical trial carried out between 2002 and 2008 (and <emphasis>comparing costs between endovascular and open abdomen repair of ascending aortic aneurysms</emphasis>) reported that &ldquo;total mean health care costs did not differ significantly between the 2 groups (endovascular group, $142 745; open repair group, $153 533)&rdquo; (Lederle et al, 2016).</para>
<para>Another recent study found that &ldquo;the adjusted mean cost difference for <emphasis role="strong">emergent </emphasis>versus <emphasis role="strong">elective care </emphasis>was $8741.22 (30% increase) for <emphasis>abdominal aortic aneurysm</emphasis> repair&rdquo; (Haider et al, 2015).</para>
</listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0059note0092"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Aorta: </emphasis>Largest blood vessel of the body. Is composed of four parts: (1) ascending aorta (supplies coronary arteries and aortic valve), (2) aortic arch (brings blood to head, neck, and arms), (3) descending thoracic aorta (supplies blood to ribs and some chest structures), and (4) abdominal aorta (most major organs receive blood from branches of the abdominal aorta). The walls of the aorta have three layers: (1) inner (also known as the <emphasis role="bi">intima,</emphasis> a thin layer closest to blood flow); (2) middle (also called <emphasis role="bi">media</emphasis>), which provides the aorta its strength and elasticity; and (3) outer (also called <emphasis role="bi">adventitia</emphasis>), which provides structure and support. The intima is the portion that swells and forms a bulge (aneurysm) when the media weakens (Bellomo &amp; Cichminski, 2013; Hiratzka et al, 2010).</para>
<para><emphasis role="strong">Aortic aneurysm (AA): </emphasis>Balloon-like bulge in aorta resulting in aortic dilation. Risk factors include (1) direct mechanical forces on the aortic wall, such as hypertension, and (2) factors that affect the composition of the aortic wall (e.g., connective tissue disorders) (Green &amp; Kron, 2003; Strauss &amp; Davis, 2014). Symptomatic abdominal aortic aneurysms (AAAs) that are not dissected are often treated with surgery and endovascular grafting. AA can be a cause of AD (see below).</para>
<para><emphasis role="strong">Aortic dissection (AD): </emphasis>When aortic dissection (tearing) occurs, blood enters the linings of the aorta, tearing apart the layers of the wall, creating another pathway within which the blood runs (a false lumen). The dissection (a potentially life-threatening event) can travel along the length of the aorta, occluding blood vessels that arise from the aorta and causing damage to the organs supplied by those blood vessels. The primary tear is often more than 50% of the circumference of the aorta (Green &amp; Kron, 2003) and is more common in the ascending aorta.</para>
<para><emphasis role="strong">Aortic rupture: </emphasis>Dissection can result in an early or late rupture (a catastrophic event). Because the aorta is the body&rsquo;s main supplier of blood, rupture can cause life-threatening bleeding.</para>
<para><emphasis role="strong">Endoleak: </emphasis>A condition in which blood leaks into a vessel that has had a stent graft inserted to correct an aortic aneurysm.</para></note>
<sect2 id="ch0002s0060"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Emergency department: Screening may identify presence of aneurysm in patient being evaluated for pain. Patient risk and need for admission must be classified as high, medium, or low. These levels are determined by presence of high-risk conditions, such as pain and outcome of physical examination (White et al, 2013).</para></listitem>
<listitem><para>Acute care for emergent or elective surgical repair of aneurysm.</para></listitem>
<listitem><para>Community care for medical management of slow-growing aneurysms. Medical management includes periodic monitoring for changes in size of aneurysm and medications to reduce hypertension and lessen pulsatile load or aortic stress (White et al, 2013).</para></listitem>
<listitem><para><emphasis>Note:</emphasis> Medical management is not addressed in this care plan.</para></listitem></orderedlist>
<para><emphasis role="bi">Note:</emphasis>&nbsp;<emphasis role="strong">Focus of this care plan is postoperative care.</emphasis></para>
</sect2>
<sect2 id="ch0002s0061"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0032">Acute coronary syndrome</link></para>
<para><link linkend="ch0004s0114">Cerebrovascular accident (CVA)/stroke</link></para>
<para><link linkend="ch0002s0053">Cardiac surgery</link></para>
<para><link linkend="ch0002s0022">Hypertension: severe</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0005s0144">Upper gastrointestinal bleeding</link></para>
<para><link linkend="ch0003s0084">Pneumothorax/hemothorax</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0008s0244">Acute kidney injury (acute renal failure)</link></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<table frame="top" id="ch0002s0059ta0052"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE (PRERUPTURE/PREOPERATIVE)</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec namest="1" nameend="2" spanname="1-2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Data depend on the duration and severity of underlying problem and involvement of other body systems. Refer to specific plans of care for or relevant data and Diagnostic Studies and nursing diagnoses.</para>
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of poorly controlled hypertension and current hypertension</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;">
<listitem><para>Hypertension (70% of patients with AD have chronic hypertension) (White et al, 2013)</para></listitem>
<listitem><para>Blood pressure differential &gt;20 mm Hg between right and left arms (dissection)</para></listitem>
<listitem><para>Hypotension (with rupture)</para></listitem>
<listitem><para>Hypertension potentially followed by hypotension (with dissection)</para></listitem>
<listitem><para><emphasis role="bi">Pulses:</emphasis> Tachycardia (with rupture); bounding pulses, wide pulse pressure (dissection). Pulse deficit is not always present but occurs more commonly in type A dissections than in type B. Absence of upper extremity pulses may suggest ascending aortic aneurysm. Absent or reduced lower extremity peripheral pulses may occur if aneurysm is affecting either iliac artery.</para></listitem>
<listitem><para><emphasis role="bi">Heart rate and rhythm:</emphasis> Tachycardia and/or various dysrhythmias may occur. ECG may show ischemia or patterns of myocardial damage if coronary arteries are involved.</para></listitem>
<listitem><para><emphasis role="bi">Heart sounds:</emphasis> Abnormal sounds are not always present. Aortic insufficiency murmurs are present in about 44% of patients with type A dissections (White et al, 2013). Diastolic murmurs may be heard. Heart sounds are distant if pericardial tamponade is occurring.</para></listitem>
<listitem><para><emphasis role="bi">Skin:</emphasis> Pallor, clamminess, diaphoresis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Feeling anxious</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Restlessness, self-focus, alteration in attention; decreased perceptual field</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May have decreased/or absent output if renal arteries are involved or hypotension/shock is present</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May have decreased urinary output if renal arteries are involved or hypotension shock is occurring secondary to right coronary artery occlusion or cardiac tamponade due to rupture into pericardial space (Strauss &amp; Davis, 2014).</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Nausea</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Vomiting</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Diaphoresis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dizziness</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May have syncope; loss of consciousness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weakness on one side of body</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May have symptoms similar to stroke if aortic arch is involved.</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pulsating mass near navel</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Mass may be palpated in abdomen (size must be about 4 cm before it can be felt) (Thompson &amp; Szalay, 2014).</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pain reports:</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Client may not experience pain (particularly in slow-developing thoracic or abdominal aneurysm).</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Chest pain can mimic those of acute coronary syndromes</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Differential diagnosis will clarify issues, but diagnostic studies are usually necessary.</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pain with <emphasis role="strong">dissection:</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Although opiates can positively influence hemodynamics, they may not relieve patient&rsquo;s pain because of its severity (White et al, 2013).</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>For acute type A dissections, pain is often &ldquo;tearing or ripping.&rdquo; Pain is at maximal intensity at onset, rather than gradual (White et al, 2013).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>For type B dissections, chest pain and back pain may be about equally reported (Strauss &amp; Davis, 2014; White et al, 2013).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pain may migrate as dissection increases in size.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pain with <emphasis role="strong">rupture:</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pain may occur in abdominal, lower back, flank, groin</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Lower limb pain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pallor, lack of pulses, cool extremity (if AAA rupture)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Respiratory distress or use of accessory muscles</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tobacco use (smoking), which is a major risk factor</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Adventitious breath sounds, such as crackles or wheezes</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pallor or cyanosis generally associated with advanced cardiopulmonary effects of sustained or severe hypertension</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Lightheadedness; fainting</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fever</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May or may not be present</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Familial and individual risk factors, including hypertension, atherosclerosis; prior aneurysms in other large blood vessels (e.g., behind knee, thoracic aorta); diseases that cause blood vessels to become inflamed</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>While certain risk factors (e.g., gender, age, race) are nonmodifiable, smoking and drug use are behaviors that should be addressed in teaching.</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with ADLs, transportation, homemaking tasks, dressing(s)/supplies</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Possible placement in rehabilitation or long-term care facility</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for post discharge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0059ta0053"><title><emphasis role="strong">DIAGNOSTIC STUDIES (PREOPERATIVE)</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests that typically includes hemoglobin (Hgb); hematocrit (Hct); red blood cell (RBC) count; morphology, indices, and distribution width index; platelet count and size; and white blood cell (WBC) count and differential.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of leukocytes in WBCs may indicate stress state. Decreased Hgb and Hct levels in the CBC may be present with leaking or rupture of dissection anywhere along the aorta.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cardiac enzymes, including troponin I and troponin T, also possibly creatinine kinase (CK) and myoglobin:</emphasis> Substances released from heart muscle when it is damaged.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Troponins are reliable markers for cardiac tissue damage (if coronary arteries involved). Myoglobin is not specific to cardiac muscle tissue, but if negative, it can help rule out MI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Smooth-muscle myosin heavy-chain assay:</emphasis> A cytoplasmic structural protein that is a major component of the contractile apparatus in smooth muscle cells.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Test is performed in the first 24 hours. Increased levels in the first 24 hours are 90% sensitive and 97% specific for aortic dissection. Levels are highest in the first 3 hours (Mancini, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum lipids, including total lipids, cholesterols, and triglycerides:</emphasis> A group of tests that make up a lipid profile.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of high cholesterol increases risk of atherosclerosis, which can cause aortic aneurysms, and increases risk of stroke when aneurysm is large or unstable.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN) and creatinine (Cr):</emphasis> These tests measure the amount of nitrogen and chemical waste product in the blood that passes through the kidneys to be filtered and eliminated in urine. When measured together (in certain ratios), information is obtained about kidney function.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in kidney function may occur with renal artery involvement and/or with hypotension/shock state.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC STUDIES (IMAGING TESTS)</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Ultrasound (abdominal or thoracic) (also called sonography): Imaging method that uses high-frequency sound waves to produce images of structures within the body.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Test most commonly done to diagnose abdominal aortic aneurysm (AAA). May be used to monitor size and other aspects of slow-growing thoracic aneurysms to determine risk of rupture. May be used as screening tool for male 65 to 75 who has ever smoked or is at least 60 years with a close family member (e.g., father, brother) who has had an aneurysm.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Computerized tomography (CT) scan with or without contrast:</emphasis> Imaging method that uses x-rays to create pictures of cross sections of the body.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides clear images of aorta; can detect size and shape of aneurysm. May be used to monitor slow-growth aneurysm over time.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Evaluates organs and structures within the chest.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May show widened mediastinum or aorta, and/or pulmonary congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart showing rhythm and rate, electrical conduction, signs of ischemia, and muscle damage to the heart.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May show inferior ischemic changes, ST elevation or depression, T-wave inversions (if right coronary artery involved), low-voltage ECG and electrical alternans (signs of cardiac tamponade), and rhythm disturbances.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Echocardiogram (may be transthoracic [TTE] or transesophageal [TEE]):</emphasis> Noninvasive scan similar to ultrasound that shows the size and shape of the heart and how well the heart chambers and valves are working.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be done to evaluate the function of the heart when aortic arch aneurysm is suspected or when coronary arteries are involved. May be first diagnostic scan that diagnoses a thoracic aortic aneurysm, especially in client too unstable to be transported to radiology. <emphasis>Note:</emphasis> TEE is as accurate as CT and MRI in terms of sensitivity and specificity, and it can be used at the bedside, which makes it ideal for hemodynamically unstable patients (Mancini, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnetic resonance imaging (MRI):</emphasis> Diagnostic technique that uses magnetic fields and radio waves to produce a detailed image of the body&rsquo;s soft tissue and bones.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used to diagnose aneurysm, its location, and size. MRI is the most sensitive method for diagnosing aortic dissection and has similar specificity to CT but is not always a desired tool (e.g., unstable client, client has certain prosthetic devices) (Mancini, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnetic resonance angiogram (MRA):</emphasis> Type of magnetic resonance imaging scan that uses a magnetic field and pulses of radio wave energy to provide pictures of blood vessels inside the body.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used if view more detailed than ultrasound is needed (e.g., aneurysm&rsquo;s relation to blood vessels or kidney or other organs).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Aortogram:</emphasis> X-ray test that uses dye and fluoroscopy to evaluate blood flow in an artery (such as the aorta). The procedure involves placement of a catheter in the aorta and injection of contrast material while taking x-rays of the aorta.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Can determine presence and/or size of aneurysm, confirm dissection, blood clots, or other blood vessel involvement. <emphasis>Note:</emphasis> Test is mostly being replaced by newer, less invasive imaging studies.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0062"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain organ functioning.</para></listitem>
<listitem><para>Monitor for/prevent complications.</para></listitem>
<listitem><para>Promote optimal wellness.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0063"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Systemic complications prevented or minimized.</para></listitem>
<listitem><para>Necessary lifestyle or behavioral changes initiated.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<para><emphasis role="strong">These postoperative Nursing Diagnoses and Interventions are recommended in conjunction with general surgical interventions. Refer to Care Plan: <link linkend="ch0014s0348">Surgical Interventions</link>.</emphasis></para>
<note id="ch0002s0059note0093"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for ineffective Tissue Perfusion (Specify: cardiovascular, cerebral, renal, peripheral)</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Cardiac perfusion: Cardiovascular surgery; hypertension or hypotension; hypovolemia; hypoxia</para><para>Cerebral perfusion: Cerebrovascular impairment; aortic dissection; mechanical prosthetic valve</para><para>Renal perfusion: Cardiac surgery; vascular embolism; treatment regimen; hypovolemia; hypoxemia</para><para>Peripheral perfusion: Endovascular trauma or procedure</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para><para><emphasis role="strong">Circulation Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain BP within individually acceptable range.</para>
<para>Demonstrate stable perfusion as appropriate (e.g., vital signs within client&rsquo;s normal range; chest pain/discomfort absent or at manageable level; neurological signs within client&rsquo;s normal range; peripheral pulses present and strong; absence of edema).</para></note>
<note role="none" id="ch0002s0059note0094"><table frame="top" id="ch0002s0059ta0054"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Hemodynamic Regulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence of condition(s) (such as recent thoracic or abdominal aortic surgery, recent aortic rupture or surgical clamping, blood loss, hypovolemia, hypoxemia).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Factors that affect systemic circulation, tissue oxygenation, and organ function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for changes in level of consciousness or mentation, purposeful movement, and ability to follow commands and to move extremities appropriately</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in cerebral or peripheral circulation and perfusion may reflect state of impairment due to damage from aneurysm or may show postoperative changes, either improvement or impairments from surgical procedure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs, especially noting changes/trends in blood pressure, including hypertension or hypotension.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in blood pressure may be subtle or sudden and may be indicative of several things (e.g., increased vascular resistance, hyper/hypovolemia, leaking of surgical anastomosis with slow bleeding, or hemorrhage), all complications that require monitoring for prevention or early intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess heart sounds, as well as apical and peripheral pulses. Document dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in heart sounds and pulses may indicate inadequate oxygenation or hydration status. Dysrhythmias may be present because of ischemia or surgical changes to the aorta, coronary arteries, or valves.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note and act upon changes and trends.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate breathing patterns and respiratory rate outside of acceptable parameters.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These may indicate oxygen exchange problems; postoperative changes in the chest (e.g., ventilation or chest tubes); response to deficient hemoglobin or fluids; or respiratory depression associated with anesthesia/analgesia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note reports of difficulty breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess lung sounds, noting presence/absence of air movement in any area.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may have chest tubes in following thoracic surgery. When drainage has slowed/stopped and air is moving freely in all lung fields, the tube(s) will be removed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect skin for cyanosis, pallor, mottling, cool or clammy skin, and increased capillary refill time.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Skin can reveal the status of systemic and/or local oxygenation and perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe/measure all-source output, noting changes, trends, and imbalances.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may have preoperative and perioperative conditions associated with the aneurysm, which are affecting postoperative output (e.g., renal vascular involvement) and/or perioperative issues (e.g., hypotension/shock, bleeding, chest tubes) that affect fluid status and organ perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of pain, noting if pain is a new or different pain than client reported prior to surgery.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps differentiate whether this pain is related to surgical procedure and/or if this pain differs from that experienced prior to surgery. Nonsurgical pain may be associated with inadequate systemic or localized tissue oxygenation/organ perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Perform Doppler assessment of extremity pulses, if needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In patients who have undergone aortic reconstructions, neither distal pulses nor Doppler signals may be present initially, because of vasoconstriction from hypothermia. For upper extremities, a Doppler signal is nearly always audible in the wrist in the immediate postoperative period.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with and encourage early ambulation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances circulation and return of normal organ function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate in management of underlying conditions, such as bleeding, hypertension, hypovolemia, dysrhythmias, diabetes, COPD, etc.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To correct or manage acute or chronic conditions that would influence organ perfusion and function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain patent airway.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates air movement.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide supplemental oxygen by appropriate route (e.g., ventilator, mask, nasal cannula).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oxygen may be needed to improve systemic circulation and tissue perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer IV fluids and blood products, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains circulating volume and supports tissue/organ perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Various drugs may be needed to support cardiac function, to promote systemic hemostasis, and/or to prevent or limit risk of perfusion complications (e.g., dysrhythmias, bleeding, thromboembolic phenomena, electrolyte imbalances).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Apply antiembolic hose or sequential compression devises, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prevents venous stasis and promotes circulation.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0059note0095"><title><emphasis role="strong">NURSING DIAGNOSIS: risk for Bleeding</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Aneurysm</para>
<para>Abnormal blood profile [e.g., altered clotting factors, decreased hemoglobin]</para>
<para>Treatment regimen [e.g., surgery, medications, administration of platelet-deficient blood products]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Bleeding Loss Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of signs of active bleeding such as hemoptysis, hematuria; or excessive blood loss [preoperative, perioperative, and/or postoperative].</para>
<para>Demonstrate stable vital signs, skin and mucous membranes free of pallor; usual mentation and urinary output.</para></note>
<note role="none" id="ch0002s0059note0096"><table frame="top" id="ch0002s0059ta0055"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Bleeding Precautions</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence of condition(s) (such as recent thoracic or abdominal aortic surgery, recent aortic rupture or surgical clamping, hemorrhage/blood loss, hypovolemia, hypoxemia). Be aware of bleeding risks, both for sudden hemorrhage and for hidden internal blood loss.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Factors that affect systemic circulation, clotting factors, and tissue/organ perfusion. Both aneurysm rupture and open abdomen repair may result in significant blood loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for frank bleeding from incisions, tubes, and body orifices. Hematest secretions and excretions as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hemorrhage may occur because of an inability to achieve hemostasis in the setting of aortic aneurysm, surgery, or development of a coagulopathy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess vital signs, including blood pressure, pulse, and respiration, especially when associated by impaired mental status.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists in determining intravascular fluid deficits. Tachycardia, tachypnea, hypotension, and any change in mentation can herald hypovolemia, impending shock.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor hemodynamic measurements (e.g., central venous pressure or arterial blood pressures) where available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Invasive monitoring lines will be in place in the critically ill patient, whose early postoperative care will be provided in intensive care units.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor skin and mucous membrane color and moisture. Note increased capillary refill time and poor skin turgor (late sign).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypovolemia associated with bleeding may be demonstrated in pale, cool, and clammy skin with dry mucous membranes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe/measure all-source output, noting changes, trends, and imbalances.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may have preoperative and perioperative conditions associated with the aneurysm, which are affecting postoperative output (e.g., renal vascular involvement) and/or perioperative issues (e.g., hypotension/shock, bleeding, chest tubes), which affect fluid status and organ perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of pain in specific areas and whether pain is increasing, diffuse, or localized.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can help locate possible sources of bleeding, especially in setting of falling hemoglobin, and downward trend in vital signs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate and mark boundaries of soft tissues (e.g., abdomen, flank, back) if hematomas present/spreading.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be prepared for emergency interventions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This is a fragile client. Prompt interventions may be needed to prevent/manage complications and save life.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review laboratory data (e.g., hemoglobin, hematocrit, platelets, and coagulation profiles), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists in determining intravascular fluid volume, status of blood volume, and bleeding risks.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer IV fluids and blood products/specific components, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Restores and maintains circulating volume.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0059note0097"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Physical injury agents (e.g., operative procedure)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Verbal/coded report; expressive behavior (e.g., restlessness, crying)</para>
<para>Changes in physiological parameters (e.g., blood pressure, heart/respiratory rate; oxygen saturation)</para>
<para>Guarding/protective behavior; positioning to ease pain</para>
<para>Self-focus</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para><para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report pain or discomfort is relieved or controlled.</para>
<para>Verbalize nonpharmacological methods that provide relief.</para>
<para>Follow prescribed pharmacological regimen.</para></note>
<note role="none" id="ch0002s0059note0098"><table frame="top" id="ch0002s0059ta0056"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine and document presence of possible pathophysiological causes of pain (e.g., surgical incision(s), tissue trauma, comorbidities such as complication from ischemia or clotting prior to surgery).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establishes a baseline for pain assessments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate pain in immediate postoperative period and regularly (e.g., hourly, per protocol).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about need for and effectiveness of interventions. Regular monitoring also permits early recognition of developing complication (such as might occur with abdominal distention associated with internal bleeding).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consider patient&rsquo;s age and current situation (e.g., sedated, on ventilator, cognitively impaired), coexisting medical or psychological conditions: size and location of incisions/drains/tubes, etc.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many factors affect pain situation and perception. This surgery is complex and often performed on emergent basis on elderly person (although it can be performed on person of any age) with very little time for preoperative preparation of postoperative expectations. Early postoperative situation is often complex and confusing, filled with medical/nursing interventions and activity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine specifics of pain&mdash;location (e.g., incision, deep in abdomen), characteristics (e.g., throbbing, stabbing), and intensity (0 to 10, or similar scale).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates diagnosis of problem and initiation of appropriate interventions. Helpful in evaluating need for/effectiveness of therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate vital signs on ongoing basis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in blood pressure and heart rate often accompany acute pain (especially in early postoperative period) and may occur before patient reports pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in vital signs can also point toward potential complication (e.g., bleeding, infection) causing or exacerbating pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess causes of possible discomfort other than operative procedure.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows for identification of other discomforts (e.g., nausea, infiltrated IV, chest tube, abdominal distention, need to urinate; anxiety/fear; disorientation), which may require intervention in order to promote overall comfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client in determining acceptable level of discomfort.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It may not always be possible to eliminate pain; however, patient may be &ldquo;comfortable&rdquo; at a level 5 if pain has been a level 10 for a length of time. Or eliminating another discomfort (e.g., nausea) can promote improved analgesia effect.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate with patient in pain management. Instruct in early reporting of pain and ongoing evaluation of effectiveness of current interventions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes client&rsquo;s sense of control and maximizes efforts for pain control.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide and promote nonpharmacological measures for pain relief (such as repositioning; rest in a quiet environment; family presence; splinting of incision during coughing; relaxation techniques, such as deep breathing; soft music/other diversion).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps relieve muscle and emotional tension. Enhances sense of well-being.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Document effects of pain management (nonpharmacological measures and analgesics).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain should be reassessed after each pain management intervention once a sufficient time has elapsed for the treatment to reach peak effect. Reassessment should include whether the patient&rsquo;s goal for pain relief was met (e.g., pain intensity, effect on function [physical or psychosocial], patient satisfaction with pain relief, whether side effects had occurred and were tolerable).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer analgesics by appropriate route (e.g., IV, patient-controlled analgesia [PCA], oral), as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Pain control is essential to quality patient care. It ensures patient comfort, promotes tissue healing and effective pulmonary toilet.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0059note0099"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity of therapeutic regimen</para><para>Insufficient knowledge</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reported difficulty with prescribed regimens</para>
<para>Failure to include treatment regimen in daily living or to take action to reduce risk factors</para><para>Ineffective choices in daily living for meeting health goal</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Treatment Regimen</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process and treatment regimen.</para>
<para>List signs and symptoms that require immediate intervention.</para>
<para>Identify and engage available resources.</para>
<para><emphasis role="strong">Self-Management: Hypertension</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain BP within individually acceptable parameters.</para></note>
<note role="none" id="ch0002s0059note0100"><table frame="top" id="ch0002s0059ta0057"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s circumstances, observing age, functional and cognitive status. Note type of aneurysm repair (e.g., open abdomen or endovascular), whether more than one chronic condition (e.g., COPD, stroke, renal impairment) is present at the same time.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These factors affect how the client/caregiver views and manages postoperative self-care. Elder patients (about 60% in one study) often present with worse comorbidities and severe complications such as myocardial infarction, pneumonia, and acute renal failure (Raval &amp; Escandari, 2012). In another study, elder patients reported that health-related quality of life after AAA repair was significantly impaired in the early postoperative period (Pol et al, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify immediate care needs, complexity of care needs, care support system, and where convalescence will take place.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When being discharged from acute care, client may continue care in rehabilitation, long-term care, or home. This is dependent upon client&rsquo;s discharge status and presence or absence of support systems. This, in turn, determines the type and amount of teaching, support, and care coordination required. For example, client in early postoperative period may need assistance with surgical wound care, blood pressure monitoring, and medication safety. Client in later stages of recovery may need more teaching and support in areas of prevention of recurrence (e.g., remaining smoke-free, adhering to medical follow-up monitoring).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client/caregiver in identifying modifiable risk factors, such as smoking, hypertension, and diet high in sodium and saturated fats.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is appropriate to address preventable or manageable conditions that are known to contribute to cardiovascular disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Problem-solve with client/caregiver to identify ways in which appropriate lifestyle changes can be made to reduce modifiable risk factors.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changing &ldquo;comfortable or usual&rdquo; behavior patterns can be very difficult and stressful. Support, guidance, and empathy can enhance client&rsquo;s success in accomplishing his or her health goals.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss importance of eliminating smoking, and assist client in formulating a plan to quit smoking. Refer to smoking cessation program or healthcare provider for helpful medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nicotine increases catecholamine discharge, resulting in increased heart rate, blood pressure, and vasoconstriction, interfering with optimal organ perfusion and function. <emphasis>Note:</emphasis> Several studies have demonstrated that tobacco use is associated with an increased rate of aneurysm expansion (preoperatively) and smoking cessation is likely the most important recommendation that can be made to a patient with AAA (Brady et al, 2004).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct in and demonstrate BP self-monitoring technique. Observe client&rsquo;s technique in return, and ascertain that client understands blood pressure readings. Evaluate client&rsquo;s hearing, visual acuity, manual dexterity, and coordination.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitoring BP at home is reassuring to client because it provides visual feedback to determine treatment outcomes and helps promote early detection of deleterious changes. <emphasis>Note:</emphasis> Client may be on multiple medications with goal of keeping blood pressure at or below 120/80, to reduce flow force in aorta.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help client develop a simple, convenient schedule for taking medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individualizing schedule to fit client&rsquo;s personal habits may make it easier to get in the habit of including medications in healthcare management activities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain prescribed medications along with their rationale, dosage, expected and adverse side effects, and particular traits.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adequate information and understanding about beneficial and expected side effects can enhance client&rsquo;s commitment to the treatment plan.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain rationale for prescribed dietary regimen&mdash;such as diet low in sodium, saturated fat, and cholesterol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Excess saturated fats, cholesterol, sodium, alcohol, and calories have been defined as nutritional risks in hypertension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to establish a regular exercise program, within client&rsquo;s capabilities and potential.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Besides helping to lower BP, aids in toning the cardiovascular system and improves general health and well-being.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review symptoms that require the client to notify the healthcare provider, such as failure of healing in surgical wound; fever; sudden or continued increase of BP; chest (or other) unrelieved pain; shortness of breath; peripheral or abdominal swelling; and other symptoms as individually appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection and reporting of potentially developing complications (early or late) allow for timely intervention. <emphasis>Note:</emphasis> One author reporting on postoperative thoracic aortic aneurysm follow-up stated that &ldquo;development of another aneurysm postoperatively is not uncommon&rdquo; (Tseng &amp; Bush, 2016). Also, patients who have had endovascular aneurysm repair need lifelong radiographic monitoring of graft placement and for developing endoleaks. <emphasis>Note:</emphasis> An endoleak is a common complication of an endovascular aneurysm repair (EVAR) and is found in 30% to 40% of patients intraoperatively and in 20% to 40% during follow-up (Tinkham, 2013).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide information regarding community resources for both client and caregiver support. Initiate referrals, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Community resources such as stop smoking clinics, stress management classes, home care, caregiver respite, and counseling services may be helpful in efforts to support lifestyle changes and enhance recovery efforts.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0059note0101"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Activity Intolerance</emphasis>&mdash;generalized weakness, imbalance between oxygen supply and demand</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, perceived seriousness</para></listitem>
<listitem><para><emphasis role="bi">Self-Care Deficit [specify]</emphasis>&mdash;pain/discomfort, weakness, fatigue</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;alteration in skin integrity, decrease in hemoglobin, smoking</para></listitem></itemizedlist></note>
</sect2></sect1>
<sect1 id="ch0002s0064"><title><emphasis role="strong">VENOUS THROMBOEMBOLISM (VTE) DISEASE INCLUDING DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM (PE)</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology: </emphasis>Venous thromboembolism (VTE) results from a combination of hereditary and acquired risk factors, known as thrombophilia or hypercoagulable states. Also, vessel wall damage, venous stasis, and alterations in the clotting mechanism (Virchow&rsquo;s triad) remain the fundamental issues in thrombosis (Ozaki &amp; Bartholomew, 2012).</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Mechanical (e.g., trauma, surgery) or physiological (e.g., hypertension, phlebitis) damage to the vessel wall leads to platelet activation, with platelets adhering to one another and clumping together, forming a thrombus.</para></listitem>
<listitem><para>The thrombus either dissolves over time or grows and becomes large enough to occlude a vessel, which causes blood flow to slow, expands the veins to accommodate the increased volume, and causes more clots to form.</para></listitem>
<listitem><para>Proximal venous thromboembolism (VTE) extending to the popliteal, femoral, or iliofemoral vessels&mdash;more likely to break away from the vessel and cause pulmonary embolism (PE).</para></listitem>
<listitem><para>Although most deep vein thromboses (DVTs) occur in lower extremities, a small percentage do occur in upper extremities. These are usually due to (1) effort-induced thrombosis (Paget-von Schr&ouml;tter syndrome) or (2) secondary thrombosis, which is sometimes associated with the use of central venous catheters (Patel et al, 2016).</para></listitem>
<listitem><para>Approximately 50% of clients with VTE are asymptomatic.</para></listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Thromboembolism can affect superficial or deep veins, although VTE is more serious in terms of potential complications, including PE, postthrombotic syndrome (PTS), chronic venous insufficiency, and vein valve destruction.</para></listitem>
<listitem><para>Predisposing and risk factors:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Previous episode of VTE (single most powerful risk factor for DVT) (Patel et al, 2016)</para></listitem>
<listitem><para>Major surgery, especially orthopedic; trauma; prolonged immobilization for any cause; paralysis, paresis, or recent plaster immobilization of lower extremities; spinal cord injury; extended travel</para></listitem>
<listitem><para>Cardiovascular conditions such as valvular heart disease with dysrhythmias, myocardial infarction (MI), heart failure, and stroke</para></listitem>
<listitem><para>Cancer (active or ongoing treatment within last 6 months); central venous catheter use</para></listitem>
<listitem><para>Obesity with BMI &gt;30</para></listitem>
<listitem><para>Age greater than 40</para></listitem>
<listitem><para>Pregnancy-related complications; hormone replacement therapy, oral estrogen birth control</para></listitem>
<listitem><para>Intravenous (IV) drug users, pills</para></listitem>
<listitem><para>Indwelling central venous catheters, pacemaker; or presence of inferior vena cava (IVC) filter</para></listitem></orderedlist>
</listitem></orderedlist>
</listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Morbidity: </emphasis>VTE is the third most common cardiovascular illness after acute coronary syndrome and stroke. Approximately 900,000 incidents of VTE occur annually in the United States (Centers for Disease Control and Prevention [CDC], 2015).</para></listitem>
<listitem><para><emphasis role="strong">Mortality: </emphasis>It is estimated that 60,000 to 100,000 die of DVT/PE annually in the United States (10% to 30% within one month of diagnosis). Sudden death is the first symptom in about one-quarter (25%) of people who have a PE.</para></listitem>
<listitem><para><emphasis role="strong">Costs: </emphasis>Annual health plan payments for services related to VTE were an average of $15,123 for a VTE event from 2008 to 2011 (Fernandez et al, 2015).</para></listitem></orderedlist>
</listitem></orderedlist>
<note id="ch0002s0064note0102"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Coagulation: </emphasis>Complex process or cascade of events involving more than 30 types of cells and substances by which blood cells clump together to form a clot via one of two pathways: extrinsic (blood is exposed to a subendo-thelial tissue factor) or intrinsic (triggered when the blood is exposed to a foreign substance). Disorders of coagulation can lead to an increased risk of bleeding and clotting or thrombus formation.</para>
<para><emphasis role="strong">Embolus: </emphasis>Something that travels through the bloodstream, lodges in a blood vessel, and blocks it. Examples of emboli are a detached blood clot, a clump of bacteria, and foreign material such as air.</para>
<para><emphasis role="strong">Homans&rsquo; sign: </emphasis>Deep calf pain in affected leg upon dorsiflexion of the foot, which is present in approximately one-third of cases of DVT. Homans&rsquo; sign is not specific to DVT (can occur in about 50% of persons with leg pain unrelated to DVT).</para>
<para><emphasis role="strong">Postthrombotic syndrome: </emphasis>Occurs when blood can no longer circulate properly because venous circulation is impaired from veins and valves that have been damaged by thrombosis. It can mimic recurrent DVT.</para>
<para><emphasis role="strong">Pulmonary embolism (PE): </emphasis>A thrombus that dislodges from a vessel wall and travels through the right side of the heart into the pulmonary artery, thereby obstructing blood flow.</para>
<para><emphasis role="strong">Recurrent VTE: </emphasis>Occurs within a year after the initial event. Because of persistent abnormalities in affected vasculature after the initial VTE, it can be difficult to differentiate an acute event from an ipsilateral limb recurrence clinically. Diagnosis requires evidence of new clot formation.</para>
<para><emphasis role="strong">Thrombophlebitis: </emphasis>Inflammation of a vein that occurs when a blood clot develops in the vein. <emphasis>Note:</emphasis> Superficial thrombophlebitis is characterized by the finding of a palpable, cordlike, tender, subcutaneous venous segment. <emphasis>Note:</emphasis> Forty percent of patients with superficial thrombophlebitis without coexisting varicose veins and with no other obvious etiology (e.g., intravenous catheters, intravenous drug abuse, soft tissue injury) have an associated DVT (Patel et al, 2016).</para>
<para><emphasis role="strong">Venous thromboembolism (VTE): </emphasis>Disease that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE).</para>
</note>
<sect2 id="ch0002s0065"><title><emphasis role="strong">CARE SETTINGS</emphasis></title>
<para>DVT is primarily treated at the community level, with short inpatient stay indicated in the presence of embolization. Client with sudden-onset pulmonary embolism is usually critically ill and requires initial care in critical care unit.</para>
</sect2>
<sect2 id="ch0002s0066"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0014s0370">Cancer</link></para>
<para><link linkend="ch0011s0293">Fractures</link></para>
<para><link linkend="ch0004s0129">Spinal cord injury</link></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<para><link linkend="ch0003s0094">Respiratory failure/ventilatory assistance</link></para>
<table frame="top" id="ch0002s0064ta0058"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Occupation that requires sitting or standing for long periods of time</para></listitem>
<listitem><para>Prolonged immobility</para></listitem>
<listitem><para>Leg pain with activity</para></listitem>
<listitem><para>Fatigue, general malaise</para></listitem>
<listitem><para>Weakness of affected extremity; generalized weakness</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Generalized or extremity weakness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of previous peripheral vascular disease, venous thrombosis, varicose veins</para></listitem>
<listitem><para>Presence of other predisposing factors, such as pregnancy-induced hypertension, diabetes mellitus, MI or valvular heart disease, thrombotic stroke, or blood dyscrasias</para></listitem>
<listitem><para>Fainting</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachycardia &gt;100/min</para></listitem>
<listitem><para>Accentuated second heart sound (53% with PE)</para></listitem>
<listitem><para>Peripheral pulse may be diminished in the affected extremity</para></listitem>
<listitem><para>Varicosities or dilated veins</para></listitem>
<listitem><para>Skin color and temperature in affected extremity: variable discoloration, may be pinkish red, warm along the superficial vein (over area of thrombosis in DVT) (Patel et al, 2016)</para></listitem>
<listitem><para>Pallor or cyanosis (PE)</para></listitem>
<listitem><para>Differences in leg circumferences: affected leg may be larger than the unaffected leg when measured 10 cm (4 inches) below the kneecap (tibial tuberosity)</para></listitem>
<listitem><para>Syncope</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Sense of impending doom (PE)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Apprehension</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Poor skin turgor, dry mucous membranes (dehydration predisposes to hypercoagulability)</para></listitem>
<listitem><para>Obesity (predisposes to stasis and pelvic vein pressure)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Throbbing, tenderness, aching pain aggravated by standing or movement of affected extremity (DVT)</para></listitem>
<listitem><para>Severe crushing chest pain (during onset of PE)</para></listitem>
<listitem><para>Pleuritic chest pain (sharp pain on inhalation or exhalation) may be present (84%)</para></listitem>
<listitem><para>Pain may radiate through to back or into jaws and/or ears (PE)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Guarding of affected extremity</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Sudden-onset shortness of breath</para></listitem>
<listitem><para>Cough, with or without sputum production</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dyspnea (73% with PE)</para></listitem>
<listitem><para>Tachypnea (rate over 18 breaths/min) (96%) (Ouellette et al, 2016)</para></listitem>
<listitem><para>Normal lung sounds can be present (PE), although crackles (rales) are common (53%)</para></listitem>
<listitem><para>Sputum may be pink tinged</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of direct or indirect injury to extremity or vein, such as major trauma or fractures, orthopedic or pelvic surgery, surgical procedures longer than 2 hours, urologic surgery, pregnancy, prolonged labor with fetal head pressure on pelvic veins, heart failure, venous cannulation or catheterization, or IV therapy</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fever, chills</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Presence of malignancy, particularly neoplasms of the pancreas, lung, gastrointestinal system, prostate</para></listitem>
<listitem><para>Sepsis</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Use of oral contraceptives and estrogens; recent anticoagulant therapy predisposes to hypercoagulability</para></listitem>
<listitem><para>Use of vitamins and herbal supplements, such as vitamin B<subscript>6</subscript>, vitamin E, niacin, magnesium, L-carnitine, and bromelain, for heart or blood pressure health</para></listitem>
<listitem><para>Recurrence and lack of resolution of previous thrombophle-botic episode</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Temporary assistance with shopping, transportation, and homemaker and maintenance tasks</para></listitem>
<listitem><para>Properly fitted antiembolic hose</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0002s0064ta0059"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests, which typically includes hemoglobin (Hgb), hematocrit (Hct), red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; and white blood cell (WBC) count and differential.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hemoconcentration (elevated Hct) potentiates risk of thrombus formation. WBC count may be normal or elevated in patients with pulmonary embolism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Coagulation profile:</emphasis> (e.g., prothrombin time and activated partial thromboplastin time) to evaluate for a hypercoagulable state.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies clotting problems that may increase one&rsquo;s risk of VTE. For example, antithrombin is useful in determining cause of hypercoagulation; inherited biochemical conditions; and deficits in certain other coagulation modulators, such as antithrombin III, protein S, or protein C, that can predispose client to thrombus formation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">D-dimer assay:</emphasis> Measures fibrin degradation fragments generated by fibrinolysis.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An elevated D-dimer level indicates a thrombotic process but is not specific to DVT. Combining D-dimer results with measurement of the exhaled end-tidal ratio of carbon dioxide to oxygen (etCO<subscript>2</subscript>/O<subscript>2</subscript>) can be useful for diagnosis of pulmonary embolism (Ouellette et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Troponins:</emphasis> Protein molecules that are part of cardiac and skeletal muscle.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac troponins (cTnT and CTnI) may be elevated in patients with confirmed PE. Elevated cTnTs and cTnIs also correlate with the severity of right ventricular (RV) dysfunction, most likely because of acute right ventricular myocardial stretch (Glatter, 2008; Konstantinides, 2008).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES (WILBER &amp; SHIAN, 2012)</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Noninvasive flow studies (Doppler ultrasound; compression ultrasonography duplex venous ultrasound):</emphasis> Detect and measure blood flow.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ultrasound imagery can reveal a thrombus in a deep vein, especially above the knee. The Doppler ultrasound measures the blood flow velocity in veins and can detect flow abnormalities. <emphasis>Note:</emphasis> In most circumstances, compression ultrasonography is the test of choice for patients with suspected DVT. When a blood clot is present in a vein, it is relatively difficult to collapse, making compression ultrasound a reliable indicator of DVT, especially in veins of the groin and thigh (Fogoros, 2016; Pai &amp; Douketis, 2016). Duplex venous ultrasonography appears to be the most accurate noninvasive method for diagnosing multiple proximal VTE in iliac, femoral, and popliteal veins but is less reliable in detecting isolated calf vein thrombi.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Contrast venography:</emphasis> A special x-ray of the veins that is performed by first injecting a radiopaque contrast into the vein in question and then taking a conventional x-ray.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Used to demonstrate a vein blockage. Radiographically confirms diagnosis through changes in blood flow and size of channels. <emphasis>Note:</emphasis> Although considered the gold standard for diagnosing DVT, this study carries a risk of inducing VTE and therefore is reserved for the client with negative or difficult to interpret noninvasive studies.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">CT scan with or without contrast:</emphasis> A series of x-ray images taken from different angles using computer processing to create cross-sectional images of body.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Contrast-enhanced CT scanning is increasingly used as the initial radiologic study in the diagnosis of PE, especially in patient with abnormal chest x-ray.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Computed tomography angiography (CTA):</emphasis> Uses an injection of iodine-rich contrast material and CT scanning to help diagnose and evaluate blood vessel disease or blockages.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Considered by the American College of Radiology to be standard of care for detection of PE.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Ventilation-perfusion (V/Q) scanning:</emphasis> Imaging test that uses special x-ray scanners to create pictures of air and blood flow patterns in the lungs.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used to establish PE when CT scanning not available or contraindicated.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnetic resonance imaging (MRI):</emphasis> Technique that uses the properties of magnetic fields to provide images of the body.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be done for diagnosis of both proximal and distal VTE and is believed to be superior to other diagnostic tests for detection of pelvic VTE or suspected VTE of the inferior vena cava or pelvic veins. MRI is highly sensitive for detection of central, lobar, or segmental PE.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0002s0067"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain or enhance tissue perfusion and facilitate resolution of thrombus.</para></listitem>
<listitem><para>Maintain adequate oxygenation.</para></listitem>
<listitem><para>Promote optimal comfort.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment regimen.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0002s0068"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Tissue perfusion improved in affected limb.</para></listitem>
<listitem><para>Pain or discomfort relieved.</para></listitem>
<listitem><para>Absence of symptoms of respiratory distress.</para></listitem>
<listitem><para>Complications prevented or resolved.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic needs understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0002s0064note0103"><title><emphasis role="strong">NURSING DIAGNOSIS: ineffective peripheral tissue Perfusion</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Deficient knowledge of disease process or aggravating factors (e.g., sedentary lifestyle/immobility, trauma, smoking, obesity)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Edema, extremity pain</para>
<para>Diminished pulses, capillary refill &gt;3 seconds</para>
<para>Alteration in skin characteristics (e.g., color, temperature, sensation)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Tissue Perfusion: Peripheral</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate improved perfusion as evidenced by peripheral pulses present, equal skin color, and temperature normal and absence of edema.</para>
<para>Engage in behaviors or actions to enhance tissue perfusion (e.g., engage in regular exercise, cessation of smoking, disease management).</para>
<para>Display increasing tolerance to activity.</para>
</note>
<note role="none" id="ch0002s0064note0104"><table frame="top" id="ch0002s0064ta0060"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Embolus Care: Peripheral</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Inspect legs from groin to foot for skin color and temperature changes as well as edema. Note symmetry of calves; measure and record calf circumference. Report proximal progression of inflammatory process and traveling pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Symptoms help distinguish between thrombophlebitis and VTE. Redness, heat, tenderness, and localized edema are characteristic of superficial involvement. Calf vein involvement is associated with the absence of edema; femoral vein involvement is associated with mild to moderate edema, and iliofemoral vein thrombosis is characterized by severe edema. <emphasis>Note:</emphasis> Unilateral edema is one of the most reliable physical findings in DVT.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Examine extremity for obviously prominent veins. Palpate gently for local tissue tension, stretched skin, and knots or bumps along the course of the vein.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Distention of superficial veins can occur in DVT because of backflow through communicating veins. Thrombophlebitis in superficial veins may be visible or palpable.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate client for Homans&rsquo; sign (pain in the calf of the leg upon dorsiflexion of the foot with the leg extended) per protocol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Homans&rsquo; sign is easily applied at point of care and is an assessment that clinicians often perform. However, its use is considered unreliable because Homans&rsquo; sign is absent in many clients with VTE and can be positive in several other conditions beside DVT. A negative Homans&rsquo; sign, on the other hand, doesn&rsquo;t automatically exclude DVT (Patel et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Promote early ambulation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Short, frequent walks are better for extremities and prevention of pulmonary complications than one long walk. If client is confined to bed, engage in range-of-motion exercises.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Elevate legs when in bed or chair, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces tissue swelling and rapidly empties superficial and tibial veins, preventing overdistention and thereby increasing venous return. <emphasis>Note:</emphasis> Some physicians believe that elevation may potentiate release of thrombus, thus increasing risk of embolization and decreasing circulation to the most distal portion of the extremity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Initiate active or passive exercises while in bed or chair; for example, flex, extend, and rotate feet periodically. Assist with ambulation as needed as soon as client is out of bed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These measures are designed to increase venous return from lower extremities and reduce venous stasis as well as improve general muscle tone and strength.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Caution client to avoid crossing legs or hyperflexion at knee, such as seated position with legs dangling or lying in jackknife position.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Physical restriction of circulation impairs blood flow and increases venous stasis in pelvic, popliteal, and leg vessels, thus increasing swelling and discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client to avoid rubbing or massaging the affected extremity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This activity potentiates risk of fragmenting and dislodging thrombus, causing embolization and increasing risk of complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage deep-breathing exercises.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases negative pressure in thorax, which assists in emptying large veins.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Increase fluid intake to at least 1500 to 2000 mL/d, within cardiac tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dehydration increases blood viscosity and venous stasis, predisposing to thrombus formation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer pharmacological measures, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pharmacological measures involve various types of anticoagulation to reduce blood coagulability.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Heparin sodium via continuous or intermittent IV and intermittent subcutaneous (SC) injections</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Heparin prevents extension of the thrombus by preventing the conversion of prothrombin to prothrombin at low doses and preventing the conversion of fibrinogen to fibrin in higher does. It has been shown to significantly reduce (but may not eliminate) the incidence of fatal and nonfatal pulmonary embolism and recurrent thrombosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low-molecular-weight heparin (LMWH) preparations, such as enoxaparin (Lovenox), dalteparin (Fragmin), tinzaparin (Innohep), and fondaparinux (Arixtra) via SC injections</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The efficacy and safety of LMWH for the initial treatment of deep venous thrombosis have been well established in several trials. May be used as &ldquo;bridging&rdquo; drugs while client starts oral anticoagulant therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oral anticlotting agents; vitamin K antagonists, e.g., warfarin (Coumadin, Jantoven)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Coumadin has a potent depressant effect on liver formation of prothrombin from vitamin K and impairs formation of factors VII, IX, and X (extrinsic pathway). Coumadin is generally used for long-term postdischarge therapy to keep international normalized ratio (INR) at 2 to 3. However, it does have a narrow therapeutic window and requires frequent monitoring. Many foods, drugs, and disease processes alter Coumadin&rsquo;s effectiveness, sometimes making it difficult to regulate.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Factor Xa inhibitors, e.g., rivaroxaban (Xarelto), apixaban (Eliquis), and fondaparinux (Arixtra)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs have been approved for treating DVT and PE and for prevention of recurrences. Benefits of these agents include no need for heparin bridging, and drugs can be given in fixed doses without routine coagulation monitoring. <emphasis>Note:</emphasis> Fondaparinux is administered SC, whereas other drugs listed here are given orally (&ldquo;Antiarrhythmic Agents,&rdquo; 2017; Patel et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Direct thrombin inhibitors, e.g., dabigatran (Pradaxa) and bivalirudin (Angiomax)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inhibits free and clot-bound thrombin and thrombin-induced platelet aggregation. Used in both treatment and prevention of VTE (Patel et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Thrombolytic agents, such as tenecteplase (TNKase), activase (Alteplase), and reteplase (Retavase)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used in hemodynamically unstable client with PE or massive VTE. <emphasis>Note:</emphasis> Currently accepted indications for thrombolytic therapy include hemodynamic instability (systolic BP &lt;90 mm Hg) or a clinical risk factor assessment that suggests that hypotension is likely to develop (Ouellette et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Platelet counts (if on heparin); prothrombin time (PT), partial thromboplastin time (PTT), activated prothrombin time (aPTT), international normalized ratio (INR) (if on warfarin), hemoglobin/hematocrit (Hgb/Hct), as indicated</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitors response to therapy, identifies presence of risk factors, such as hemoconcentration and dehydration, which potentiate clot formation. <emphasis>Note:</emphasis> Xa factor and thrombin inhibitors do not require serial monitoring because PT and aPTT are not affected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Apply and regulate graduated compression stockings and intermittent pneumatic compression if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sequential compression devices may be used to improve blood flow velocity and empty vessels by providing artificial muscle-pumping action.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Apply elastic support hose following acute phase. Take care to avoid tourniquet effect.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Properly fitted support hose are useful, once ambulation has begun, to minimize risk of postphlebotic syndrome. They must exert a sustained, evenly distributed pressure over entire surface of calves and thighs to reduce the caliber of superficial veins and increase blood flow to deep veins.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for and assist with procedures, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Surgical intervention, such as thrombectomy and vena cava screen, when indicated</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Thrombectomy (excision of thrombus) may be done in very rare cases when condition does not respond to typical treatments or circulation is severely restricted. Multiple or recurrent thrombotic episodes unresponsive to medical treatment (or when anticoagulant therapy is contraindicated) may require insertion of a vena cava filter (Siskin &amp; Kwan, 2015).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0064note0105"><title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Biological injury agent (e.g., ischemia)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports of pain (e.g., extremity or chest); evidence of pain using standard pain behavior checklist</para>
<para>Changes in physiological parameters (e.g., blood pressure, heart/respiratory rate, oxygen saturation)</para>
<para>Guarding/protective behavior</para>
<para>Expressive behaviors&mdash;restlessness, moaning</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report that pain or discomfort is alleviated or controlled.</para>
<para>Verbalize methods that provide relief.</para>
<para>Display relaxed manner; can sleep or rest and engage in desired activity.</para>
</note>
<note role="none" id="ch0002s0064note0106"><table frame="top" id="ch0002s0064ta0061"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess degree and characteristics of discomfort and pain, using standardized pain checklist.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Degree of pain is directly related to extent of circulatory deficit, inflammatory process, degree of tissue ischemia, and extent of edema associated with thrombus development. Changes in characteristics of pain may indicate development of complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain bedrest (if indicated) during acute phase.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Studies suggest that individuals with DVT or PE who are receiving appropriate anticoagulant therapy do better (both immediately and later on) with early ambulation (Pai &amp; Douketis, 2016; Thompson &amp; Kabrhel, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate affected extremity above heart level, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be done to reduce symptoms such as swelling and pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs, noting elevated temperature.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevations in heart rate may indicate increased discomfort or may occur in response to fever and inflammatory process. Fever can also increase client&rsquo;s discomfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of sudden or sharp chest pain, accompanied by dyspnea, tachycardia, and apprehension.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These signs and symptoms suggest the presence of PE as a complication of VTE.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated; for example, analgesics (opioid and nonopioid).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Relieves pain and decreases muscle tension. <emphasis>Note:</emphasis> NSAIDs should not be used when patient is on anticoagulants because of increased risk of bleeding.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0064note0107"><title><emphasis role="strong">NURSING DIAGNOSIS: impaired Gas Exchange (in presence of Pulmonary Embolus)</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Ventilation-perfusion imbalance [altered blood flow to portions of the lung]</para>
<para>Alveolar-capillary membrane changes</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Abnormal breathing pattern (e.g., rate, rhythm, depth)</para>
<para>Restlessness, irritability, somnolence</para>
<para>Abnormal arterial blood gases, hypoxemia, hypercapnia</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Gas Exchange</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate adequate ventilation and oxygenation by ABGs within client&rsquo;s normal range.</para>
<para>Report or display resolution or absence of symptoms of respiratory distress.</para>
</note>
<note role="none" id="ch0002s0064note0108"><table frame="top" id="ch0002s0064ta0062"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Embolus Care: Pulmonary</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note respiratory rate and depth and work of breathing, such as use of accessory muscles or nasal flaring and pursedlip breathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachypnea and dyspnea accompany pulmonary obstruction. Dyspnea and increased work of breathing may be first or only sign of subacute PE. Severe respiratory distress and failure accompany moderate to severe loss of functional lung units.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate lungs for areas of decreased and absent breath sounds and the presence of adventitious sounds, such as crackles or wheezing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nonventilated areas may be identified by the absence of breath sounds. Crackles occur in fluid-filled tissues and airways or may reflect cardiac decompensation. Wheezing can occur because of airway restriction. <emphasis>Note:</emphasis> A PE is a lung injury and results in postacute reactive airways that resemble asthma and may require long-term medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for generalized duskiness and cyanosis in &ldquo;warm tissues,&rdquo; such as earlobes, lips, tongue, and buccal membranes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicative of systemic hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs. Note changes in cardiac rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia, tachypnea, and changes in BP are associated with advancing hypoxemia and acidosis. Rhythm alterations and extra heart sounds may reflect increased cardiac workload related to worsening ventilation imbalance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess level of consciousness and evaluate mentation changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Systemic hypoxemia may be demonstrated initially by restlessness and irritability, then by progressively decreased mentation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess activity tolerance, such as reports of weakness and fatigue, vital sign changes, or increased dyspnea during exertion. Encourage rest periods, and limit activities to client tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These parameters assist in determining client response to resumed activities and ability to participate in self-care.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Institute measures to restore or maintain patent airways, such as deep-breathing exercises, coughing, and suctioning.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Plugged or collapsed airways reduce number of functional alveoli, negatively affecting gas exchange.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Elevate head of bed as client tolerates.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes maximal chest expansion, making it easier to breathe and enhancing physiological and psychological comfort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with frequent changes of position, and get client out of bed to ambulate as tolerated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Turning and ambulation enhance aeration of different lung segments, thereby improving oxygen diffusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist client to deal with fear and anxiety that may be present:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Feelings of fear and severe anxiety are associated with difficulty breathing and may cause increased oxygen consumption.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage expression of feelings and inform client and SOs of normalcy of anxious feelings and sense of impending doom.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding basis of feelings may help client regain some sense of control over emotions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide brief explanations of what is happening and expected effects of interventions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May allay anxiety related to unknown and help reduce fears concerning personal safety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor frequently, and arrange for someone to stay with client, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides assurance that changes in condition will be noted and that assistance is readily available.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Embolus Care: Pulmonary</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for CT or VQ lung scan.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reveals pattern of abnormal perfusion in areas of ventilation, reflecting ventilation and perfusion mismatch, confirming diagnosis of PE and degree of obstruction. Absence of both ventilation and perfusion reflects alveolar congestion or airway obstruction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor constant pulse oximetry and/or serial ABGs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypoxemia may be (but is not always) present, depending on the amount of airway obstruction, usual cardiopulmonary function, and presence and degree of shock. Respiratory alkalosis and metabolic acidosis may also be present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Airway Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer supplemental oxygen by appropriate method, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes available oxygen for gas exchange, reducing work of breathing. When pulse oximeter shows O<subscript>2</subscript> saturation 89% or higher, it is not likely that oxygen will help/is needed. <emphasis>Note:</emphasis> If obstruction is large or hypoxemia does not respond to supplemental oxygenation, it may be necessary to move client to critical care area for intubation and mechanical ventilation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer fluids, IV or by mouth (PO), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased fluids may be given to reduce hyperviscosity of blood, which can potentiate thrombus formation, or to support circulating volume and tissue perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Thrombolytic agents, such as alteplase (Activase, t-PA), reteplase (Retavase), and tenecteplase (TNKase)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicated in massive pulmonary obstruction when client is seriously hemodynamically threatened. <emphasis>Note:</emphasis> These clients will probably be initially cared for in, or transferred to, the critical care setting.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Morphine sulfate and antianxiety agents</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be necessary initially to control pain or anxiety and improve work of breathing, maximizing gas exchange.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide supplemental humidification, such as ultrasonic nebulizers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Delivers moisture to mucous membranes and helps liquefy secretions to facilitate airway clearance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with respiratory therapy, such as incentive spirometer.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates deeper respiratory effort.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for surgical intervention, if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Vena caval ligation or insertion of an intracaval umbrella may be useful for clients who experience recurrent emboli despite adequate anticoagulation, when anticoagulation is contraindicated, or when septic emboli arising from below the renal veins do not respond to treatment. Additionally, pulmonary embolectomy may be considered in life-threatening situations.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0064note0109"><title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge [Learning Need] regarding condition, treatment program, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information or insufficient interest in learning</para><para>Insufficient knowledge of resources</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports the problem</para>
<para>Inaccurate follow-through of instructions</para>
<para>Development or preventable complications</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para><para><emphasis role="strong">Knowledge: Thrombus Threat Reduction</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process, treatment regimen, and limitations.</para>
<para>Participate in learning process.</para>
<para>Identify signs and symptoms requiring medical evaluation.</para>
<para>Correctly perform therapeutic actions and explain reasons for actions.</para></note>
<note role="none" id="ch0002s0064note0110"><table frame="top" id="ch0002s0064ta0063"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain client&rsquo;s/SO&rsquo;s level of knowledge about condition and ability, readiness, or barriers to learning. Note personal factors (e.g., age, functional and developmental level) that may impact ability to understand condition and treatment regimen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individual may not be physically, emotionally, or mentally capable of learning early in disease process. Information may be presented in small units over time, relayed to family members, and repeated/reinforced.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review pathophysiology of condition and signs and symptoms of possible complications, such as PE, chronic venous insufficiency, and venous stasis ulcers (postphlebotic syndrome).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides a knowledge base from which client can make informed choices and understand and identify healthcare needs. A significant number of clients experience a recurrence of DVT. <emphasis>Note:</emphasis> Genetic blood testing may help identify inherited thrombotic disorders. Screening tests should be done when venous thrombosis occurs in those aged 45 years or younger; when a thrombus occurs at an unusual location such as in gastrointestinal tract, brain, or arm; and when there is an immediate family history of VTE.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain purpose of activity restrictions (if any) and need for balance between activity and rest.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rest reduces oxygen and nutrient needs of compromised tissues. Balancing rest with activity prevents exhaustion and further impairment of cellular perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish appropriate exercise and activity program.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in developing collateral circulation, enhances venous return, and reduces risk of recurrence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Problem-solve solutions to predisposing factors that may be present, such as employment that requires prolonged standing or sitting, wearing restrictive clothing, use of oral contraceptives, obesity, prolonged immobility, and dehydration.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Actively involves client in identifying and initiating lifestyle and behavior changes to promote health and prevent recurrence of condition or development of complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review position recommendations, such as sitting with feet touching the floor, avoiding crossing of legs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents excess pressure on the popliteal space and enhances venous return.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review purpose and demonstrate correct application and removal of antiembolic hose.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding may enhance cooperation with prescribed therapy and prevent improper or ineffective use.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct in meticulous skin care of lower extremities, such as prevent or promptly treat breaks in skin and report development of ulcers or changes in skin color.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chronic venous congestion and postphlebotic syndrome may develop, especially in the presence of severe vascular involvement and recurrent VTE, potentiating risk of stasis ulcers.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Prescribed Medication</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss purpose and dosage of anticoagulant. Emphasize importance of taking drug as prescribed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes client safety by reducing risk of inadequate therapeutic response and deleterious side effects, such as bleeding.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify safety precautions, such as use of soft toothbrush, electric razor for shaving, gloves for gardening, avoiding sharp objects (including toothpicks), walking barefoot, engaging in rough sports and activities, or forceful blowing of nose.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces the risk of traumatic injury, which potentiates bleeding or clot formation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review client&rsquo;s usual medications and foods (when on warfarin); emphasize need to read ingredient labels of over-the-counter (OTC) drugs and herbal supplements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Warfarin (Coumadin) interacts with many foods, drugs, and herbals, either increasing or decreasing the anticoagulant effect. All anticoagulant medications require stopping the use of aspirin/other NSAIDs. Client needing pain management should know that even use of acetaminophen may prolong clotting times; alternate treatments may be required. Also, use of herbal products, such as ginkgo, garlic, and vitamin E, impairs clotting and should be avoided during anticoagulant therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Remind client to discuss anticoagulant use with all healthcare providers (including dentists) before starting new medications and when changing medications.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Medications should be periodically reviewed for potential interactions, adverse effects, and side effects.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify untoward anticoagulant effects requiring medical attention, such as bleeding from mucous membranes (nose, gums), continued oozing from cuts and punctures, severe bruising after minimal trauma, and development of petechiae.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection of deleterious effects of therapy, such as prolongation of clotting time, allows for timely intervention and may prevent serious complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of medical follow-up and laboratory testing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding that close supervision of warfarin therapy is necessary (therapeutic dosage range is narrow and complications may prove fatal) promotes client participation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Encourage wearing of medical ID bracelet or necklace, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Alerts emergency healthcare providers to history of thrombotic problems or current use of or need for anticoagulants, such as prophylactic before and after any procedure or event with an increased risk of venous thromboembolism.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0002s0064note0111"><para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following discharge from care setting (dependent on client&rsquo;s age, physical condition, and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;perceived seriousness/benefit</para></listitem>
<listitem><para><emphasis role="bi">risk for Bleeding</emphasis>&mdash;treatment regimen</para></listitem></itemizedlist></note>
</sect2></sect1></chapter>